EOS Med Chem Impurity Stock 20201029-23

   

EOS Med Chem is serving more than 100 Pharma companies, we have the original Drug Discovery Compounds, Like Impurity, small molecule and inhibitor.

Impurity we keep stock more than 80000, most in stock, we are World Sole Original Supplier, Each impurity we could supply: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA.

EOS Med Chem Quotation include: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, COA, MSDS.

Welcome to visit: our youtube:  https://youtu.be/r5cJdXKNXHk 

Contact:

EOS Med Chem, Medicinal Chemical is Big

執大象，天下往，往而無害，安平泰

Ms Nina

Youtube: https://youtu.be/r5cJdXKNXHk 

E: info@eosmedchem.com 

W: www.eosmedchem.com 

Tel: 0086-531-69905422

SALE OFFICE: 16F, China Overseas Plaza, Jinan City, China

Mono-tert-butyl Malonate-(N-Boc)-L-lysine, CAS: /, stock: 5.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₄N₂O₇.

Mono-tert-butyl Malonate-N-succinimide, CAS: /, stock: 8.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₆.

Monobenzyl Malonate, CAS: 40204-26-0, stock: 2.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₄.

Monoethyl Potassium Malonate, CAS: 6148-64-7, stock: 1.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇KO₄.

Mouse Aldh6a1 (Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial) ELISA Kit (96T), CAS: /, stock: 1.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

N-[1,1-Bis[(acetyloxy)methyl]-3-(4-octylphenyl)propyl]acetamide, CAS: 162358-09-0, stock: 3.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₉NO₅.

PF-06651600, CAS: /, stock: 2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉N₅O•C₃H₄O₄.

Phenylmalonic Acid Mono-5-indanyl Ester, CAS: 27932-00-9, stock: 10g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆O₄.

Phyllocactin, CAS: 15167-85-8, stock: 6.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₈N₂O₁₆.

rac-Fenoxaprop P-Ethyl-2-ethylformate, CAS: 154879-59-1, stock: 2.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀ClNO₇.

Rat Aldh6a1 (Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial) ELISA Kit (96T), CAS: /, stock: 6.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

sec-Butylethyl-d5-malonic Acid Diethyl Ester, CAS: /, stock: 4.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉D₅O₄.

sec-Butylmalonic Acid Diethyl Ester, CAS: 83-27-2, stock: 1.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀O₄.

SK-216, CAS: 654080-03-2, stock: 7.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₉NNa₂O₆.

tert-Butyl Ethyl Malonate, CAS: 32864-38-3, stock: 1.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆O₄.

tert-Butyl Methyl Malonate, CAS: 42726-73-8, stock: 1.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄O₄.

Tetrahydro-α-(1-naphthalenylmethyl)-2-furanpropanoic Acid Ethyl Ester, CAS: 35997-58-1, stock: 4.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄O₃.

Triethyl Methanetricarboxylate, CAS: 6279-86-3, stock: 6.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆O₆.

Zicronapine Fumarate, CAS: 170381-17-6, stock: 8.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₁ClN₂O₄.

4,6’-O-(tert-Butyldimethylsilyl)mycophenolic Acid Acyl-β-D-glucoside, CAS: /, stock: 10g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₅₈O₁₁Si₂.

Methyl 6-[Methyl-β-D-glucuronato]mycophenolate, CAS: /, stock: 9.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₂O₁₂.

Mycophenolic Acid Methyl Ester 6-(Tri-O-acetyl-β-D-glucuronic Acid Methyl Ester), CAS: 39938-00-6, stock: 2.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₈O₁₅.

Mycophenolic Acid Methyl Ester-d6 6-(Tri-O-acetyl-β-D-glucuronic Acid Methyl Ester), CAS: /, stock: 1.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₂D₆O₁₅.

2-Chloro-3-hydroxymupirocin, CAS: /, stock: 4.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₅ClO₉.

2H,5H-Pyrano[4,3-b]pyranyl Mupirocin Methyl Ester, CAS: /, stock: 7.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O₉.

2H,5H-Pyrano[4,3-b]pyranyl Mupirocin Sodium Impurity, CAS: 116182-44-6, stock: 7.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₃NaO₉.

3-Chloro-2-hydroxymupirocin, CAS: /, stock: 7.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₅ClO₉.

4H-Furo[2,3-c]pyranyl Mupirocin Sodium Impurity, CAS: 116182-43-5, stock: 7.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₃NaO₉.

4H-Furo[3,2-c]pyranyl Mupirocin Methyl Ester, CAS: /, stock: 8.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O₉.

Dihydro Mupirocin, CAS: 1246812-11-2, stock: 8.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₆O₉.

1-Acetyl-2-imidazolidinone, CAS: 5391-39-9, stock: 5.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈N₂O₂.

4-Hydroxy Moxonidine, CAS: 352457-34-2, stock: 9.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃N₅O₂.

4-Methoxy Moxonidine, CAS: 75439-01-9, stock: 4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅N₅O₂.

4-Methoxy Moxonidine-d4, CAS: /, stock: 9.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁D₄N₅O₂.

6-O-Desmethyl Moxonidine, CAS: 352457-33-1, stock: 8.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀ClN₅O.

Dihydroxy Moxonidine, CAS: 352457-32-0, stock: 5.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁N₅O₂.

Moxonidine, CAS: 75438-57-2, stock: 8.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂ClN₅O.

Moxonidine-13C,d3, CAS: /, stock: 8.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³CH₉D₃ClN₅O.

Moxonidine-d4, CAS: 1794811-52-1, stock: 5.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈D₄ClN₅O.

(1R,6S)-2,8-Diazabicyclo[4.3.0]nonane, CAS: 169533-56-6, stock: 9.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄N₂.

(1R,6S)-trans-Moxifloxacin, CAS: 855661-74-4, stock: 3.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₄FN₃O₄.

(1S,6R)-2,8-Diazabicyclo[4.3.0]nonane, CAS: 169533-55-5, stock: 1.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄N₂.

(1S,6R)-trans-Moxifloxacin, CAS: 855661-71-1, stock: 4.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₄FN₃O₄.

(4aR,7aR)-Octahydro-​1-​methyl-1H-pyrrolo[3,4-b]pyridine Hydrochloride, CAS: /, stock: 1.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₇ClN₂.

(S,S)-2,8-Diazabicyclo[4.3.0]nonane, CAS: 151213-40-0, stock: 2.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄N₂.

(T-4)-Bis(acetato-κO)[1-cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-7-4-(oxo-κO)-3-quinolinecarboxylato-κO3]boron-13C,D3, CAS: /, stock: 2.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇¹³CH₁₃D₃B₃F₂NO₈.

(T-4)-Bis(acetato-κO)[1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-(oxo-κO)-3-quinolinecarboxylato-κO3]boron-13C,D3, CAS: /, stock: 6.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄¹³CH₂₆D₃B₃FN₃O₈.

1-​Cyclopropyl-​6,​7-​difluoro-​1,​4-​dihydro-​8-​methoxy-​4-​oxo-3-​quinolinecarboxylic Acid Methyl Ester-13C2,d6, CAS: /, stock: 9.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃¹³C₂H₇D₆F₂NO₄.

1-Cyclopropyl-3-(((difluoroboryl)oxy)carbonyl)-6-fluoro-8-methoxy-7-((4-methoxybenzyl)amino)quinolin-4(1H)-one, CAS: /, stock: 1.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₀BF₃N₂O₅.

1-Cyclopropyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid, CAS: 94695-52-0, stock: 8.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈F₃NO₃.

1-Cyclopropyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid Ethyl Ester, CAS: 94242-51-0, stock: 2.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂F₃NO₃.

1-Cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid, CAS: 93107-30-3, stock: 3.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉F₂NO₃.

1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-hydroxy-4-oxo-3-quinolinecarboxylic Acid, CAS: 154093-72-8, stock: 4.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉F₂NO₄.

1-Cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid, CAS: 112811-72-0, stock: 2.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁F₂NO₄.

1-Cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid-13C,d3, CAS: /, stock: 6.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃¹³CH₈D₃F₂NO₄.

1-Cyclopropyl-6-fluoro-8-methoxy-7-((4-methoxybenzyl)amino)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid, CAS: /, stock: 2.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₁FN₂O₅.

1-Cyclopropyl-7,8-difluoro-6-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid, CAS: 1641561-55-8, stock: 4.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁F₂NO₄.

1-Cyclopropyl-7-8-difluoro-6-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid Ethyl Ester, CAS: 1329836-33-0, stock: 4.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅F₂NO₄.

1-Cyclopropyl-7-fluoro-6,8-dimethoxy-4-quinolone-3-carboxylic Acid, CAS: /, stock: 3.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄FNO₅.

1-Cyclopropyl-7-fluoro-6,8-dimethoxy-4-quinolone-3-carboxylic Acid Ethyl Ester, CAS: /, stock: 7.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈FNO₅.

1-Cyclopropyl-8-ethoxy-6,7-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid, CAS: 143158-55-8, stock: 5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃F₂NO₄.

1-Cyclopropyl-8-ethoxy-6,7-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid Ethyl Ester, CAS: 172602-83-4, stock: 7.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇F₂NO₄.

1-Cyclopropyl-8-ethoxy-6,7-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid Ethyl Ester-d5, CAS: /, stock: 2.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₂D₅F₂NO₄.

1-Cyclopropyl-8-ethoxy-6,7-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid-d5, CAS: /, stock: 6.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₈D₅F₂NO₄.

6,8-Dimethoxy Moxifloxacin Hydrochloride, CAS: /, stock: 3.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₇N₃O₅•xHCl.

7-Amino-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic Acid, CAS: 172426-88-9, stock: 4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃FN₂O₄.

8-Desmethoxy-8-fluoro Moxifloxacin, CAS: 151213-15-9, stock: 9.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁F₂N₃O₃.

8-Desmethoxy-8-hydroxy Moxifloxacin N-Allyloxycarbonate, CAS: /, stock: 6.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₀FN₃O₆.

8-Ethoxy Moxifloxacin Hydrochloride, CAS: /, stock: 9.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₇ClFN₃O₄.

8-Fluoro-6-methoxy Moxifloxacin Dihydrochloride, CAS: /, stock: 4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆Cl₂FN₃O₄.

8-Hydroxy Moxifloxacin Hydrobromide, CAS: 1292904-74-5, stock: 8.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂FN₃O₄ • (HBr).

8-Hydroxy Moxifloxacin Hydrochloride Salt, CAS: /, stock: 5.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂FN₃O₄ • (HCl).

cis-Octahydropyrrolo[3,4-b]pyridine, CAS: 147459-51-6, stock: 2.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄N₂.

Decarboxy Moxifloxacin, CAS: 1322062-57-6, stock: 3.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄FN₃O₂.

ent-Moxifloxacin Hydrochloride, CAS: 1346603-25-5, stock: 3.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅ClFN₃O₄.

ent-Moxifloxacin N-(3-Propanoic Acid) Hydrochloride, CAS: /, stock: 8.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₈FN₃O₆.

Moxifloxacin Hydrochloride, CAS: 186826-86-8, stock: 5.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₄FN₃O₄  •HCl.

Moxifloxacin Hydrochloride Monohydrate, CAS: 192927-63-2, stock: 7.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇ClFN₃O₅.

Moxifloxacin Hydrochloride-13CD3, CAS: 1246816-75-0, stock: 9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀¹³CH₂₂D₃ClFN₃O₄.

Moxifloxacin Methyl Ester, CAS: 721970-35-0, stock: 6.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆FN₃O₄.

Moxifloxacin N-Sulfate Disodium Salt, CAS: /, stock: 5.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂FN₃Na₂O₇S.

Moxifloxacin-13C,D3 N-Allyloxycarbonate 3’-Ethyl Ester, CAS: /, stock: 2.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆¹³CH₂₉D₃FN₃O₆.

Moxifloxacin-13Cd3 N-Sulfate Disodium Salt, CAS: /, stock: 8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀¹³CH₁₉D₃FN₃Na₂O₇S.

N-Allyloxycarbonyl 8-Ethoxy Moxifloxacin Ethyl Ester, CAS: 1329840-03-0, stock: 8.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₄FN₃O₆.

N-Allyloxycarbonyl Moxifloxacin, CAS: 1391053-44-3, stock: 9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₈FN₃O₆.

N-Allyloxycarbonyl Moxifloxacin-d4, CAS: /, stock: 1.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₄D₄FN₃O₆.

N-Methyl Moxifloxacin Hydrochloride, CAS: 1350716-67-4, stock: 5.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₇ClFN₃O₄.

rac cis-Moxifloxacin Acyl-β-D-glucuronide, CAS: 733002-61-4, stock: 8.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₂FN₃O₁₀.

rac cis-Moxifloxacin-d4 Acyl-β-D-glucuronide, CAS: /, stock: 1.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₈D₄FN₃O₁₀.

rac cis-Moxifloxacin-d4 Hydrochloride (Major), CAS: 1217802-65-7, stock: 3.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁D₄ClFN₃O₄.

rac N-Allyloxycarbonyl cis-Moxifloxacin Acyl-β-D-glucuronide Allyl Ester, CAS: /, stock: 7.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₄₀FN₃O₁₂.

rel-syn-Octahydro-​6-​(phenylmethyl)​-1H-pyrrolo[3,4-b]pyridine, CAS: 161594-54-3, stock: 4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀N₂.

Tetrahydro-​6-​(phenylmethyl)​-1H-​pyrrolo[3,​4-​b]​pyridine-​5,​7(2H,​6H)​-​dione, CAS: 128740-13-6, stock: 7.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆N₂O₂.

trans-2,8-Diazabicyclo[4.3.0]nonane, CAS: 158060-81-2, stock: 1.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄N₂.

1,5-Dimethyl Citrate, CAS: 53798-96-2, stock: 7.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂O₇.

2-Aminomethyl-4-(4-fluorobenzyl)morpholine, CAS: 112914-13-3, stock: 4.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇FN₂O.

3-Aminomethyl-4-(4-fluorobenzyl)morpholine, CAS: 174561-70-7, stock: 9.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇FN₂O.

Mosapride citrate, CAS: 112885-42-4, stock: 2.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅ClFN₃O₃ •  C₆H₈O₇.

Mosapride Citric Amide Disodium Salt, CAS: /, stock: 7.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₉ClFN₃Na₂O₉.

Mosapride-d5 Citric Amide, CAS: 1329797-02-5, stock: 2.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₆D₅ClFN₃O₉.

(I2,3S)-23-des(methoxyimino)-23-[(methylsulfanyl)methoxy]moxidectin, CAS: /, stock: 6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₅₆O₈S.

14,15-Epoxy-25-des(dimethylbutenyl)-25-(1,3-dimethyl-2,3-epoxybutnyl) Moxidectin (>85%), CAS: /, stock: 8.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₃NO₁₀.

14,15-Epoxy-moxidectin (>85%), CAS: /, stock: 8.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₃NO₉.

2-epi-Moxidectin, CAS: /, stock: 3.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₃NO₈.

23-Keto Nemadectin (Desmethoxyamino Moxidectin), CAS: 112124-81-9, stock: 3.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₅₀O₈.

23-Keto O-Trimethylsilyl Nemadectin, CAS: 112125-06-1, stock: 7.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₆₄O₈Si.

25-Des(dimethylbutenyl) 25-(1,3-Dimethyl-2,3-epoxybutnyl) Moxidectin (>85%), CAS: /, stock: 1.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₃NO₉.

3,4-Epoxy-moxidectin, CAS: 1402163-94-3, stock: 7.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₃NO₉.

5-O-(4-nitrobenzoyl)moxidectin, CAS: /, stock: 8.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₅₆N₂O₁₁.

7-O-[(Methylsulfanyl)methyl]moxidectin, CAS: /, stock: 3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₅₇NO₈S.

8,9-Epoxy-moxidectin (>90%), CAS: /, stock: 3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₃NO₉.

Moxidectin, CAS: 113507-06-5, stock: 1.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₃NO₈.

Moxidectin-d3, CAS: /, stock: 7.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₀D₃NO₈.

Lithium Hydroxide, CAS: 1310-65-2, stock: 9.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  HLiO.

Lithium Hydroxide Monohydrate, CAS: 1310-66-3, stock: 3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  HLiO•H₂O.

O-Desmethyl Mebeverine Acid Methyl Ester O-β-D-Glucuronide Methyl Ester Triacetate, CAS: /, stock: 3.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₁NO₁₂.

O-Desmethyl Mebeverine Alcohol, CAS: 155172-67-1, stock: 8.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₅NO₂.

O-Desmethyl Mebeverine Alcohol-d5, CAS: /, stock: 9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀D₅NO₂.

(+)-DIP-chloride, CAS: 112246-73-8, stock: 1.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₄BCl.

(1-(Cyanomethyl)cyclopropyl)methyl Methanesulfonate, CAS: 152922-86-6, stock: 6.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₁NO₃S.

(3S)-3-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-4,5-dihydro-2-benzoxepin-1(3H)-one, CAS: 1100617-38-6, stock: 3.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₀ClNO₂.

(R,E)-2-(1-(((1-(3-(2-(7-Chloroquinolin-2-yl)vinyl)phenyl)-3-(2-(methoxy(methyl)carbamoyl)phenyl)propyl)thio)methyl)cyclopropyl)acetic Acid, CAS: /, stock: 6.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₅ClN₂O₄S.

(R,R)-Montelukast Bis-sulfide, CAS: 1187586-61-3, stock: 3.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₄₆ClNO₅S₂.

(R,S)-Montelukast Bis-sulfide, CAS: 1187586-58-8, stock: 9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₄₆ClNO₅S₂.

(S)-α-[3-[2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-4-methoxy-2-carboxylatebenzenepropanol Methyl Ester, CAS: /, stock: 1.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₆ClNO₄.

(S,E)-1-(3-(2-(7-Chloroquinolin-2-yl)vinyl)phenyl)-3-(2-(2-hydroxypropan-2-yl)phenyl)propyl-d6 Methanesulfonate, CAS: /, stock: 9.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₄D₆ClNO₄S.

(S,E)-2-(3-(1-((tert-Butyldimethylsilyl)oxy)-3-(2-(1-((tert-butyldimethylsilyl)oxy)vinyl)phenyl)propyl)styryl)-7-chloroquinoline, CAS: /, stock: 3.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₅₂ClNO₂Si₂.

1,1’-[Dithiobis(methylene)]biscyclopropaneacetic Acid, CAS: 162515-67-5, stock: 2.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈O₄S₂.

1,1’-[Dithiobis(methylene)]biscyclopropaneacetic Acid Methyl Ester, CAS: 1446481-28-2, stock: 3.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂O₄S₂.

1-((Benzyloxy)methyl)cyclopropanecarbaldehyde, CAS: 288401-39-8, stock: 5.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O₂.

1-(Mercaptomethyl)cyclopropaneacetic Acid, CAS: 162515-68-6, stock: 8.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀O₂S.

1-(Mercaptomethyl)cyclopropaneacetonitrile, CAS: 866923-64-0, stock: 4.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉NS.

1-[2-[(3S)-3-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-hydroxypropyl]phenyl]acetate, CAS: 184764-13-4, stock: 1.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₄ClNO₂.

1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]-1-propanone, CAS: 1258428-71-5, stock: 8.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₆ClNO₂.

1-[[[(1R)-1-[3-[(2S,R)-2-[[(1-Carboxycyclopropyl)methyl]thio]-2-(7-chloro-2-quinolinyl)ethyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methylcyclopropaneacetic Acid, CAS: /, stock: 8.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₄₆ClNO₅S₂.

2,2-Dimethoxy-d6 Montelukast, CAS: /, stock: 8.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₃₄D₆ClNO₃S.

2,2’-((Disulfanediylbis(methylene))bis(cyclopropane-1,1-diyl))bis(2-hydroxyacetic Acid) Diethyl Ester, CAS: /, stock: 7.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₆O₆S₂.

2-((E)-3-((1S)-1-((tert-Butyldimethylsilyl)oxy)-3-(2-(2-((tert-butyldimethylsilyl)oxy)oxiran-2-yl)phenyl)propyl)styryl)-7-chloroquinoline 1-Oxide, CAS: /, stock: 6.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₅₂ClNO₄Si₂.

2-Hydroxy-2-(1-(hydroxymethyl)cyclopropyl)acetamide Benzyl Ester, CAS: /, stock: 5.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₃.

2-Hydroxy-2-(1-(hydroxymethyl)cyclopropyl)acetic Acid Benzyl Ester, CAS: /, stock: 4.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆O₄.

2-Hydroxy-2-(1-(hydroxymethyl)cyclopropyl)acetonitrile Benzyl Ester, CAS: /, stock: 1.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅NO₂.

2-Hydroxy-2-(1-(mercaptomethyl)cyclopropyl)acetic Acid, CAS: /, stock: 6.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀O₃S.

2-Methoxymethyl Montelukast 1,2-Diol(Mixture of Diastereomers), CAS: 184764-27-0, stock: 6.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₀ClNO₅S.

2-[2-[(3S)-3-[3-[(1E)-2-(7-Chloroquinolin-2-yl)ethenyl]phenyl]-3-chloropropyl]phenyl]-2-propanol, CAS: 880769-28-8, stock: 8.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₇Cl₂NO.

2-[2-[(3S)-3-[3-[(E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[(methanesulfonyl)oxy]propyl]phenyl]-2-propanol, CAS: 807638-71-7, stock: 4.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₀ClNO₄S.

2-[3-(R)-[3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl]-3-hydroxypropyl]phenyl-2-propanol, CAS: 150026-75-8, stock: 9.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₈ClNO₂.

2-[3-(S)-[3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl]-3-hydroxypropyl]phenyl-2-(1’-hydroxy-2’-methoxymethyl)propanol (Mixture of Diastereomers), CAS: 184764-20-3, stock: 1.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₂ClNO₄.

2-[3-(S)-[3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl]-3-hydroxypropyl]phenyl-2-propanol, CAS: 287930-77-2, stock: 4.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₈ClNO₂.

21(R)-Hydroxy Montelukast, CAS: 184763-26-6, stock: 4.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₆ClNO₄S.

21(R)-Hydroxy Montelukast-d6, CAS: /, stock: 5.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₀D₆ClNO₄S.

21(S)-Hydroxy Montelukast, CAS: 184763-29-9, stock: 5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₆ClNO₄S.

21(S)-Hydroxy Montelukast-d6, CAS: /, stock: 7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₀D₆ClNO₄S.

25-Hydroxy Montelukast, CAS: 200804-28-0, stock: 7.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₆ClNO₄S.

2’-Des(1-hydroxy-1-methylethyl)-2’-carboxy Montelukast Bissodium Salt, CAS: /, stock: 4.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₈ClNNa₂O₄S.

5-(1-(Hydroxymethyl)cyclopropyl)-2,2-dimethyl-1,3-dioxolan-4-one, CAS: /, stock: 6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄O₄.

5-(1-(Hydroxymethyl)cyclopropyl)-2,2-dimethyl-1,3-dioxolan-4-one Benzyl Ester, CAS: /, stock: 8.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀O₄.

7-Chloroquinaldine, CAS: 4965-33-7, stock: 4.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈ClN.

cis-Montelukast, CAS: 774538-96-4, stock: 6.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₆ClNO₃S.

Des[3-[[(1-Carboxymethyl)cyclopropyl]methyl]thio]-2-propenyl Montelukast Mesylate, CAS: 1187586-82-8, stock: 9.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₀ClNO₄S.

Des[3-[[(1-Carboxymethyl)cyclopropyl]methyl]thio]-2-propenyl Montelukast-d6 Mesylate, CAS: /, stock: 5.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₄D₆ClNO₄S.

Dihydro Montelukast Sodium Salt, CAS: 142147-98-6, stock: 3.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₇ClNNaO₃S.

ent-Montelukast Sodium Salt, CAS: 190078-45-6, stock: 1.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₅ClNNaO₃S.

α-Hydroxy Montelukast, CAS: /, stock: 3.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₆ClNO₄S.

Methoxy Montelukast, CAS: 1351973-25-5, stock: 9.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₈ClNO₃S.

Methoxy Montelukast Methyl Ester, CAS: /, stock: 5.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₀ClNO₃S.

Methoxy-d3 Montelukast, CAS: /, stock: 7.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₅D₃ClNO₃S.

Methoxy-d3 Montelukast Methyl Ester-d3, CAS: /, stock: 1.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₃₄D₆ClNO₃S.

Montelukast 1,2-Diol(Mixture of Diastereomers), CAS: 186352-97-6, stock: 1.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₆ClNO₄S.

Montelukast Acyl-b-D-glucuronide, CAS: 188717-17-1, stock: 1.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₄₄ClNO₉S.

Montelukast Acyl-β-D-glucuronide, CAS: /, stock: 9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₄₂ClNO₉S.

Montelukast Acyl-β-D-glucuronide Acetic Acid Salt, CAS: /, stock: 3.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₄₈ClNO₁₁S.

Montelukast Acyl-β-D-glucuronide-d6, CAS: /, stock: 9.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₃₈D₆ClNO₉S.

Montelukast Bis-sulfide (mixture of diastereomers), CAS: 1242260-05-4, stock: 8.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₄₆ClNO₅S₂.

Montelukast Bisolefin Impurity, CAS: /, stock: 9.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₄ClNO₃S.

Montelukast cyclopropaneacetamide (Impurity), CAS: 866923-63-9, stock: 8.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₇ClN₂O₂S.

Montelukast Cyclopropaneacetamide-d6 (Impurity), CAS: /, stock: 5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₁D₆ClN₂O₂S.

Montelukast Cyclopropaneacetonitrile, CAS: 866923-62-8, stock: 1.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₅ClN₂OS.

Montelukast Cyclopropaneacetonitrile-d6, CAS: /, stock: 1.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₂₉D₆ClN₂OS.

Montelukast Dicarboxylic Acid(Mixture of Diastereomers), CAS: 213380-27-9, stock: 7.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₄ClNO₅S.

Montelukast Dicyclohexylamine Salt, CAS: 577953-88-9, stock: 1.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₅₉ClN₂O₃S.

Montelukast Ketocarbinol Impurity, CAS: /, stock: 1.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₂ClNO₄S.

Montelukast Methyl Ester, CAS: 855473-51-7, stock: 1.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₈ClNO₃S.

Montelukast Methyl Ester-d3, CAS: /, stock: 8.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₅D₃ClNO₃S.

Montelukast Methyl Ketone, CAS: 937275-23-5, stock: 8.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₂ClNO₃S.

Montelukast Sodium Salt, CAS: 151767-02-1, stock: 8.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₅ClNNaO₃S.

Montelukast Styrene, CAS: 918972-54-0, stock: 9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₄ClNO₂S.

Montelukast Sulfone, CAS: 1266620-74-9, stock: 5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₆ClNO₅S.

Montelukast Sulfoxide(Mixture of Diastereomers), CAS: 909849-96-3, stock: 2.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₆ClNO₄S.

Montelukast-d6, CAS: 1093746-29-2, stock: 5.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₀D₆ClNO₃S.

Montelukast-d6 Bis-sulfide (mixture of diastereomers), CAS: /, stock: 2.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₄₀D₆ClNO₅S₂.

Montelukast-d6 Sodium Salt, CAS: /, stock: 9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₂₉D₆ClNNaO₃S.

S-((1-(2,2-Dimethyl-5-oxo-1,3-dioxolan-4-yl)cyclopropyl)methyl) Ethanethioate, CAS: /, stock: 5.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆O₄S.

[1-[(Benzyloxy)methyl]cyclopropyl]methanol, CAS: 177200-76-9, stock: 4.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₂.

[1-[Bis(Benzyloxy)methyl]cyclopropyl]methanol, CAS: /, stock: 6.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂O₂.

(+)-trans-Jasmonic Acid, CAS: 126372-33-6, stock: 2.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈O₃.

(+)-Tuberonic Acid, CAS: 124649-26-9, stock: 6.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈O₄.

(-)-Jasmonic Acid Methyl Ester, CAS: 1211-29-6, stock: 9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀O₃.

(-)-trans Jasmonic Acid, CAS: 6894-38-8, stock: 3.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈O₃.

(±)-9,10-Dihydrojasmonic Acid, CAS: 3572-64-3, stock: 3.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀O₃.

(±)-Jasmonic Acid, CAS: 3572-66-5, stock: 3.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈O₃.

(±)-Jasmonic Acid Methyl Ester, CAS: 879490-89-8, stock: 9.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀O₃.

(±)-Jasmonic Acid-d2, CAS: 903510-50-9, stock: 5.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆D₂O₃.

(±)-Tuberonic Acid, CAS: 221682-86-6, stock: 8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈O₄.

(±)-Tuberonic Acid Methyl Ester, CAS: 81761-06-0, stock: 2.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀O₄.

(±)-Tuberonic Acid-d2, CAS: 903510-54-3, stock: 9.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆D₂O₄.

(E)-9-Oxononyl4-((2S,3R,4R,5S)-3,4-dihydroxy-5-((3-hydroxy-4,5-dimethyltetrahydrofuran-2-yl)methyl)tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoate(Mupirocin Impurity), CAS: /, stock: 2.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₄O₈.

(E)-Methyl 9-((tert-Butyldimethylsilyl)oxy)non-4-enoate, CAS: /, stock: 6.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₃₂O₃Si.

(E)-Methyl 9-Iodonon-4-enoate, CAS: /, stock: 9.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇IO₂.

1,5-Pentanediol, CAS: 111-29-5, stock: 1.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂O₂.

2-O-tert-Butyldimethylsilyl-6,7-O-(1-methylethylene)-monic Acid A Methyl Ester, CAS: 1314406-71-7, stock: 6.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₈O₇Si.

4,8-Anhydro-1,3,7-trideoxy-7-[[3-((1R,2S)-2-hydroxy-1-methylpropyl)oxiranyl]methyl]-5,6-O-(1-methylethylidene)-L-talo-2-octulose, CAS: /, stock: 3.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₀O₆.

4,8-Anhydro-1,3,7-trideoxy-7-[[3-((1R,2S)-2-tert-butyldimethylsilyloxy-1-methylpropyl)oxiranyl]methyl]-5,6-O-(1-methylethylidene)-L-talo-2-octulose, CAS: /, stock: 7.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₄O₆Si.

6,7-O-Isopropylidenepseudomonic Acid A, CAS: 85362-54-5, stock: 4.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₈O₉.

7-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-1-hepten-3-ol, CAS: 154672-42-1, stock: 8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₈O₂Si.

8-((tert-Butyldimethylsilyl)oxy)oct-1-en-4-yl Acetate, CAS: /, stock: 7.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₃₂O₃Si.

8-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-1-octen-4-ol, CAS: 339563-66-5, stock: 6.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₃₀O₂Si.

Allyl 6,7-O-Isopropylidenepseudomonic Acid A, CAS: /, stock: 5.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₅₂O₉.

Allyl 6,7-O-Isopropylidenepseudomonic Acid A-O-t-butyldimethylsilyl 6,7-O-Isopropylidenepseudomonic Acid A, CAS: /, stock: 2.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₇H₁₁₂O₁₇Si.

Antimony Tin Oxide, CAS: 12673-86-8, stock: 2.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  SnO₂/Sb₂O₅.

Betamethasone 9,11-Epoxide 21-Valerate, CAS: /, stock: 9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₆O₆.

Decyl [2E,8[2S,3S(1S,2S)]]-5,9-Anhydro-2,3,4,8-tetradeoxy-8-[[3-(2-hydroxy-1-methylpropyl)oxiranyl]methyl]-3-methyl-L-talo-Non-2-enonic Acid Ester, CAS: 153900-96-0, stock: 8.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₈O₇.

Hexafluoroantimonic acid hexahydrate, CAS: 72121-43-8, stock: 2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  F₅Sb.HF • 6(H₂O).

Jasmonic Acid, CAS: 221682-41-3, stock: 2.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈O₃.

Jasmonic Acid-d5 (Mixture of Diastereomers, (-)-trans major), CAS: /, stock: 9.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃D₅O₃.

Methyl 9-Hydroxynon-4-enoate, CAS: 87238-54-8, stock: 5.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈O₃.

Monic Acid A, CAS: 66262-68-8, stock: 9.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₈O₇.

Monic Acid A-d5 (d4 Major), CAS: /, stock: 9.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₃D₅O₇.

Mupirocin, CAS: 12650-69-0, stock: 7.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₄O₉.

Mupirocin III, CAS: /, stock: 9.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₈O₉.

Mupirocin Lithium, CAS: 73346-79-9, stock: 8.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₄LiO₉.

Mupirocin-d4, CAS: /, stock: 8.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₀D₄O₉.

N-[(-)-Jasmonoyl]-(L)-methionine, CAS: 221682-72-0, stock: 5.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₇NO₄S.

Potassium Hexahydroxyantimonate (KSb(OH)6), CAS: 12208-13-8, stock: 8.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  H₆KO₆Sb₅⁴⁻ •  K⁺.

Pseudomonic Acid B, CAS: 40980-51-6, stock: 4.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₄O₁₀.

Pseudomonic Acid C, CAS: 71980-98-8, stock: 7.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₄O₈.

Pseudomonic Acid D Sodium, CAS: 85178-60-5, stock: 4.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₁NaO₉.

Pseudomonic Acid F, CAS: 167842-64-0, stock: 1.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₀O₉.

rac 12-Oxophytodienoic Acid, CAS: 85551-10-6, stock: 9.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₈O₃.

rac 12-Oxophytodienoic Acid-d5, CAS: /, stock: 5.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₃D₅O₃.

rac-Jasmonic Acid-d6, CAS: 139435-19-1, stock: 1.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂D₆O₃.

rac-trans (Z)-Jasmonic Acid-d3, CAS: 914250-26-3, stock: 6.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅D₃O₃.

rac-trans Jasmonic Acid Methyl Ester, CAS: 20073-13-6, stock: 3.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀O₃.

rac-trans Jasmonic Acid-13C2, CAS: /, stock: 9.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀¹³C₂H₁₈O₃.

rac-trans Jasmonic Acid-13C2 Methyl Ester, CAS: /, stock: 2.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁¹³C₂H₂₀O₃.

rac-trans Jasmonic Acid-d3, CAS: 903510-51-0, stock: 8.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅D₃O₃.

Sodium Monate A, CAS: 66290-00-4, stock: 5.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₇NaO₇.

2-Amino-2-hydroxymethylpropionitrile, CAS: 122556-12-1, stock: 3.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈N₂O.

t-Butyldimethylsilyl 6,7-O-Isopropylidenepseudomonic Acid A, CAS: /, stock: 1.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₆₂O₉Si.

trans-Jasmonic Acid (1 g/ 10 mL Ethanol), CAS: 77026-92-7, stock: 9.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈O₃.

Trimethyl Orthoacetate, CAS: 1445-45-0, stock: 6.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂O₃.

[1(Z),2E,8[2S,3S(1S,2S)]]- 5,9-Anhydro-2,3,4,8-tetradeoxy-8-[[3-(2-hydroxy-1-methylpropyl)oxiranyl]methyl]-3-methyl-L-talo-Non-2-enonic Acid 9-Methoxy-9-oxo-5-nonenyl Ester, CAS: 89254-47-7, stock: 5.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₉.

[2S-[2α,3β(1R*,2R*)]]-4,8-Anhydro-1,3,7-trideoxy-5,6-bis-O-[(1,1-dimethylethyl)dimethylsilyl]-7-[[3-[2-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-1-methylpropyl]oxiranyl]methyl]-L-talo-2-octulose-d5, CAS: /, stock: 7.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₆₃D₅O₆Si₃.

[2S-[2α,3β(1R*,2R*)]]-4,8-Anhydro-1,3,7-trideoxy-7-[[3-(2-hydroxy-1-methylpropyl)oxiranyl]methyl]-L-talo-2-octulose, CAS: 66262-70-2, stock: 2.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₆O₆.

(4-Morpholinylimino)acetonitrile, CAS: 26179-71-5, stock: 8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉N₃O.

3-Morpholino Sydnonimine Hydrochloride, CAS: 16142-27-1, stock: 3.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁ClN₄O₂.

3-Morpholinosydnonimine-15N3 Hydrochloride, CAS: /, stock: 7.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁ClN¹⁵N₃ O₂.

Molsidomine, CAS: 25717-80-0, stock: 6.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄N₄O₄.

Molsidomine-15N3, CAS: /, stock: 8.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄N¹⁵N₃O₄.

Molsidomine-d5, CAS: /, stock: 8.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉D₅N₄O₄.

(S)-(+)-Modafinic Acid, CAS: 112111-44-1, stock: 3.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄O₃S.

(S)-Modafinil Carboxylate Methyl Ester, CAS: 865811-65-0, stock: 6.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆O₃S.

2-(Benz-d5-hydrylthio)acetamide, CAS: /, stock: 9.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀D₅NOS.

2-[(Diphenylmethyl)thio]acetic Acid, CAS: 63547-22-8, stock: 5.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄O₂S.

2-[(Diphenylmethyl)thio]acetic Acid-d10, CAS: 1216659-66-3, stock: 3.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₄D₁₀O₂S.

Adrafinil, CAS: 63547-13-7, stock: 6.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅NO₃S.

Benzhydrol, CAS: 91-01-0, stock: 9.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂O.

Benzhydrol-d10, CAS: 74563-01-2, stock: 6.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂D₁₀O.

Benzhydrol-d5, CAS: 95450-78-5, stock: 7.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₇D₅O.

Deoxy Modafinil, CAS: 68524-30-1, stock: 4.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅NOS.

Dibenzhydryl Disulfide, CAS: 1726-02-9, stock: 5.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₂S₂.

Modafinil, CAS: 68693-11-8, stock: 4.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅NO₂S.

Modafinil Carboxylate, CAS: 63547-24-0, stock: 1.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄O₃S.

Modafinil Sulfone, CAS: 118779-53-6, stock: 5.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅NO₃S.

(E)-2-Octenedioic Acid, CAS: 124791-62-4, stock: 1.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂O₄.

1R, 1’R-cis,cis-Mivacurium Chloride, CAS: 107740-65-8, stock: 7.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₈H₈₀N⁺₂O₁₄  •  2(Cl   ⁻).

1R, 1’R-trans,cis-Mivacurium Chloride, CAS: 107740-63-6, stock: 8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₈H₈₀N⁺₂O₁₄  •  2(Cl   ⁻).

1R, 1’R-trans,trans-Mivacurium Chloride, CAS: 104758-51-2, stock: 1.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₈H₈₀N⁺₂O₁₄  •  2(Cl   ⁻).

Mivacurium Chloride (mixture of isomers), CAS: 106861-44-3, stock: 9.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₈H₈₀Cl₂N₂O₁₄.

rac Mivacurium Chloride-13C4, CAS: /, stock: 9.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₄¹³C₄H₈₀Cl₂N₂O₁₄.

trans-1,2,3,4-Tetrahydro-2-(3-hydroxypropyl)-6,7-dimethoxy-2-(methyl-13C)-1-[(3,4,5-trimethoxyphenyl)methyl]isoquinolinium Chloride, CAS: /, stock: 7.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄¹³CH₃₆ClNO₆.

Morpholine-d8 Hydrochloride, CAS: 1107650-56-5, stock: 9.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂D₈ClNO.

N-2-(2,3-Didehydro)-moclobemide, CAS: /, stock: 8.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅ClN₂O₂.

N-2-(2,3-Didehydro)-moclobemide-d4, CAS: /, stock: 9.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁D₄ClN₂O₂.

(1R, 2R)-1,2-Bis(4-(benzoisothiazol-3-yl)piperazin-1-yl)methylcyclohexane, CAS: /, stock: 6.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₈N₆S₂.

(1R,2R)-2-(exo-2,3-Norbornanedicarbpximidylmethylcyclohexyl)methyl-4-benzoisothiazol-3-yl), CAS: /, stock: 4.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₆N₄O₄S.

(1R,2R)-2-[(4-Benzoisothiazol-3-yl)piperazin-1-yl-methylcyclohexyl)]methyl 4-benzoisothiazol-3-yl)piperazine-1-carboxylate, CAS: /, stock: 2.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₈N₆O₂S₂.

(R,R)-Cyclohex-4-ene-1,2-dicarboxylic Acid, CAS: 15573-40-7, stock: 9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀O₄.

3-(tert-Butoxy)benzo[d]isothiazole, CAS: /, stock: 7.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NOS.

6-​Chloro-​1,​3-​dihydro-​5-​[2-​(1-​piperazinyl)​ethyl]​-2H-​Indol-​2-​one, CAS: 188797-79-7, stock: 1.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈ClN₃O.

Cantharene, CAS: 4430-91-5, stock: 2.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂.

Cantharene-d6, CAS: /, stock: 6.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆D₆.

endo-cis-Lurasidone Hydrochloride, CAS: /, stock: 3.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₆N₄O₂S • (HCl).

endo-cis-Lurasidone-D8 Hydrochloride, CAS: /, stock: 9.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₈D₈N₄O₂S • (HCl).

ent-Lurasidone Hydrochloride, CAS: /, stock: 2.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₆N₄O₂S • (HCl).

ent-Lurasidone-D8 Hydrochloride, CAS: /, stock: 1.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₈D₈N₄O₂S • (HCl).

exo-cis-Lurasidone Hydrochloride, CAS: 139563-25-0, stock: 3.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₆N₄O₂S • (HCl).

exo-cis-Lurasidone-D8 Hydrochloride, CAS: /, stock: 3.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₈D₈N₄O₂S • (HCl).

N-[1R,2R-(2-Methylamino)cyclohex-1-yl)methyl]-N’-(1,2-benzisothiazol-3-yl)piperazine, CAS: 1260138-03-1, stock: 6.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₈N₄S.

N-[1R,2R-(2-Methylamino)cyclohex-1-yl)methyl]-N’-(1,2-benzisothiazol-3-yl)piperazine Dihydrochloride, CAS: 1260025-93-1, stock: 8.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₀Cl₂N₄S.

trans-2-(Chloromethyl)cyclohexanemethanol, CAS: 10479-74-0, stock: 3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅ClO.

trans-2-(Chloromethyl)cyclohexanemethanol Mesylate, CAS: /, stock: 9.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇ClO₃S.

2,2’-Ethylenedianiline, CAS: 34124-14-6, stock: 2.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆N₂.

Betulin, CAS: 473-98-3, stock: 1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₀O₂.

Betulin-d3, CAS: /, stock: 10g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₇D₃O₂.

Lupeol, CAS: 545-47-1, stock: 2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₀O.

Lupeol-d3, CAS: /, stock: 8.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₇D₃O.

Methyl (Methylthio)​acetate, CAS: 16630-66-3, stock: 5.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈O₂S.

(+)-13α-Hydroxylupanine, CAS: 15358-48-2, stock: 9.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₄N₂O₂.

(+)-Lupanine Perchlorate, CAS: 550-90-3, stock: 6.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₅ClN₂O₅.

α-Isolupanin Perchlorate, CAS: 14691-01-1, stock: 8.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₄N₂O  •HClO₄.

Lumiflavin, CAS: 1088-56-8, stock: 6.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂N₄O₂.

Lumiflavin-13C,15N2, CAS: /, stock: 3.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂¹³CH₁₂N₂¹⁵N₂O₂.

Lumiflavin-d3, CAS: /, stock: 5.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉D₃N₄O₂.

N3-Ethylthiosulfonylmethyl Lumiflavin, CAS: /, stock: 6.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈N₄O₄S₂.

(αR)-α-(Bromomethyl)-2,4-dichloro-benzenemethanol 1-Methanesulfonate, CAS: /, stock: 7.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉BrCl₂O₃S.

α-(Bromomethyl)-2,4-dichloro-1-methanesulfonate Benzenemethanol, CAS: /, stock: 6.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉BrCl₂O₃S.

α-(Bromomethyl)-2,4-dichlorobenzenemethanol, CAS: 53066-15-2, stock: 1.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇BrCl₂O.

2-[(4-Acetylphenyl)methyl]cyclopentan-1-one, CAS: 96824-28-1, stock: 6.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆O₂.

2-[4-(Bromomethyl)phenyl]propionic Acid, CAS: 111128-12-2, stock: 8.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁BrO₂.

4-(1-Carboxyethyl)-δ-oxo-benzenehexanoic Acid, CAS: 1091621-61-2, stock: 4.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈O₅.

4-Hydroxy Loxoprofen Alcohol (Mixture of Diastereomers), CAS: 88378-22-7, stock: 5.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀O₄.

4-[[1-(Ethoxycarbonyl)-2-oxocyclopentyl]methyl]-α-methylbenzeneacetic Acid-d3 Ethyl Ester, CAS: /, stock: 2.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃D₃O₅.

6-(4-(1-Carboxyethyl)phenyl)-6-oxohexanoic Acid, CAS: /, stock: 6.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈O₅.

Hydroxyloxoprofen Alkoxy Glucuronide, CAS: /, stock: 5.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈O₉.

Loxoprofen, CAS: 68767-14-6, stock: 5.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈O₃.

Loxoprofen Related Compound 2, CAS: 1091621-62-3, stock: 8.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈O₄.

Loxoprofen Sodium (Mixture of diastereomers), CAS: 80382-23-6, stock: 7.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇NaO₃.

Loxoprofen Sodium Dihydrate, CAS: 226721-96-6, stock: 3.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇NaO₃ • 2H ₂O.

Loxoprofen-d3, CAS: /, stock: 6.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅D₃O₃.

rac cis-Loxoprofen Alcohol, CAS: 371753-20-7, stock: 6.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀O₃.

rac cis-Loxoprofen-d3 Alcohol, CAS: /, stock: 9.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇D₃O₃.

rac trans-Loxoprofen Alcohol, CAS: 371753-19-4, stock: 8.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀O₃.

rac trans-Loxoprofen-d3 Alcohol, CAS: /, stock: 7.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇D₃O₃.

1-Chloro-3-methyl-4-(4-methoxy-2-nitrophenoxy)benzene, CAS: 1217090-10-2, stock: 8.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂ClNO₄.

3-Bromomethyl-1-chloro-4-(4-methoxy-2-nitrophenoxy)benzene, CAS: 1215782-19-6, stock: 2.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁BrClNO₄.

3-Chloro Loxapine, CAS: 3454-96-4, stock: 5.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈ClN₃O.

7-​(Acetyloxy)​-​2-​chloro-dibenz[b,​f]​[1,​4]​oxazepin-​11(10H)​-​one, CAS: 51370-03-7, stock: 7.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀ClNO₄.

7-Chloro Loxapine, CAS: 714220-73-2, stock: 7.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇Cl₂N₃O.

7-Chloro Loxapine-d6, CAS: /, stock: 3.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₉D₈Cl₂N₃O.

7-Hydroxy Loxapine, CAS: 37081-75-7, stock: 5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈ClN₃O₂.

7-Hydroxy Loxapine N-Oxide, CAS: 37081-77-9, stock: 9.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈ClN₃O₃.

7-Hydroxy Loxapine-D8, CAS: /, stock: 7.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₀D₈ClN₃O₂.

7-Hydroxy-loxapine-glucuronide, CAS: /, stock: 4.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆ClN₃O₈.

7-Hydroxy-loxapine-sulfate Sodium Salt, CAS: /, stock: 5.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇ClN₃NaO₅S.

8-Hydroxy Loxapine, CAS: 61443-77-4, stock: 4.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈ClN₃O₂.

8-Hydroxy Loxapine N-Oxide, CAS: /, stock: 7.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈ClN₃O₃.

8-Hydroxy Loxapine-d3, CAS: 1189863-10-2, stock: 2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅D₃ClN₃O₂.

8-Hydroxy-loxapine-glucuronide, CAS: /, stock: 5.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆ClN₃O₈.

8-Hydroxy-loxapine-sulfate Sodium Salt, CAS: /, stock: 9.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇ClN₃NaO₅S.

8-Methoxy Loxapine, CAS: 70020-54-1, stock: 8.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₀ClN₃O₂.

8-Methoxy Loxapine-d3, CAS: 1189647-48-0, stock: 2.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇D₃ClN₃O₂.

Loxapine N-Glucuronide Chloride, CAS: 145823-23-0, stock: 1.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₇Cl₂N₃O₇.

Loxapine N-Oxide, CAS: 25967-34-4, stock: 5.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈ClN₃O₂.

Loxapine, Succinate, CAS: 27833-64-3, stock: 3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄ClN₃O₅.

Loxapine-d8 Hydrochloride, CAS: 1246820-19-8, stock: 7.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₀D₈ClN₃O + x(HCl).

Loxapine-d8 Hydrochloride (Major), CAS: 1246820-19-8, stock: 7.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₀D₈ClN₃O + x(HCl).

N-[2-(4-Chlorophenoxy)phenyl]-4-methyl-1-piperazinecarboxamide Hydrochloride, CAS: 21530-86-9, stock: 2.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁Cl₂N₃O₂.

N-[2-(4-Chlorophenoxy)phenyl]-4-methyl-1-piperazinecarboxamide Hydrochloride-d8, CAS: /, stock: 5.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₃D₈Cl₂N₃O₂.

1,5-Cyclooctadiene(pyridine)(tricyclohexylphosphine)iridium(I) Hexafluorophosphate, CAS: 64536-78-3, stock: 1.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₄₈F₆IrNP₂.

2,2-Dimethylbutanoyl Chloride, CAS: 5856-77-9, stock: 4.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁ClO.

2’-Ethyl Simvastatin, CAS: 79902-42-4, stock: 8.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₄O₅.

2’-Ethyl Simvastatin-d6, CAS: /, stock: 4.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈D₆O₅.

4α,5-Dihydro Simvastatin, CAS: /, stock: 8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₀O₅.

4α,5-Dihydro Simvastatin-d6, CAS: /, stock: 8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₄D₆O₅.

Cis-2,3-Dehydro Lovastatin Acid Sodium Salt, CAS: 1649450-58-7, stock: 5.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₅NaO₅.

Des(2-methylbutyryl) Lovastatin Hydroxy Acid Sodium Salt, CAS: 132294-94-1, stock: 5.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₉NaO₅.

Epi Lovastatin Hydroxy Acid Sodium Salt, CAS: 101400-30-0, stock: 4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₇NaO₆.

Epi Lovastatin Hydroxy Acid-d3 Sodium Salt, CAS: 1329834-74-3, stock: 2.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₄D₃NaO₆.

Keto Lovastatin, CAS: /, stock: 5.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₄O₆.

Lovastatin Dimer, CAS: 149756-62-7, stock: 9.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₇₂O₁₀.

Lovastatin Hydroxy Acid, Sodium Salt, CAS: 75225-50-2, stock: 9.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₇NaO₆.

Lovastatin-d3 Hydroxy Acid Sodium Salt, CAS: 1217528-38-5, stock: 6.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₄D₃NaO₆.

Lovastatin-d9 Hydroxy Acid Sodium Salt (Mixture of Diastereomers), CAS: /, stock: 7.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₈D₉NaO₆.

Simvastatin Carboxylic Acid 2,2-Dimethyl-3-hydroxy Ester, CAS: /, stock: 8.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₀O₇.

Simvastatin Hydroxy Acid Sodium Salt, CAS: 101314-97-0, stock: 4.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₉NaO₆.

(11β,16α)-9,21-Dichloro-11-Hydroxy-16-methylpregna-1,4-diene-3,20-dione, CAS: /, stock: 2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈Cl₂O₃.

(11β,16α)-9-Chloro-11,17-dihydroxy-16-methyl-pregna-1,4-diene-3,20-dione (Mometasone Impurity M), CAS: 57780-86-6, stock: 2.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₉ClO₄.

(11β,16α)-9-Chloro-17-[(2-furanylcarbonyl)oxy]-11-hydroxy-16-methyl-21-[(methylsulfonyl)oxy]-pregna-1,4-diene-3,20-dione (Mometasone Impurity R), CAS: 1370190-08-1, stock: 3.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₃ClO₉S.

(11β,16α,17α)-9-Chloro-17-(2,2-dioxido-5H-1,2-oxathiol-4-yl)-17-[(2-furanylcarbonyl)oxy]-11-hydroxy-16-methyl-androsta-1,4-dien-3-oneMometasone Furoate Impurity B, CAS: 223776-49-6, stock: 6.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₁ClO₈S.

(16α)-21-Chloro-17-hydroxy-16-methylpregna-1,4,9(11)-triene-3,20-dione, CAS: 151265-36-0, stock: 8.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₇ClO₃.

(16α)-21-Chloro-17-[(2-furanylcarbonyl)oxy]-16-methyl-pregna-1,4-diene-3,11,20-trioneMometasone Furoate Impurity C, CAS: 1305334-31-9, stock: 8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₉ClO₆.

11,17-Difuroate Mometasone FuroateMometasone Furoate Impurity E, CAS: 1370190-33-2, stock: 3.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₂Cl₂O₈.

17,21-Dihydroxy-16α-methylpregna-1,4,9(11)-triene-3,20-dione 21-Acetate, CAS: 10106-41-9, stock: 8.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₀O₅.

17α-Hydroxy-21-chloro-9β,11β-epoxy-16α-methylpregna-1,4-diene-3,20-dione-d5, CAS: /, stock: 1.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂D₅ClO₄.

21-Acetyloxy Deschloromometasone Furoate, CAS: 83897-05-6, stock: 5.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₃ClO₈.

21-Acetyloxy Deschloromometasone Furoate 9,11-Epoxide, CAS: 109183-56-4, stock: 3.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₂O₈.

21-Chloro-17α-[(2-furanylcarbonxyl)oxy]-9β,11β-oxido-16α-methylpregna-1,4-diene-3,20-dioneMometasone Furoate Impurity D, CAS: 83881-09-8, stock: 8.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₉ClO₆.

21-Chloro-17α-[(2-furanylcarbonxyl-d3)oxy]-9β,11β-oxido-16α-methylpregna-1,4-diene-3,20-dione, CAS: /, stock: 8.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₆D₃ClO₆.

21-Hydroxy Deschloromometasone Furoate (Impurity)Mometasone Furoate Impurity H, CAS: 148596-90-1, stock: 2.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₁ClO₇.

4,5-Dihydro Mometasone Furoate 6-Acetate, CAS: /, stock: 9.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₄Cl₂O₈.

6,7-Didehydro Mometasone Furoate, CAS: /, stock: 7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₈Cl₂O₆.

6-Oxo Mometasone FuroateMometasone Furoate Impurity F, CAS: 1305334-30-8, stock: 2.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₈Cl₂O₇.

6α-Methyl Mometasone Furoate, CAS: /, stock: 1.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₂Cl₂O₆.

6α-Methyl Mometasone Furoate-d3, CAS: /, stock: 6.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₉D₃Cl₂O₆.

6α-Methyl Mometasone Furoate-d3, CAS: /, stock: 4.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₉D₃Cl₂O₆.

6β-Hydroxy Mometasone Furoate, CAS: 132160-74-8, stock: 3.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₀Cl₂O₇.

9,12-Dichloro-11β-hydroxy-16α-methyl-3,20-dioxopregna-1,4-dien-17-yl 5-Chlorofuran-2-carboxylate(Mometasone Impurity T), CAS: /, stock: 5.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₉Cl₃O₆.

9,​21-Dichloro-​17-​[(2-​furanylcarbonyl)​oxy]​-​11-​hydroxy-​16-​methylpregna-​1,​4-​diene-​3,​20-​dione, CAS: 2231764-75-1, stock: 2.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₀Cl₂O₆.

9-Deschloro Mometasone, CAS: /, stock: 5.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₇ClO₄.

9β,11β-Epoxy-17,21-dihydroxy-16β-methylpregna-1,4-diene-3,20-dione, CAS: 981-34-0, stock: 6.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈O₅.

Icomethasone, CAS: 4647-20-5, stock: 8.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₉ClO₅.

Icomethasone 21-Mesylate, CAS: 352315-75-4, stock: 3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₁ClO₇S.

Icomethasone 21-Propionate, CAS: 107085-37-0, stock: 1.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₃ClO₆.

Icomethasone 21-Propionate-d5, CAS: /, stock: 9.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₈D₅ClO₆.

Mometasone, CAS: 105102-22-5, stock: 3.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈Cl₂O₄.

Mometasone Furoate, CAS: 83919-23-7, stock: 2.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₀Cl₂O₆.

Mometasone Furoate Impurity A, CAS: 83880-65-3, stock: 5.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₉ClO₅.

Mometasone Furoate-d3, CAS: /, stock: 9.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₇D₃Cl₂O₆.

Mometasone Furoate-d8, CAS: /, stock: 1.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₂D₈Cl₂O₆.

Mometasone-17,20-Difuroate, CAS: /, stock: 6.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₂Cl₂O₈.

Mometasone-d5 (Major), CAS: /, stock: 6.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₃D₅Cl₂O₄.

2,2’-Bistetrazole-1,1’-bisphenyl (Losartan Impurity ), CAS: 1159977-11-3, stock: 3.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀N₈.

2-(2-Trityl-2H-tetrazol-5-yl)phenylboronic Acid, CAS: 143722-25-2, stock: 4.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₁BN₄O₂.

2’-Des-(1H-tetrazol-5-yl)-2’-phenyl-Losartan, CAS: /, stock: 3.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₇ClN₂O.

5-(2-Fluorophenyl)-1H-tetrazole Hydrochloride, CAS: 1216901-77-7, stock: 3.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆ClFN₄.

5-(2-Fluorophenyl)-1H-tetrazole Sodium Salt, CAS: /, stock: 6.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄FN₄Na.

5-Deshydroxymethyl-5-chloro Losartan (Losartan Impurity K), CAS: 1159977-26-0, stock: 2.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀Cl₂N₆.

5-Phenyl-2-trityltetrazole, CAS: 87268-78-8, stock: 5.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₀N₄.

8-Bromo-3-butyl-1-chloro-5,10-dihydroimidazo[1,5-b]isoquinolin-10(5H)-one, CAS: 1246816-60-3, stock: 1.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄BrClN₂O.

Deshydroxymethyl Losartan Trifluoroacetic Acid Salt, CAS: 1215727-33-5, stock: 3.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₂ClF₃N₆O₂.

Losartan Carboxylic Acid Acyl-β-D-Glucuronide, 90%, CAS: 1799830-02-6, stock: 7.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₉ClN₆O₈.

Losartan α-Butyl-losartan Aldehyde Adduct (Losartan Impurity), CAS: 1159977-48-6, stock: 3.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₄₄Cl₂N₁₂O₂.

Methyl 6-(Hydroxymethyl)-2-pyridinecarboxylate, CAS: 39977-44-1, stock: 6.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₃.

N-Trityl-5-(2-fluorophenyl)-1H-tetrazole, CAS: /, stock: 3.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₁₉FN₄.

Triphenylmethanol, CAS: 76-84-6, stock: 9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆O.

1,3-Dipalmitoyl-2-chloropropanediol, CAS: 169471-41-4, stock: 6.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₆₇ClO₄.

1,3-Dipalmitoyl-2-chloropropanediol-d5, CAS: 1426395-62-1, stock: 5.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₆₂D₅ClO₄.

5-Chloro-3-(N-(1,2,3-trihydroxybutyl)sulfinamoyl)thiophene-2-carboxamide, CAS: /, stock: 4.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃ClN₂O₅S₂.

5-Hydroxy Lornoxicam, CAS: 123252-96-0, stock: 3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀ClN₃O₅S₂.

6-Chloro-4-hydroxy-2-methyl-2H-thieno[2,3-e]-1,2-thiazine-3-carboxylic Acid Methyl Ester 1,1-Dioxide, CAS: 70415-50-8, stock: 4.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈ClNO₅S₂.

Cetearyl Alcohol, CAS: 67762-27-0, stock: 1.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₈O • C  ₁₆H₃₄O.

N-Des(2-pyridinyl)-N-(5-carboxy-2-thiazolyl) Lornoxicam, CAS: 1246819-40-8, stock: 4.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈ClN₃O₆S₃.

N-Des(2-pyridinyl)-N-(5-hydroxymethyl-2-thiazolyl) Lornoxicam, CAS: 1246818-50-7, stock: 9.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀ClN₃O₅S₃.

(2R)-2-Methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, CAS: 743374-52-9, stock: 4.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N.

(2R)-2-Methyl-2,3,4,5-tetrahydro-1H-3-benzazepine Hydrochloride, CAS: 76210-00-9, stock: 8.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆ClN.

(2R)-2-Methyl-2,3,4,5-tetrahydro-1H-3-benzazepine-d3, CAS: /, stock: 5.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N.

(2R)-2-Methyl-2,3,4,5-tetrahydro-1H-3-benzazepine-d3 Hydrochloride, CAS: /, stock: 6.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃D₃ClN.

(2S)-2-Methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, CAS: 76209-98-8, stock: 4.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N.

(2S)-2-Methyl-2,3,4,5-tetrahydro-1H-3-benzazepine Hydrochloride, CAS: 76209-99-9, stock: 6.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆ClN.

(2S)-2-Methyl-2,3,4,5-tetrahydro-1H-3-benzazepine-d3, CAS: /, stock: 2.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂D₃N.

(2S)-2-Methyl-2,3,4,5-tetrahydro-1H-3-benzazepine-d3 Hydrochloride, CAS: /, stock: 5.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃D₃ClN.

(4-Chlorophenyl)acetic Acid Methyl Ester, CAS: 52449-43-1, stock: 6.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉ClO₂.

(±)-8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine Hydrochloride Hemihydrate, CAS: 856681-05-5, stock: 2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  2(C₁₁H₁₄ClN) • 2(HCl) • H ₂O.

(Lorcaserin-d4) N-β-D-Glucuronide Sodium Salt, CAS: /, stock: 2.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇D₄ClNNaO₅.

(S)-Lorcaserin Hydrochloride, CAS: 1006037-59-7, stock: 3.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄ClN  • (HCl).

1-Methyl-2,3,4,5-tetrahydro-1H-3-benzazepine-d4, CAS: /, stock: 5.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁D₄N.

1-Methyl-2,3,4,5-tetrahydro-1H-3-benzazepine-d4 Hydrochloride, CAS: /, stock: 2.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂D₄ClN.

2,3,4,5-Tetrahydro-1H-3-benzazepin-7-amine, CAS: 107393-73-7, stock: 4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂.

2,3,4,5-Tetrahydro-1H-3-benzazepin-7-amine Hydrochloride, CAS: 188412-52-4, stock: 4.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅ClN₂.

2,3,4,5-Tetrahydro-1H-3-benzazepin-7-amine-d4, CAS: /, stock: 7.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀D₄N₂.

2-Oxo Lorcaserin, CAS: 824430-77-5, stock: 3.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂ClNO.

4-Chloro-N-(2-chloropropyl)benzeneethanamine Hydrochloride, CAS: 953789-37-2, stock: 7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆Cl₃N.

4-Chloro-N-(2-hydroxypropyl)benzeneacetamide, CAS: 1030624-36-2, stock: 2.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄ClNO₂.

4-Chloro-N-(2-hydroxypropyl)benzeneacetamide-d6, CAS: /, stock: 7.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈D₆ClNO₂.

7-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, CAS: 616201-89-9, stock: 5.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄ClN.

7-Fluoro-2,3,4,5-tetrahydro-1H-3-benzazepine, CAS: 324558-64-7, stock: 1.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂FN.

7-Fluoro-2,3,4,5-tetrahydro-1H-3-benzazepine Hydrochloride, CAS: /, stock: 7.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃ClFN.

7-Fluoro-2,3,4,5-tetrahydro-1H-3-benzazepine-d4, CAS: /, stock: 3.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈D₄FN.

7-Fluoro-2,3,4,5-tetrahydro-1H-3-benzazepine-d4 Hydrochloride, CAS: /, stock: 7.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉D₄ClFN.

Dechloro Lorcaserin (>50% ee), CAS: 929297-55-2, stock: 8.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N.

Lorcaserin hydrochloride, CAS: 846589-98-8, stock: 4.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄ClN • HCl.

Lorcaserin Hydrochloride-d4 (>50% ee), CAS: /, stock: 9.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁D₄Cl₂N.

Lorcaserin N-β-D-Glucuronide Sodium Salt, CAS: /, stock: 9.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁ClNNaO₅.

Lorcaserin Sulfamate, CAS: 1361572-46-4, stock: 5.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄ClNO₃S.

Lorcaserin-d4 Sulfamate, CAS: /, stock: 5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀D₄ClNO₃S.

N-Hydroxy Lorcaserin, CAS: 1421747-19-4, stock: 8.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄ClNO.

o-Chloro-α,α-dimethylphenethylamine Hydrochloride, CAS: 10389-72-7, stock: 9.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄ClN •HCl.

(2,6-Xylyloxy)acetyl Lopinavir, CAS: 943250-65-5, stock: 7.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₅₈N₄O₇.

(2R,4R,5S)-Lopinavir, CAS: /, stock: 7.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₈N₄O₅.

(2R,4S,5S)-Lopinavir, CAS: 1217628-64-2, stock: 2.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₈N₄O₅.

(2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl)amino-3-hydroxy-5-trifluromethylcarbonylamino-1,6-diphenylhexane, CAS: /, stock: 8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₃F₃N₂O₄.

(2S,3S,5S)-2-(N,N-Dibenzylamino)-3-hydroxy-5-(tert-butyloxycarbonylamino)-1,6-diphenylhexane, CAS: 162849-93-6, stock: 2.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₄N₂O₃.

(2S,3S,5S)-2-Amino-3-hydroxy-5-(tert-butyloxycarbonylamino)-1,6-diphenylhexane, CAS: 144163-85-9, stock: 7.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₂N₂O₃.

(2S,4R,5S)-Lopinavir, CAS: 1798014-18-2, stock: 6.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₈N₄O₅.

(αS)-3-[2-(2,6-Dimethylphenoxy)acetyl]-N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-α-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide, CAS: 943250-66-6, stock: 9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₅₈N₄O₇.

(S)-2-(2,4-Dioxo-tetrahydropyrimidin-1-yl)-3-methylbutyric Acid, CAS: 192725-86-6, stock: 6.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄N₂O₄.

(S)-Tetrahydro-α-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetic Acid, CAS: 192725-50-1, stock: 6.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆N₂O₃.

(S)-Tetrahydro-α-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetic Acid-d8, CAS: 1323257-58-4, stock: 5.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈D₈N₂O₃.

(S)-Tetrahydro-α-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetyl Chloride, CAS: 192800-77-4, stock: 4.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅ClN₂O₂.

(Z)-N,N’-(Ethene-1,2-diyl)bis(2-(2,6-dimethylphenoxy)acetamide), CAS: /, stock: 6.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆N₂O₄.

2,4-Phenoxy Lopinavir Impurity, CAS: /, stock: 4.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₈N₄O₅.

2,4-Phenoxy Lopinavir-d8 Impurity, CAS: /, stock: 2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₀D₈N₄O₅.

4,5-Dehydro(pyrimidin-2(1H)-one) Lopinavir, CAS: /, stock: 2.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₆N₄O₅.

Isolopinavir, CAS: 1132765-59-3, stock: 2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₅₀N₄O₅.

Isolopinavir-d9, CAS: /, stock: 7.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₄₁D₉N₄O₅.

Lopinavir, CAS: 192725-17-0, stock: 9.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₈N₄O₅.

Lopinavir 4-O-Tetrahydropyrimidin-2-(1H)-onyl-L-valinate, CAS: /, stock: 5.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₆₂N₆O₇.

Lopinavir 4-O-Tetrahydropyrimidin-2-(1H)-onyl-L-valinate-d8, CAS: /, stock: 1.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₅₄D₈N₆O₇.

Lopinavir D-Valine Diastereomer, CAS: 1623021-24-8, stock: 8.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₈N₄O₅.

Lopinavir D-Valine Diastereomer-d9, CAS: /, stock: 1.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₃₉D₉N₄O₅.

Lopinavir EP-T Impurity, CAS: 1797024-56-6, stock: 4.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₇H₆₆N₄O₇.

Lopinavir Metabolite M-1, CAS: 192725-39-6, stock: 6.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₆N₄O₆.

Lopinavir Metabolite M-3/M-4, CAS: 357275-54-8, stock: 6.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₈N₄O₆.

Lopinavir Metabolite M-3/M-4, CAS: 221553-72-6, stock: 9.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₈N₄O₆.

Lopinavir N2,N5-(2,6-Xylyloxy)acetyl Impurity, CAS: /, stock: 9.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₄₄N₂O₅.

Lopinavir N2,N5-(2,6-Xylyloxy)acetyl Impurity-d9, CAS: /, stock: 5.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₃₅D₉N₂O₅.

Lopinavir N2,N5-Divalinate Impurity, CAS: /, stock: 7.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₅₂N₆O₅.

Lopinavir N2,N5-Divalinate Impurity-d8, CAS: /, stock: 8.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₄D₈N₆O₅.

Lopinavir O-β-D-Glucuronide, CAS: /, stock: 8.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₅₆N₄O₁₁.

Lopinavir O-Sulfate, CAS: /, stock: 8.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₈N₄O₈S.

Lopinavir O-Sulfate-d8, CAS: /, stock: 2.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₀D₈N₄O₈S.

Lopinavir-d8, CAS: 1322625-54-6, stock: 6.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₀D₈N₄O₅.

N,N’-(Ethane-1,2-diyl)bis(2-(2,6-dimethylphenoxy)acetamide), CAS: 651294-97-2, stock: 3.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈N₂O₄.

N,N’-(Ethane-d4-1,2-diyl)bis(2-(2,6-dimethylphenoxy)acetamide), CAS: /, stock: 8.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄D₄N₂O₄.

N-(3-Methoxy-3-oxopropyl)-L-valine tert-Butyl Ester, CAS: 192725-86-3, stock: 1.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₅NO₄.

N-(3-Propanamido)-L-valine tert-Butyl Ester, CAS: 192725-87-4, stock: 8.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₄N₂O₃.

N2-Des(L-valinyl) Lopinavir N2,O5-Oxazine, CAS: /, stock: 5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₂N₂O₄.

N2-Des(L-valinyl) Lopinavir N2,O5-Oxazine-d9, CAS: /, stock: 1.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₃D₉N₂O₄.

N2-Des(L-valinyl) N2-Acetyl Lopinavir, CAS: /, stock: 6.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₆N₂O₄.

N2-Des(L-valinyl) N2-Acetyl Lopinavir-d3, CAS: /, stock: 8.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₃D₃N₂O₄.

N2-Des(L-valinyl) N2-Acetyl Lopinavir-d9, CAS: /, stock: 6.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₇D₉N₂O₄.

N2-Des(L-valinyl) N2-Formal Lopinavir, CAS: /, stock: 2.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₄N₂O₄.

N2-Des(L-valinyl) N2-Formal Lopinavir-d9, CAS: /, stock: 6.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₅D₉N₂O₄.

N5-Des[(2,6-dimethylphenoxy)acetyl] N5-Formal Lopinavir, CAS: /, stock: 3.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₈N₄O₄.

Ritonavir Impurity Q, CAS: /, stock: 6.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₈N₆O₅S₂.

Ritonavir Impurity R, CAS: /, stock: 9.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₈N₆O₅S₂.

(3-O-Methyl)-D-α-mannopyranosyl)-4-(3-OMe)-D-mannose, CAS: /, stock: 1.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₆O₁₁.

(R)-Phenyl 3-O-[(4-methoxyphenyl)methyl]-2-O-(phenylmethyl)-4,6-O-(phenylmethylene)-1-thio-α-D-mannopyranoside, CAS: 177943-74-7, stock: 9.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₄O₆S.

1,2,3,4,6-Penta-O-benzoyl-D-mannopyranose, CAS: 96996-90-6, stock: 8.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₃₂O₁₁.

1,2,3,4-Tetra-O-acetyl-6-diphenylphosphoryl-β-D-mannopyranose, CAS: 108321-48-8, stock: 8.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₉O₁₃P.

1,2,3,6-Tetra-O-benzoyl-α-D-mannose, CAS: 56994-11-7, stock: 3.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₂₈O₁₀.

1,3,4,6-Tetra-O-acetyl-2-O-trifluoromethanesulfonyl-β-D-mannopyranose, CAS: 92051-23-5, stock: 8.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉F₃O₁₂S.

1,3-Bis-(1,6-anhydro-2,3-O-isopropylidene-β-D-mannopyranose-4-yloxy)-2-propylamine, CAS: 95245-29-7, stock: 1.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₃NO₁₀.

1,4-Dideoxy-1,4-imino-D-mannitol, Hydrochloride, CAS: 114976-76-0, stock: 2.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄ClNO₄.

1,4-β-D-Mannotriose, CAS: 28173-52-6, stock: 1.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₂O₁₆.

1,6,2,3-Di(isopropylidene) β-D-Mannose, CAS: /, stock: 3.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀O₆.

1,6-Anhydro-β-D-mannopyranose, CAS: 14168-65-1, stock: 6.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀O₅.

1,6-Anhydro-β-D-mannopyranose-13C3, CAS: /, stock: 6.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³C₃H₁₀O₅.

1-Amino-11-azido-3,6,9-trioxaundecane, CAS: 134179-38-7, stock: 3.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₈N₄O₃.

2,3,4,6-Tetra-O-acetyl-D-mannopyranose, CAS: 58645-20-8, stock: 1.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀O₁₀.

2,3,4,6-Tetra-O-benzyl-D-mannopyranose, CAS: 61330-61-8, stock: 3.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₆O₆.

2,5-Anhydro D-Mannose Oxime, Technical grade, CAS: 127676-61-3, stock: 7.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NO₅.

2,5-Anhydro-D-mannose, CAS: 495-75-0, stock: 9.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀O₅.

2-Deoxy-2-fluoro-D-mannopyranose 2-Deacetate Triacetate, CAS: /, stock: 7.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇FO₈.

2-Deoxy-2-fluoro-D-mannopyranose Tetraacetate, CAS: 141395-49-5, stock: 1.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉FO₉.

2-Deoxy-2-fluoro-D-mannose, CAS: 38440-79-8, stock: 8.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁FO₅.

2-N-[4-(1-Azitrifluoroethyl)benzoyl]-1,3-bis-(1,6-anhydro-D-mannos -4-yloxy)-2-propylamine, CAS: /, stock: 1.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₈F₃N₃O₁₁.

2-Naphthyl Phosphate, Monosodium Salt, CAS: 14463-68-4, stock: 3.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉O₄P  • Na.

2-O-(2-Acetamido-2-deoxy-3,4,6-tri-O-acetyl-β-D-glucopyranosyl)-3-O-benzyl-4,6-O-benzylidene-α-D-mannose, CAS: 865488-84-2, stock: 3.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₄₇NO₁₄.

2-O-(2-Acetamido-2-deoxy-β-D-glucopyranosyl)-D-mannose, CAS: 34621-73-3, stock: 6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₅NO₁₁.

2-O-(2-Deoxy-2-N-phthalimido-3,4,6-tri-O-acetyl-β-D-glucopyranosyl)-3-O-benzyl-4,6-O-benzylidene-α-D-mannose, CAS: 865488-82-0, stock: 4.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₄₇NO₁₅.

2-O-(α-D-Galactopyranosyluronic Acid)-L-rhamnose, CAS: 6118-79-2, stock: 6.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀O₁₁.

2-O-β-D-Mannopyranosyl-D-mannose, CAS: 50728-38-6, stock: 6.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₁₁.

3,4,6-Tri-O-acetyl-β-D-mannopyranose 1,2-(Methyl Orthoacetate), CAS: 06/05/4435, stock: 8.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂O₁₀.

3-Amino-3-deoxy-D-mannose Hydrochloride, CAS: 69880-85-9, stock: 4.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄ClNO₅.

3,10-Dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine, CAS: 272107-22-9, stock: 3.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀Br₂ClN.

3-Deoxy-3-fluoro-D-mannose, CAS: 87764-46-3, stock: 7.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁FO₅.

3-O-Benzyl-α,β-D-mannopyranoside, CAS: 65926-00-3, stock: 1.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈O₆.

3-O-α-D-Mannopyranosyl D-Mannose, CAS: 23745-85-9, stock: 4.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₁₁.

3-O-β-D-Mannopyranosyl D-Mannose, CAS: 50692-75-6, stock: 8.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₁₁.

3-O-Methyl-D-mannose, CAS: 27552-10-9, stock: 3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄O₆.

4,4’-O-(2-Amino-1,3-propanediyl)bis-D-mannose Hydrochloride, CAS: 95245-30-0, stock: 9.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₃₀ClNO₁₂.

4-Deoxy-4-fluoro-1,2,3,6-tetra-O-benzoyl-α-D-mannose, CAS: 1309463-38-4, stock: 8.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₂₇FO₉.

4-Deoxy-4-fluoro-D-mannose, CAS: 87764-47-4, stock: 4.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁FO₅.

4-Isothiocyanatophenyl α-D-Mannopyranoside, CAS: 96345-79-8, stock: 8.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅NO₆S.

4-O-(b-D-Mannopyranosyl)-D-mannose, CAS: 14417-51-7, stock: 7.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₁₁.

4-O-α-D-Mannopyranosyl-D-mannose, CAS: 35438-40-5, stock: 6.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₁₁.

4-O-β-D-Mannopyranosyl-D-mannose, CAS: f, stock: 4.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₁₁.

4-Penten-1-ol, CAS: 821-09-0, stock: 9.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O.

6-O-α-D-Mannopyranosyl-D-mannose, CAS: 6614-35-3, stock: 3.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₁₁.

6-O-β-D-Mannopyranosyl-D-mannose, CAS: 71184-87-7, stock: 7.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₁₁.

6-O-Tosyl-D-mannose, CAS: 105265-64-3, stock: 6.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈O₈S.

a-D-Mannose-1-phosphate Dipotassium Salt, CAS: 71888-67-0, stock: 7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁K₂O₉P.

alpha-D-Thiomannose Sodium Salt, CAS: 111057-34-2, stock: 8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁O₅SNa.

Benzyl 4,6-O-Benzylidene-α-D-mannopyranoside, CAS: 40983-94-6, stock: 4.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂O₆.

Benzyl-2-O-(2-Acetamido-2-deoxy-β-D-glucopyranosyl)-3-O-benzyl-4,6-O-benzylidene-α-D-mannose, CAS: /, stock: 2.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₄₁NO₁₁.

Bovine M6PR (Cation-dependent mannose-6-phosphate receptor) ELISA Kit (96T), CAS: /, stock: 1.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Bovine MPI (Mannose-6-phosphate isomerase) ELISA Kit (96T), CAS: /, stock: 7.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Bromo 2,3,4,6-Tetra-O-acetyl-α-D-mannopyranoside(Stabilized with 4% CaCO3), CAS: 13242-53-0, stock: 8.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉BrO₉.

Chicken POMK (Protein O-mannose kinase) ELISA Kit (96T), CAS: /, stock: 7.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

D-Mannosamine Hydrochloride, CAS: 5505-63-5, stock: 8.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄ClNO₅.

D-Mannosamine-13C6 Hydrochloride, CAS: /, stock: 7.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₁₄ClNO₅.

D-Mannose, CAS: 3458-28-4, stock: 9.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₆.

D-Mannose-1,2,3-13C3, CAS: /, stock: 9.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₃C₃H₁₂O₆.

D-Mannose-1,2-13C2, CAS: /, stock: 8.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₂C₄H₁₂O₆.

D-Mannose-1,6-13C2, CAS: /, stock: 4.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₂C₄H₁₂O₆.

D-Mannose-1-13C, CAS: 70849-31-9, stock: 4.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³CC₅H₁₂O₆.

D-Mannose-1-C-d, CAS: 288846-86-6, stock: 8.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁DO₆.

D-Mannose-2-13C, CAS: 70849-16-0, stock: 9.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³CC₅H₁₂O₆.

D-Mannose-2-C-d, CAS: /, stock: 1.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁DO₆.

D-Mannose-3,4-13C2, CAS: /, stock: 1.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₂C₄H₁₂O₆.

D-Mannose-3-13C, CAS: 101615-89-8, stock: 8.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³CC₅H₁₂O₆.

D-Mannose-3-C-d, CAS: /, stock: 2.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁DO₆.

D-Mannose-4-13C, CAS: /, stock: 3.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³CC₅H₁₂O₆.

D-Mannose-4-C-d, CAS: /, stock: 2.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁DO₆.

D-Mannose-5-13C, CAS: /, stock: 4.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³CC₅H₁₂O₆.

D-Mannose-5-C-d, CAS: /, stock: 2.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁DO₆.

D-Mannose-6,6’-C-d2, CAS: /, stock: 5.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀D₂O₆.

D-Mannose-6-13C, CAS: 115973-81-4, stock: 2.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³CC₅H₁₂O₆.

D-Mannose-6-O-sulphate Sodium Salt, CAS: 204575-08-6, stock: 3.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁O₉SNa.

D-Mannose-6-phosphate Disodium Salt Hydrate, CAS: /, stock: 5.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁O₉PNa₂ • H ₂O.

D-Mannose-6-phosphate Sodium Salt, CAS: 70442-25-0, stock: 7.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂NaO₉P.

D-Mannose-UL-13C6, CAS: 287100-74-7, stock: 6.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₁₂O₆.

D-Mannose-UL-d7, CAS: /, stock: 1.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅D₇O₆.

Deoxymannojirimycin Hydrochloride, CAS: 73465-43-7, stock: 5.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄ClNO₄.

Human M6PR (Cation-dependent mannose-6-phosphate receptor) ELISA Kit (96T), CAS: /, stock: 6.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human MBP/MBL(Mannose Binding Protein/Mannose Binding Lectin) ELISA Kit (96T), CAS: /, stock: 9.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human MRC1(Macrophage mannose receptor 1) ELISA Kit (96T), CAS: /, stock: 5.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human MRC2(C-type mannose receptor 2) ELISA Kit (96T), CAS: /, stock: 5.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human POMGNT1(Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1) ELISA Kit (96T), CAS: /, stock: 9.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human POMK (Protein O-mannose kinase) ELISA Kit (96T), CAS: /, stock: 9.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

α-D-Mannose 1-Phosphate, CAS: 15978-07-1, stock: 5.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃O₉P.

L-Mannose, CAS: 10030-80-5, stock: 4.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₆.

L-Mannose-1-13C, CAS: /, stock: 1.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³CC₅H₁₂O₆.

L-Rhamnose Diethyl Dithioacetal, CAS: 6748-70-5, stock: 1.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₂O₄S₂.

Mannose Pentasulfate, Potassium Salt, Technical Grade, CAS: 359436-63-8, stock: 7.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇K₅O₂₁S₅.

Mannotetraose, CAS: 51327-76-5, stock: 4.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₂O₂₁.

Methyl 2,3:4,6-Di-O-isopropylidene-mannopyranoside, CAS: 50705-56-1, stock: 3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₂O₆.

Mouse Gmds (GDP-mannose 4,6 dehydratase) ELISA Kit (96T), CAS: /, stock: 4.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

3,5-Diamino-4-chlorobenzonitrile-15N2, CAS: /, stock: 7.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆ClN¹⁵N₂.

Mouse M6pr (Cation-dependent mannose-6-phosphate receptor) ELISA Kit (96T), CAS: /, stock: 3.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Mbl2( Mannose-binding protein C) ELISA Kit (96T), CAS: /, stock: 1.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

3-Amino-4-chloro-5-nitrobenzonitrile-15N2,d2, CAS: /, stock: 9.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₂D₂ClN¹⁵N₂O₂.

Mouse Mpi (Mannose-6-phosphate isomerase) ELISA Kit (96T), CAS: /, stock: 5.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Pomk (Protein O-mannose kinase) ELISA Kit (96T), CAS: /, stock: 4.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

4-Chloro-3,5-dinitrobenzonitrile, CAS: 1930-72-9, stock: 9.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₂ClN₃O₄.

N-Acetyl-D-mannosamine-d3, CAS: 376645-66-8, stock: 5.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂D₃NO₆.

N-Acetyl-D-[1-13C]mannosamine, CAS: /, stock: 5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇¹³CH₁₅NO₆.

4-Chloro-3,5-dinitrobenzonitrile-15N2, CAS: /, stock: 1.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₂ClN¹⁵N₂O₄.

Lodoxamide, CAS: 53882-12-5, stock: 3.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₆ClN₃O₆.

N-Acetyl-D-[15N]mannosamine, CAS: 72-87-7, stock: 3.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅¹⁵NO₆.

N-Acetyl-D-[2-13C]mannosamine, CAS: /, stock: 9.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇¹³CH₁₅NO₆.

Lodoxamide Diethyl Ester, CAS: 53882-13-6, stock: 5.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄ClN₃O₆.

Lodoxamide Diethyl Ester-5N2,d2, CAS: /, stock: 4.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂D₂ClN¹⁵N₂O₆.

N-Carbobenzyloxy Mannosamine, CAS: 137157-50-7, stock: 1.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₇.

Lodoxamide-15N2,d2, CAS: /, stock: 8.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₄D₂ClN¹⁵N₂O₆.

p-Nitrophenyl 6-Phospho-α-D-mannopyranoside, CAS: 74160-60-4, stock: 6.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆NO₁₁P.

Phenyl 2,3,4,6-Tetra-O-acetyl-1-thio-α-D-mannopyranoside, CAS: 108032-93-5, stock: 9.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄O₉S.

Pramipexole Mannose Adduct, CAS: /, stock: 3.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₇N₃O₅S.

Rat M6pr (Cation-dependent mannose-6-phosphate receptor) ELISA Kit (96T), CAS: /, stock: 4.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Mpi (Mannose-6-phosphate isomerase) ELISA Kit (96T), CAS: /, stock: 3.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Pomk (Protein O-mannose kinase) ELISA Kit (96T), CAS: /, stock: 6.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

trans-Zeatin-O-β-D-glucuronide, CAS: 147663-51-2, stock: 6.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁N₅O₇.

Tyvelose, CAS: 08/12/5658, stock: 8.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₄.

1-Ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid, CAS: 75338-42-0, stock: 3.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈F₃NO₃.

1-Ethyl-6,8-difluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid, CAS: 99726-76-8, stock: 4.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇F₂N₃O₃.

1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic Acid Ethyl Ester, CAS: 98079-83-5, stock: 4.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃F₂N₃O₃.

1-Ethyl-6,8-difluoro-7-(3-methyl-1-piperazinyl)-4(1H)-quinolinone, CAS: 183235-15-6, stock: 7.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉F₂N₃O.

1-Ethyl-6-fluoro-1,4-dihydro-7-(4-methyl-2-oxo-1-imidazolidinyl)-4-oxo-3-quinolinecarboxylic Acid, CAS: 195259-12-2 , stock: 4.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆FN₃O₄.

1-Ethyl-6-fluoro-8-hydroxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid, CAS: /, stock: 3.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀FN₃O₄.

2,3,4-Trichloronitrobenzene, CAS: 17700-09-3, stock: 7.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₂Cl₃NO₂.

4,5-Dichloro-1,3-dihydro-2H-benzimidazol-2-one, CAS: 273930-54-4, stock: 9.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄Cl₂N₂O.

7-((2-aminopropyl)amino)-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid, CAS: 195259-19-9, stock: 4.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈FN₃O₃.

8-Chloro-1-ethyl-6-fluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic Acid, CAS: 111234-01-6, stock: 1.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉ClFN₃O₃.

8-Fluoro-1,2-dihydro-9-(3-methyl-1-piperazinyl)-6-oxo-6H-Pyrrolo[3,2,1-ij]quinoline-5-carboxylic Acid, CAS: 195259-11-1, stock: 7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈FN₃O₃.

Lomefloxacin, CAS: 98079-51-7, stock: 6.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉F₂N₃O₃.

Lomefloxacin Aspartate, CAS: 211690-33-4, stock: 1.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆F₂N₄O₇.

Lomefloxacin Hydrochloride, CAS: 98079-52-8, stock: 3.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀ClF₂N₃O₃.

(E)-Ethyl 4-Oxo-4-phenyl-d5-but-2-enoate, CAS: /, stock: 4.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₇D₅O₃.

(R)-Lisinopril, CAS: 85955-59-5, stock: 3.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₁N₃O₅.

(R)-Lisinopril Sodium Salt, CAS: 1356019-70-9, stock: 1.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₁N₃NaO₅.

(S)-Lisinopril, CAS: 76547-98-3, stock: 5.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₁N₃O₅.

(S)-Lisinopril Dihydrate, CAS: 83915-83-7, stock: 4.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₁N₃O₅•2H₂O.

(S)-Lisinopril Dimer, CAS: 1356839-89-8, stock: 5.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₆₀N₆O₉.

(S)-Lisinopril Dimer-d5, CAS: 1356847-97-6, stock: 6.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₅₅D₅N₆O₉.

(S)-Lisinopril-d5, CAS: 1356905-39-9, stock: 7.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆D₅N₃O₅.

(S)-Lisinopril-d5 Sodium, CAS: 1356847-28-3, stock: 6.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅D₅N₃NaO₅.

Lisinopril Cyclohexyl Analogue, CAS: 1132650-67-9, stock: 3.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₇N₃O₅.

Lisinopril Dimer Impurity H, CAS: /, stock: 8.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₃N₅O₈.

Lisinopril N6-Ethyl Carbamate, CAS: /, stock: 1.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₅N₃O₇.

N-(1-Carboxy-3-phenylpropyl)-S-lisinopril (Mixture of diastereomers), CAS: 927819-64-5, stock: 9.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₄₁N₃O₇.

N-Benzyloxycarbonyl (S)-Lisinopril, CAS: 1356382-88-1, stock: 8.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₇N₃O₇.

N-Benzyloxycarbonyl (S)-Lisinopril Ethyl Methyl Diester, CAS: 1356011-68-1, stock: 4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₃N₃O₇.

N-Benzyloxycarbonyl (S)-Lisinopril-d5, CAS: 1356931-02-6, stock: 3.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₂D₅N₃O₇.

N-Benzyloxycarbonyl (S)-Lisinopril-d5 Ethyl Methyl Diester, CAS: 1356383-20-4, stock: 7.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₈D₅N₃O₇.

N-Benzyloxycarbonyl Lisinopril Cyclohexyl Analogue Ethyl Methyl Diester, CAS: 1356930-73-8, stock: 10g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₉N₃O₇.

N-Benzyloxycarbonyl-L-lysyl]-L-proline Methyl Ester Trifluoroacetic Acid Salt, CAS: 108456-08-2, stock: 9.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₀F₃N₃O₇.

N-Carboxymethyl Lisinopril Ammonium Salt, CAS: /, stock: 7.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₃N₃O₇  •NH₃.

N2-(1-(S)-Ethoxycarbonyl-3-phenylpropyl)-n6-t rifluoroacetyl-L-lysine-L-proline, CAS: 103300-91-0, stock: 1.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₄F₃N₃O₆.

N6-[(N2-(1(S)-Carboxy-3-phenyl-propyl)-D-lysyl] Lisinopril, CAS: /, stock: 8.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₃N₅O₈.

N6-[(N2-(1(S)-Carboxy-3-phenyl-propyl)-L-lysyl] Lisinopril, CAS: /, stock: 8.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₃N₅O₈.

(S)-3-Hexyl-5,6-dihydro-6-undecyl-2H-pyran-2-one, CAS: 130676-64-1, stock: 9.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₄₀O₂.

2-Hexyl-5-hydroxy-3-oxo-hexadecanoic Acid Methyl Ester, CAS: 104801-82-3, stock: 8.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₄O₄.

(±)-α-Lipoic Acid Methyl Ester-d5, CAS: /, stock: 7.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁D₅O₂S₂.

(R)-(+)-α-Lipoic Acid, CAS: 1200-22-2, stock: 7.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄O₂S₂.

(R)-(+)-α-Lipoic Amide, CAS: 122999-10-4, stock: 5.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NOS₂.

(S)-(-)-α-Lipoic Acid, CAS: 1077-27-6, stock: 6.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄O₂S₂.

6,8-Bis[(methylsulfonyl)oxy]-octanoic Acid Methyl Ester-d5, CAS: /, stock: 6.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇D₅O₈S₂.

6,8-Dichloro-octanoate, CAS: 41443-60-1, stock: 3.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄Cl₂O₂.

6,8-Dichlorooctanoic Acid Ethyl Ester, CAS: 1070-64-0, stock: 1.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈Cl₂O₂.

6-Hydroxy-8-[(phenylmethyl)thio]-octanoic Acid Methyl Ester-d5, CAS: 1346598-50-2, stock: 5.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉D₅O₃S.

8-(Benzylthio)-6-oxo-octanoic Acid Methyl Ester-d4, CAS: 1346604-12-3, stock: 2.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈D₄O₃S.

8-Chloro-6-oxo-octanoic Acid Ethyl Ester, CAS: 50628-91-6, stock: 6.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇ClO₃.

8-Methoxy-6-oxo-octanoic Acid Methyl Ester-d4, CAS: 1346603-91-5, stock: 9.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄D₄O₄.

Homo-α-lipoic Acid, CAS: 5616-71-7, stock: 8.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆O₂S₂.

γ-Lipoic Acid, CAS: 462-20-4, stock: 2.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆O₂S₂.

Methyl (±)-6,8-Dihydroxyoctanoate-d5, CAS: /, stock: 6.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃D₅O₄.

rac α-Lipoic Acid, CAS: 1077-28-7, stock: 4.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄O₂S₂.

rac α-Lipoic Acid-d5, CAS: 1189471-66-6, stock: 6.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉D₅O₂S₂.

Monolinuron, CAS: 1746-81-2, stock: 6.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁ClN₂O₂.

N-Demethoxy Linuron, CAS: 3567-62-2, stock: 1.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈Cl₂N₂O.

N-Demethoxy Linuron-13C6, CAS: 1346603-94-8, stock: 8.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³C₆H₈Cl₂N₂O.

10β-Hydroxy Norethindrone, CAS: 1236-00-6, stock: 2.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆O₃.

11-Methylenelynestrenol, CAS: 54024-12-3, stock: 8.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈O.

6β-Hydroxy Norethindrone, CAS: 51724-44-8, stock: 1.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆O₃.

(+/-)9,10-DiHOME, CAS: 263399-34-4, stock: 1.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₄O₄.

(+/-)9-HODE, CAS: 98524-19-7, stock: 3.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₂O₃.

(4E)-4-Octenedioic Acid-1,8-13C2, CAS: 1185234-84-7, stock: 3.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³C₂H₁₂O₄.

(9Z)-12-Oxo-9-dodecenoic Acid, CAS: 60485-39-4, stock: 5.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀O₃.

(9Z,11Z)-9,11-Octadecadienoic Acid, CAS: 544-70-7, stock: 4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₂O₂.

(Z)-3-Nonenal, CAS: 31823-43-5, stock: 1.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆O.

10,12-Octadecadienoyl Chloride (Mixture of Isomers), CAS: /, stock: 1.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₁ClO.

10-Oxo-trans-8-decenoic Acid, CAS: 69152-89-2, stock: 4.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆O₃.

9-Oxononanoic Acid, CAS: 2553-17-5, stock: 3.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆O₃.

cis,cis-3,6-Nonadienal, CAS: 21944-83-2, stock: 4.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄O.

Conjugated Linoleic Acid Ethyl Ester, 90% (Mixture of Isomers), CAS: 137142-61-1, stock: 3.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₆O₂.

Conjugated Linoleic Acid Ethyl Ester-d5, 90% (Mixture of Isomers), CAS: /, stock: 3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₁D₅O₂.

Conjugated Linoleic Acid Methyl Ester, 90% (Mixture of Isomers), CAS: 1002-79-5, stock: 3.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₄O₂.

Conjugated Linoleic Acid Methyl Ester-d3, 90% (Mixture of Isomers), CAS: /, stock: 6.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₁D₃O₂.

Conjugated Linoleic Acid N-Succinimide, 90% (Mixture of Isomers), CAS: /, stock: 1.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₅NO₄.

Conjugated Linoleic Acid, 90%(Mixture of Isomers), CAS: 121250-47-3, stock: 9.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₂O₂.

Isoleukotoxin Diol, CAS: 73889-55-1, stock: 3.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₄O₄.

Linoleamide, CAS: 3072-13-7, stock: 3.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₃NO.

Linoleic Acid, CAS: 60-33-3, stock: 2.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₂O₂.

Linoleic Acid Sodium Salt, CAS: 822-17-3, stock: 2.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₁O₂Na.

Linoleic Acid-d11, CAS: /, stock: 8.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁D₁₁O₂.

Linoleic Acid-d4, CAS: 79050-23-0, stock: 7.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₈D₄O₂.

Linoleoyl Chloride, CAS: 7459-33-8, stock: 4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₁ClO.

Methyl Linoleate, CAS: 112-63-0, stock: 6.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₄O₂.

Methyl Linoleate-d3, CAS: /, stock: 2.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₁D₃O₂.

N-Linoleoylethanolamine, CAS: 68171-52-8, stock: 1.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₇NO₂.

N-Linoleoylethanolamine-d4, CAS: 1451194-69-6, stock: 7.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₃D₄NO₂.

Ricinolic Acid, CAS: 141-22-0, stock: 8.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₄O₃.

Ricinolic Acid (50% w/w Ethanol), CAS: 141-22-0, stock: 3.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₄O₃.

trans-Vaccenic acid-d4, CAS: /, stock: 4.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₀D₄O₂.

(2R)-1-Azido-3-[[3-fluoro-4-(4-morpholinyl)phenyl]amino]-2-propanol 2-Acetate, CAS: 2055572-74-0, stock: 9.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀FN₅O₃.

(2R)-1-Chloro-3-[[3-fluoro-4-(4-morpholinyl)phenyl]amino]-2-propanol, CAS: 868405-66-7, stock: 8.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈ClFN₂O₂.

(3-Fluoro-4-morpholin-4-ylphenyl)carbamic Acid Methyl Ester, CAS: 212325-40-1, stock: 3.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅FN₂O₃.

(3S,4S)-4-(4-(Benzyloxy)phenyl)-3-(but-3-en-1-yl)-1-(4-fluorophenyl)azetidin-2-one, CAS: /, stock: 7.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₄FNO₂.

(5R)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-5-[[(methylsulfonyl)oxy]methyl]-2-oxazolidinone, CAS: 174649-09-3, stock: 8.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉FN₂O₆S.

(5S,5’S)-5,5’-(Azanediylbis(methylene))bis(3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one), CAS: /, stock: 7.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₃F₂N₅O₆.

(R)-(3-(4-(((Benzyloxy)carbonyl)(2-((tert-butyldimethylsilyl)oxy)ethyl)amino)-3-fluorophenyl)-2-oxooxazolidin-5-yl)methyl Methanesulfonate, CAS: /, stock: 1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₇FN₂O₈SSi.

(R)-1-Azido-3-[[3-fluoro-4-(morpholin-4-yl)phenyl]amino]propan-2-ol, CAS: 1571118-50-7, stock: 7.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉FN₅O₂⁺.

(R)-Benzyl (2-((tert-Butyldimethylsilyl)oxy)ethyl)(2-fluoro-4-(5-(hydroxymethyl)-2-oxooxazolidin-3-yl)phenyl)carbamate, CAS: /, stock: 8.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₅FN₂O₆Si.

(R)-Benzyl (2-((tert-Butyldimethylsilyl)oxy)ethyl)(2-fluoro-4-(5-(hydroxymethyl)-2-oxooxazolidin-3-yl)phenyl)carbamate, CAS: /, stock: 8.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₅FN₂O₆Si.

(R)-Linezolid, CAS: 872992-20-6, stock: 6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀FN₃O₄.

(R)-Linezolid-d3, CAS: 1795786-02-5, stock: 6.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇D₃FN₃O₄.

(S)-(3-(3-Fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl methanesulfonate, CAS: 2180621-71-8, stock: 6.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉FN₂O₆S.

(S)-1-Azido-3-(N-(3-fluoro-4-morpholinophenyl)acetamido)propan-2-yl Acetate, CAS: /, stock: 4.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂FN₅O₄.

(S)-1-Chloro-3-((3-fluoro-4-morpholinophenyl)amino)propan-2-ol, CAS: 1610690-08-8, stock: 5.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈ClFN₂O₂.

(S)-Benzyl (4-(5-(Acetamidomethyl)-2-oxooxazolidin-3-yl)-2-fluorophenyl)(2-((tert-butyldimethylsilyl)oxy)ethyl)carbamate, CAS: /, stock: 9.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₈FN₃O₆Si.

(S)-Benzyl (4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)-2-fluorophenyl)(2-((tert-butyldimethylsilyl)oxy)ethyl)carbamate, CAS: /, stock: 2.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₆FN₃O₅Si.

(S)-N-((3-(4-((2-((tert-Butyldimethylsilyl)oxy)ethyl)amino)-3-fluorophenyl)-2-oxooxazolidin-5-yl)methyl)acetamide, CAS: /, stock: 9.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂FN₃O₄Si.

(S)-N-((3-(4-(Benzyl(2-(benzyloxy)ethyl)amino)-3-fluorophenyl)-2-oxooxazolidin-5-yl)methyl)acetamide, CAS: /, stock: 9.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₂FN₃O₆.

(S)-N-((3-Fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl)-N-methylacetamide, CAS: /, stock: 7.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂FN₃O₄.

(S)-N-(3-((3-Fluoro-4-morpholinophenyl)amino)-2-hydroxypropyl)acetamide, CAS: 1561176-27-9, stock: 9.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂FN₃O₃.

(S)-N-(Acetamido-2-hydroxypropyl)-N-(3-fluoro-4-morpholinophenyl)acetamide, CAS: /, stock: 5.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₄FN₃O₄.

1-(3-Fluoro-4-morpholinophenyl)-2-methyl-1,4,5,6-tetrahydropyrimidin-5-ol, CAS: /, stock: 5.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀FN₃O₂.

2-[(4-Amino-2-fluorophenyl)amino]ethanol, CAS: 1039868-68-2, stock: 9.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁FN₂O.

3-Fluoro-4-(4-morpholinyl) Benzenamine, CAS: 93246-53-8, stock: 5.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃FN₂O.

3-Fluoro-4-morpholinophenyl-(2R)-oxyranyl Methylamine, CAS: /, stock: 7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇FN₂O₂.

3-Fluoro-4-morpholinophenyl-(2R)-oxyranyl Methylamine-d8, CAS: /, stock: 1.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉D₈FN₂O₂.

4-Benzyloxybenzylidene 4-Fluoroaniline, CAS: 70627-52-0, stock: 9.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆FNO.

Benzyl (4-(((Benzyloxy)carbonyl)amino)-2-fluorophenyl)(2-((tert-butyldimethylsilyl)oxy)ethyl)carbamate, CAS: /, stock: 3.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₇FN₂O₅Si.

Deacetamide Linezolid Azide, CAS: 168828-84-0, stock: 8.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆FN₅O₃.

Deacetyl (R)-Linezolid, CAS: 912359-80-9, stock: 9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈FN₃O₃.

Deacetyl Linezolid, CAS: 168828-90-8, stock: 4.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈FN₃O₃.

Deacetyl Linezolid Thioacetamide, CAS: 216868-57-4, stock: 9.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀FN₃O₃S.

Deacetyl Linezolid Tosylate Salt, CAS: 1334229-25-2, stock: 5.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈FN₃O₃•SC₇H₈O₃S.

Defluoro Linezolid, CAS: 556801-15-1, stock: 2.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁N₃O₄.

Defluoro Linezolid-d3, CAS: 1795786-92-3, stock: 7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈D₃N₃O₄.

Desacetyl-N,O-descarbonyl Linezolid, CAS: 333753-72-3, stock: 2.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀FN₃O₂.

Linezolid, CAS: 165800-03-3, stock: 8.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀FN₃O₄.

Linezolid Dimer, CAS: 908143-04-4, stock: 9.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₅F₂N₅O₇.

Linezolid Diphthalimide, CAS: 1798014-14-8, stock: 3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₁FN₄O₇.

Linezolid N-Oxide, CAS: 189038-36-6, stock: 7.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀FN₃O₅.

Linezolid N-Oxide-D3, CAS: /, stock: 4.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇D₃FN₃O₅.

Linezolid-d3, CAS: 1127120-38-0, stock: 4.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇D₃FN₃O₄.

N,N’-Di-Boc (R)-1-Azido-3-[[3-fluoro-4-(morpholin-4-yl)phenyl]amino]propan-2-yl Acetate, CAS: /, stock: 3.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₈FN₃O₇.

N,O-Desethylene Linezolid, CAS: 1219708-30-1, stock: 1.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈FN₃O₄.

N-(3-Fluoro-4-morpholinophenyl)acetamide, CAS: /, stock: 4.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅FN₂O₂.

N-3-Oxobutyl Linezolid, CAS: /, stock: 1.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆FN₃O₅.

N-​[(2R)​-​3-​Azido-​2-​hydroxypropyl]​-​N-​[3-​fluoro-​4-​(4-​morpholinyl)​phenyl]​-acetamide, CAS: /, stock: 4.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₃FN₅O₄⁺.

N-​[(2R)​-​3-​Azido-​2-​hydroxypropyl]​-​N-​[3-​fluoro-​4-​(4-​morpholinyl)​phenyl]​-acetamide, CAS: 2055572-72-8, stock: 6.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁FN₅O₃⁺.

N-Boc (R)-1-Azido-3-[[3-fluoro-4-(morpholin-4-yl)phenyl]amino]propan-2-ol, CAS: /, stock: 4.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆FN₅O₄.

N-Boc (R)-1-Azido-3-[[3-fluoro-4-(morpholin-4-yl)phenyl]amino]propan-2-yl Acetate, CAS: /, stock: 9.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈FN₅O₅.

N-Boc N-Desacetyl-N,O-descarbonyl O-Acetyl Linezolid, CAS: /, stock: 2.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀FN₃O₅.

N-Desacetyl-N,O-descarbonyl O-Acetyl Linezolid, CAS: 333753-71-2, stock: 8.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂FN₃O₃.

N-Desacetyl-N,O-descarbonyl O-Acetyl Linezolid Dihydrochloride, CAS: /, stock: 1.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₄Cl₂FN₃O₃.

N-t-Butyl Linezolid, CAS: 1215006-11-3, stock: 5.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈FN₃O₄.

N-t-Butyl Linezolid-d9, CAS: /, stock: 9.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₉D₉FN₃O₄.

N-t-Butyl N-Deactyl Linezolid, CAS: 1215006-08-8, stock: 7.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆FN₃O₃.

N-t-Butyl N-Deactyl Linezolid-d9, CAS: /, stock: 6.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇D₉FN₃O₃.

N-[(2R)-3-[[3-Fluoro-4-(4-morpholinyl)phenyl]amino]-2-hydroxypropyl]acetamide, CAS: 333753-67-6, stock: 4.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂FN₃O₃.

N-[(2R)-3-[[3-Fluoro-4-(4-morpholinyl)phenyl]amino]-2-hydroxypropyl]acetamide-d8, CAS: 1795786-87-6, stock: 4.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄D₈FN₃O₃.

N-[(2S)-3-Amino-2-hydroxypropyl]-N-[3-fluoro-4-(4-morpholinyl)phenyl]acetamide Hydrochloride, CAS: 1391068-25-9, stock: 1.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₃ClFN₃O₃.

N-[2-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]ethyl]-2-fluoro-4-nitro-benzenamine, CAS: 1219708-11-8, stock: 3.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₃FN₂O₃Si.

N-[3-[[3-Fluoro-4-(4-morpholinyl)phenyl]amino]-2-hydroxypropyl]acetamide, CAS: 1666111-36-9, stock: 5.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂FN₃O₃.

N-[[(5S)-3-[4-[(2-Hydroxyethyl)amino]phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide(Linezolid Impurity), CAS: 227200-81-9, stock: 9.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉N₃O₄.

N1-[2-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]ethyl]-2-fluoro-1,4-benzenediamine, CAS: /, stock: 6.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₅FN₂OSi.

PNU 142300-13C1,d2, CAS: /, stock: 7.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅¹³CH₁₈D₂FN₃O₆.

PNU 142586-13C1,d2 Sodium Salt, CAS: /, stock: 2.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅¹³CH₁₇D₂FN₃NaO₆.

[(R)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methanol, CAS: 168828-82-8, stock: 4.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇FN₂O₄.

[3-Fluoro-4-(4-morpholinyl)phenyl]carbamic Acid Phenylmethyl Ester, CAS: 168828-81-7, stock: 2.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉FN₂O₃.

(2R)-2-[[[(1,1-Dimethylethyl)dimethylsilyl]oxy]methyl]-4-propylidene-1-pyrrolidinecarboxylic Acid 1,1-Dimethylethyl Ester, CAS: /, stock: 6.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₇NO₃Si.

(2R,4R)-2-(Hydroxymethyl)-4-propyl-1-pyrrolidinecarboxylic Acid 1,1-Dimethylethyl Ester, CAS: 1432589-42-8, stock: 3.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₅NO₃.

(2R,4R)-2-[[[(1,1-Dimethylethyl)dimethylsilyl]oxy]methyl]-4-hydroxy-1-pyrrolidinecarboxylic Acid 1,1-Dimethylethyl Ester, CAS: 216062-16-7, stock: 6.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₃₃NO₄Si.

(2R,4R)-4-Propyl-1,2-pyrrolidinedicarboxylic Acid 1-(1,1-Dimethylethyl) Ester, CAS: /, stock: 6.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₃NO₄.

(2R,4S)-2-(Hydroxymethyl)-4-propyl-1-pyrrolidinecarboxylic Acid 1,1-dimethylethyl Ester, CAS: /, stock: 8.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₅NO₃.

(2S)-4’-Depropyl-4’-propylidenelincomycin (Mixture of Diastereomers), CAS: 37744-65-3, stock: 7.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₂N₂O₆S.

(2S)-4’-Depropyl-4’-propylidenelincomycin-d3, CAS: /, stock: 5.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₉D₃N₂O₆S.

(2S,4R)-4-Ethyl-1-methylproline Hydrochloride, CAS: 2880-73-1, stock: 5.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆ClNO₂.

(2S,4R)-4-Ethyl-L-proline Hydrochloride, CAS: /, stock: 8.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄ClNO₂.

(2S,4S)-2-[[[(1,1-Dimethylethyl)dimethylsilyl]oxy]methyl]-4-propyl-1-pyrrolidinecarboxylic Acid 1,1-Dimethylethyl Ester, CAS: /, stock: 2.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₉NO₃Si.

(4R)-1-Methyl-4-propyl-D-proline, CAS: 733676-34-1, stock: 8.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₂.

(4R)-4-Propyl-D-proline Hydrochloride, CAS: 804549-25-5, stock: 3.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₂ •HCl.

1-Methyl-4-propyl-1H-pyrrole-2-carboxaldehyde, CAS: 2090590-93-3, stock: 1.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃NO.

1-Methyl-4-propyl-1H-pyrrole-2-carboxaldehyde-d3, CAS: /, stock: 8.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀D₃NO.

1’,2,3,4-Tetra-O-trimethylsilylepilincomycin, CAS: 25405-72-5, stock: 7.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₆₆N₂O₆SSi₄.

2,3,4-Tri-O-trimethylsilylepilincomycin, CAS: /, stock: 6.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₅₈N₂O₆SSi₃.

2,3,4-Tri-O-trimethylsilyllincomycin, CAS: 25420-97-7, stock: 6.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₅₈N₂O₆SSi₃.

2’-epi-(6S,7S)-Lincomycin, CAS: /, stock: 3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₄N₂O₆S.

2’-epi-(6S,7S)-Lincomycin-d3, CAS: /, stock: 9.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₁D₃N₂O₆S.

2’-epi-Lincomycin, CAS: /, stock: 5.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₄N₂O₆S.

2’-Oxo-2,3,4-tetra-O-trimethylsilylepilincomycin, CAS: /, stock: 8.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₅₆N₂O₆SSi₃.

3,4-O-Isopropylidenelincomycin, CAS: 24699-08-9, stock: 6.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₈N₂O₆S.

3,4-O-p-Anisylideneclindamycin Hydrochloride, CAS: 25908-42-3, stock: 8.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₀Cl₂N₂O₆S.

4-​Bromo-​1-​methyl-1H-​pyrrole-​2-​carboxaldehyde, CAS: 33694-79-0, stock: 3.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆BrNO.

7-Epi Clindamycin, CAS: 16684-06-3, stock: 3.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₃ClN₂O₅S.

7-Epi Lincomycin Hydrochloride Salt, CAS: 26389-84-4, stock: 1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₅ClN₂O₆S.

7-Epi-lincomycin 2,7-Dipalmitate, CAS: /, stock: 9.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀H₉₄N₂O₈S.

7-Epi-lincomycin 2,7-Dipalmitate-d62, CAS: /, stock: 9.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀H₃₂D₆₂N₂O₈S.

7-Epiclindamycin 2-Phosphate (>90%), CAS: 620181-05-7, stock: 8.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₄ClN₂O₈PS.

Bis-clindamycinyl Phosphate, CAS: /, stock: 3.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₆₅Cl₂N₄O₁₂PS₂.

(R)-8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-6-((4-methylquinazolin-2-yl)methoxy)-3,7-dihydro-2H-purin-2-one, CAS: /, stock: 4.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₈N₈O₂.

Bis-clindamycinyl-(2,2-dimethyltetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran) Phosphate, CAS: /, stock: 9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₇₃Cl₂N₄O₁₂PS₂.

Cis-Clindamycin Hydrochloride, CAS: /, stock: 6.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₃ClN₂O₅S  • ( HCl).

(S)-Linagliptin, CAS: /, stock: 4.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₈N₈O₂.

(S)-Linagliptin tert-Butyl Ester, CAS: 668273-74-3, stock: 9.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₆N₈O₄.

Clindamycin, CAS: 18323-44-9, stock: 9.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₃ClN₂O₅S.

Clindamycin 2-Phosphate, CAS: 24729-96-2, stock: 1.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₄ClN₂O₈PS.

2-(Chloromethyl)-4-methylquinazoline, CAS: 109113-72-6, stock: 4.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉ClN₂.

3-Deamino 3-Hydroxy Linagliptin, CAS: /, stock: 5.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₇N₇O₃.

Clindamycin B 2-Phosphate, CAS: 54887-31-9, stock: 3.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₈ClN₂O₁₄PS.

3-Deamino 3-Hydroxy Linagliptin-d3, CAS: /, stock: 8.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₄D₃N₇O₃.

Clindamycin Cyclomonophosphate, CAS: /, stock: 8.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₂ClN₂O₇PS.

Clindamycin Hydrochloride, CAS: 21462-39-5, stock: 2.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₃ClN₂O₅S•HCl.

4-Methyl-2-quinazolinecarboxylic Acid Ethyl Ester, CAS: 68674-74-8, stock: 4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂N₂O₂.

7-(2-Butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione, CAS: /, stock: 8.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈N₆O₂.

Clindamycin N-Oxide, CAS: /, stock: 6.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₃ClN₂O₆S.

7-(2-Butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione-d3, CAS: /, stock: 4.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₅D₃N₆O₂.

7-(But-2-yn-1-yl)-3-methyl-8-((4-methylquinazolin-2-yl)methoxy)-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione, CAS: /, stock: 2.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₆N₈O₃.

Clindamycin Pyrophosphate Triethylamine Salt, CAS: /, stock: 1.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₅ClN₂O₁₁P₂S xC ₆H₁₅N.

Clindamycin Sulfoxide(Mixture of Diastereomers), CAS: 22431-46-5, stock: 1.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₃ClN₂O₆S.

7-(But-2-yn-1-yl)-3-methyl-8-(methylamino)-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione, CAS: /, stock: 7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁N₇O₂.

7-(But-2-yn-1-yl)-8-(dimethylamino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione, CAS: 1646355-34-1, stock: 4.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₃N₇O₂.

Clindamycin-13C,D3, CAS: 2140264-63-5, stock: 3.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇¹³CH₃₀D₃ClN₂O₅S.

Clindamycin-13C,D3 Hydrochloride, CAS: 2140264-64-6, stock: 7.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇¹³CH₃₀D₃ClN₂O₅S  •  HCl.

8-Bromo-3,7-dihydro-3-methyl-7-(phenylmethyl)-1H-purine-2,6-dione, CAS: 93703-26-5, stock: 8.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁BrN₄O₂.

8-Bromo-3,7-dihydro-3-methyl-7-(phenylmethyl)-1H-purine-2,6-dione-d5, CAS: /, stock: 3.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₆D₅BrN₄O₂.

Clindamycin-13C,D3 Sulfoxide, CAS: /, stock: 3.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇¹³CH₃₀D₃ClN₂O₆S.

Clindamycin-d3 Hydrochloride, CAS: 1356933-72-6, stock: 2.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₁D₃Cl₂N₂O₅S.

8-Bromo-3,9-dihydro-3-methyl-1H-purine-2,6-dione, CAS: 93703-24-3, stock: 6.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅BrN₄O₂.

Dehydroxy-chloro 2,3,4-Tri-O-trimethylsilylepilincomycin, CAS: /, stock: 3.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₅₇ClN₂O₅SSi₃.

Epoxy p-Methoxybenzene Lincomycin Hydrochloride, CAS: /, stock: 2.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₀N₂O₇S•HCl.

8-Bromo-3-methyl-7-(2-butynyl)-xanthine, CAS: 666816-98-4, stock: 6.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉BrN₄O₂.

8-Bromo-3-methyl-9-(2-butynyl)-xanthine, CAS: /, stock: 9.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉BrN₄O₂.

Epoxy p-Methoxybenzene Triphenylmethyl Lincomycin Hydrochloride, CAS: /, stock: 4.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₅₄N₂O₇S.

L-trans-1-Methyl-4-propyl-2-pyrrolidinecarboxamide, CAS: 6838-19-3, stock: 2.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈N₂O.

L-​Cysteinyl-​L-​cysteinyl-​L-​α-​glutamyl-​L-​tyrosyl-​L-​cysteinyl-​L-​cysteinyl-​L-​asparaginyl-​L-​prolyl-​L-​alanyl-​L-​cysteinyl-​L-​threonylglycyl-​L-​cysteinyl-L-​Tyrosine Trifluoroacetate, CAS: 1638632-09-3, stock: 5.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₁H₈₆F₃N₁₅O₂₃S₆.

Des-(N-butyn-1-yl) N-(Buta-1,2-Dien-1-yl) Linagliptin (Linagliptin Diene Impurity), CAS: /, stock: 2.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₈N₈O₂.

Des-(R)-piperidin-3-amine 8-(R)-(Piperidin-3-ylamino) Linagliptin, CAS: 1446263-38-2, stock: 7.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₈N₈O₂.

Lincomycin, CAS: 154-21-2, stock: 6.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₄N₂O₆S.

Lincomycin 2,4-Diphosphate, CAS: /, stock: 3.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₆N₂O₁₂P₂S.

Linaclotide, CAS: 851199-59-2, stock: 4.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₉H₇₉N₁₅O₂₁S₆.

Linaclotide-d4, CAS: /, stock: 1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₉H₇₅D₄N₁₅O₂₁S₆.

Des-(R)-piperidin-3-amine 8-(R)-(Piperidin-3-ylamino) Linagliptin-d3, CAS: /, stock: 4.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₅D₃N₈O₂.

Linagliptin, CAS: 668270-12-0, stock: 6.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₈N₈O₂.

Lincomycin 2,7-Dipalmitate, CAS: /, stock: 9.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀H₉₄N₂O₈S.

Lincomycin 2,7-Dipalmitate-d62, CAS: /, stock: 2.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀H₃₂D₆₂N₂O₈S.

MM-419447 (Linaclotide Metabolite) Trifluoroacetic acid, CAS: /, stock: 1.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀H₇₆N₁₄O₁₉S₆ • x(C ₂HF₃O₂).

MM-419447-d4 Trifluoroacetic Acid Salt (Linaclotide Metabolite), CAS: /, stock: 8.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀H₇₂D₄N₁₄O₁₉S₆  • x(C ₂HF₃O₂).

Linagliptin Acetamide, CAS: 1803079-49-3, stock: 5.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₀N₈O₃.

Linagliptin Acetamide-d3, CAS: /, stock: 5.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₇D₃N₈O₃.

Lincomycin 2-Palmitate Hydrochloride, CAS: 23295-14-9, stock: 9.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₆₅ClN₂O₇S.

Lincomycin 2-Phosphate, CAS: 27480-30-4, stock: 2.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₅N₂O₉PS.

Linagliptin Acetyl Phenyl Impurity, CAS: /, stock: 6.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₅N₇O₃.

Linagliptin Ethyldimer, CAS: /, stock: 4.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₂H₅₈N₁₆O₄.

Lincomycin B, CAS: 2520-24-3, stock: 2.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₂N₂O₆S.

Linagliptin Impurity, CAS: /, stock: 8.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₈N₈O₂.

Linagliptin Methyldimer, CAS: 1418133-47-7, stock: 7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀H₅₆N₁₆O₄.

Lincomycin B Hydrochloride, CAS: 11021-35-5, stock: 7.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₃ClN₂O₆S.

Lincomycin B-d3 Hydrochloride, CAS: /, stock: 7.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₀D₃ClN₂O₆S.

Linagliptin Methyldimer-d6, CAS: /, stock: 7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀H₅₀D₆N₁₆O₄.

Linagliptin N-D-Glucuronide, CAS: /, stock: 7.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₈N₈O₇.

Lincomycin Hydrochloride, CAS: 859-18-7, stock: 8.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₅ClN₂O₆S.

Lincomycin hydrochloride monohydrate, CAS: 7179-49-9, stock: 8.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₄N₂O₆S • HCl • H  ₂O.

Linagliptin-d3, CAS: 1398044-48-8, stock: 8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₅D₃N₈O₂.

N-Boc Linagliptin, CAS: 668273-75-4, stock: 4.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₆N₈O₄.

Lincomycin-13C,D3, CAS: /, stock: 6.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇¹³CH₃₁D₃N₂O₆S.

Lincomycin-13C,D3 Sulfoxide, CAS: /, stock: 7.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇¹³CH₃₁D₃N₂O₇S.

N-Carbamoyl Linagliptin, CAS: /, stock: 6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₀N₈O₃.

N-Depiperidin-3-amine Linagliptin Dimer, CAS: /, stock: 8.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₄₅N₁₃O₄.

Lincomycin-d3, CAS: /, stock: 9.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₁D₃N₂O₆S.

N-Depiperidin-3-amine Linagliptin Dimer-d3, CAS: /, stock: 3.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₄₂D₃N₁₃O₄.

N-Des(2-butynyl) 3’-N-Boc Linagliptin, CAS: /, stock: 3.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₂N₈O₄.

Methyl 7-Chloro-7-deoxy-1-thiolincosaminide, CAS: 22965-79-3, stock: 9.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈ClNO₄S.

N-Demethyl Lincomycin Hydrochloride, CAS: 14600-41-0, stock: 7.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₃ClN₂O₆S.

N-Des-(2-butyn-1-yl)-N-(3-bromo-2-buten-1-yl) Linagliptin (E/Z Mixture), CAS: /, stock: 2.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₉BrN₈O₂.

N-Formyl Linagliptin, CAS: /, stock: 9.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₉N₇O₃.

(11α,13E,17S)-9-O-Acetyl-17,20-dimethyl-15-oxo-2-(phenylseleno)-11-O-tetrahydropyranyl-prosta-13-en-1-oic Acid-d3 Methyl Ester (Mixture of Diastereomers), CAS: /, stock: 3.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₅₁D₃O₇Se.

N-Demethylclindamycin, CAS: 22431-45-4, stock: 6.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₁ClN₂O₅S.

N-Phthalimide-linagliptin, CAS: 886588-63-2, stock: 1.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₀N₈O₄.

(1R,2S,3R,5S)-2-(tert-Butyldiphenylsilyloxy)methyl-3,5-dihydroxy-cyclopentaneheptanoic Acid Methyl Ester, CAS: /, stock: 6.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₄O₅Si.

(1R,2S,3R,5S)-2-(tert-Butyldiphenylsilyloxy)methyl-5-hydroxy-3-tetrahydropyranyloxy-cyclopentaneheptanoic Acid Methyl Ester (Mixture of Diastereomers), CAS: /, stock: 3.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₅₂O₆Si.

N-Phthalimide-linagliptin-d3, CAS: /, stock: 1.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₇D₃N₈O₄.

N-[1-[7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-urea, CAS: 1955514-80-3, stock: 7.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₉N₉O₃.

(1R,2S,3R,5S)-2-(tert-Butyldiphenylsilyloxy)methyl-5-hydroxy-3-tetrahydropyranyloxy-α-(phenylseleno)cyclopentaneheptanoic Acid Methyl Ester (Mixture of Diastereomers), CAS: /, stock: 8.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₅₆O₆SeSi.

(1R,2S,3R,5S)-5-Acetyloxy-2-hydroxymethyl-3-tetrahydropyranyloxy-α-(phenylseleno)cyclopentaneheptanoic Acid Methyl Ester (Mixture of Diastereomers), CAS: 61302-47-4, stock: 7.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₀O₇Se.

(1R,2S,3R,5S,δZ)-2-(tert-Butyldiphenylsilyloxy)methyl-5-hydroxy-3-tetrahydropyranyloxy-cyclopentanehept-δ-en-oic Acid Methyl Ester (Mixture of Diastereomers), CAS: 172016-60-3, stock: 9.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₅₀O₆Si.

(2E,11α,13E,15S,17S)-11,15-Di-O-tetrahydropyranyl-17,20-dimethyl-9,11,15-trihydroxy-prosta-2,13-diene-1-oic Acid-d3 Methyl Ester (Mixture of Diastereomers), CAS: 1316264-00-2, stock: 2.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₃D₃O₇.

10,11-Dehydroxy Limaprost (>85%) Sodium Salt, CAS: /, stock: 3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₄NaO₄.

10,11-Dehydroxy Limaprost-d3, CAS: /, stock: 3.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₁D₃O₄.

11-Deoxy Limaprost, CAS: 853998-93-3, stock: 8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₆O₄.

11-Deoxy Limaprost-d3, CAS: /, stock: 5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₃D₃O₄.

15-Keto Limaprost, CAS: /, stock: 4.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₄O₅.

15-Keto Limaprost-d3, CAS: /, stock: 2.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₁D₃O₅.

17epi-Limaprost, CAS: 75554-85-7, stock: 4.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₆O₅.

8-iso-Limaprost, CAS: /, stock: 8.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₆O₅.

Limaprost, CAS: 74397-12-9, stock: 7.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₆O₅.

Limaprost-d3, CAS: 1263190-37-9, stock: 5.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₃D₃O₅.

2,2’-Iminobis(N-(2,6-Dimethylphenyl)acetiamide, CAS: 745798-07-6, stock: 9.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅N₃O₂.

2,2’-Iminobis(N-(2,6-Dimethylphenyl)acetiamide-d12 Hydrochloride, CAS: /, stock: 4.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₄D₁₂ClN₃O₂.

2,5-Dimethyl-3-(2-methylphenyl)-1-propylimidazolini-4-one, CAS: /, stock: 4.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂N₂O.

2-(Diethylamino)-N-(2,3-dimethylphenyl)acetamide Hydrochloride, CAS: 857170-72-0, stock: 7.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₃ClN₂O.

2-(Diethylamino)-N-(2,3-dimethylphenyl)acetamide-d10 Hydrochloride, CAS: /, stock: 4.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃D₁₀ClN₂O.

2-(Diethylamino)-N-(2,5-dimethylphenyl)acetamide Hydrochloride, CAS: 1012864-23-1, stock: 2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₃ClN₂O.

2-(Diethylamino)-N-(2,5-dimethylphenyl)acetamide-d10 Hydrochloride, CAS: /, stock: 8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃D₁₀ClN₂O.

2-(Dimethylamino)acetanilide, CAS: 35508-96-4, stock: 3.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O.

2-(Dimethylamino)acetanilide-d6, CAS: /, stock: 8.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈D₆N₂O.

2-(Isopropylamino)-2’,6’-acetoxylidide Hydrochloride, CAS: 35891-87-3, stock: 6.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₁ClN₂O.

2-(Isopropylamino)-2’,6’-acetoxylidide-d7 Hydrochloride, CAS: /, stock: 7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄D₇N₂O.

2-​(Diethylamino)​-​N-​(2,​4-​dimethylphenyl)​acetamide Hydrochloride, CAS: 17289-54-2, stock: 4.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₃ClN₂O.

2-​(Diethylamino)​-​N-​(2,​4-​dimethylphenyl)​acetamide-d10 Hydrochloride, CAS: /, stock: 7.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃D₁₀ClN₂O.

2-Chloro-2’,6’-dimethyl-d6-acetanilide, CAS: /, stock: 4.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆D₆ClNO.

2-Chloro-2’,6’-dimethylacetanilide, CAS: 1131-01-7, stock: 4.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂ClNO.

2-Desmethyl 4-Methyl Prilocaine, CAS: 744961-76-0, stock: 1.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀N₂O.

3-(Diethylamino)-8-methyl-2(1H)-quinolinone, CAS: 113225-33-5, stock: 3.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈N₂O.

3-Amino Lidocaine, CAS: 39942-50-2, stock: 4.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₃N₃O.

3-Amino-2,4-xylenol, CAS: 100445-96-3, stock: 1.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁NO.

3-Bromo Lidocaine, CAS: 1044658-01-6, stock: 9.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₁BrN₂O.

3-Bromo Lidocaine-d5, CAS: /, stock: 5.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆D₅BrN₂O.

3-Bromo-N-desethyl-N-benzyl Lidocaine, CAS: 1797880-42-2, stock: 2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃BrN₂O.

3-Hydroxy Lidocaine, CAS: 34604-55-2, stock: 8.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂N₂O₂.

3-Hydroxy Lidocaine-d5, CAS: 1286482-71-0, stock: 3.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇D₅N₂O₂.

3-Hydroxy-N-desethyl Lidocaine, CAS: 34604-56-3, stock: 4.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂O₂.

3-Hydroxy-N-desethyl Lidocaine-d5, CAS: 1286490-96-7, stock: 2.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃D₅N₂O₂.

3-Hydroxy-N-desethyl-N-benzyl Lidocaine, CAS: 1797131-04-4, stock: 2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄N₂O₂.

3-Nitro Lidocaine, CAS: 39942-49-9, stock: 3.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₁N₃O₃.

4-Acetoxy-2,6-xylidine, CAS: 39942-44-4, stock: 6.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₂.

4-Amino-3,5-xylenol, CAS: 3096-70-6, stock: 2.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁NO.

4-Amino-3,5-xylenol-d6, CAS: /, stock: 4.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅D₆NO.

4-Hydroxylidocaine, CAS: 39942-41-1, stock: 2.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂N₂O₂.

4-Hydroxylidocaine-d10, CAS: /, stock: 8.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂D₁₀N₂O₂.

4’-Bromo-2-(diethylamino)-2’,6’-acetoxylidide, CAS: 17060-81-0, stock: 7.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₁BrN₂O.

Lidocaine, CAS: 137-58-6, stock: 9.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂N₂O.

Lidocaine Hydrochloride, CAS: 73-78-9, stock: 9.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂N₂O • HCl.

Lidocaine Hydrochloride Monohydrate, CAS: 6108-05-0, stock: 2.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₅ClN₂O₂.

Lidocaine N-Oxide, CAS: 2903-45-9, stock: 9.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂N₂O₂.

Lidocaine-d10 Hydrochloride, CAS: 1189959-13-4, stock: 9.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃D₁₀ClN₂O.

Lidocaine-d10 N-Oxide, CAS: 851528-10-4, stock: 2.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂D₁₀N₂O₂.

Lidocaine-d6 Hydrochloride, CAS: /, stock: 5.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇D₆ClN₂O.

N-(2,6-Dimethylphenyl)-2-(ethylmethylamino)acetamide Hydrochloride, CAS: 50295-20-0, stock: 6.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₁ClN₂O.

N-(2,6-Dimethylphenyl)-4-methyl-1-(2-methylphenyl)-5-oxo-3-propylimidazolidine-2-carboxamide, CAS: /, stock: 1.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉N₃O₂.

N-(2,6-Dimethylphenyl)acetamide, CAS: 2198-53-0, stock: 1.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO.

N-(2,6-Dimethylphenyl)acetamide-d3, CAS: 1329834-68-5, stock: 3.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀D₃NO.

N-(4-Bromo-2,6-dimethylphenyl)-2-chloroacetamide, CAS: 17058-74-1, stock: 9.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁BrClNO.

N-(Chloroacetyl)-2,5-dimethylaniline, CAS: 5177-35-5, stock: 9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂ClNO.

N-Desethyl 3-Bromo Lidocaine, CAS: 1246818-42-7, stock: 5.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇BrN₂O.

N-Desmethyl 3-Hydroxy Mepivacaine, CAS: 247061-17-2, stock: 5.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀N₂O₂.

N-Methyllidocaine Iodide, CAS: 1462-71-1, stock: 9.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₅IN₂O.

(2S)-2-Amino-3-(4-(4-(2-hydroxy-2-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)acetoxy)-3,5-diiodophenoxy)-3,5-diiodophenyl)propanoic Acid, Ester-Bridged, CAS: 2088032-74-8, stock: 2.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₁₇I₈NO₈.

Prilocaine, CAS: 721-50-6, stock: 4.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀N₂O.

Prilocaine Hydrochloride, CAS: 1786-81-8, stock: 3.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₁ClN₂O.

(S)-2-(2-Amino-3-(4-(3,5-diiodo-4-methoxyphenoxy)-3,5-diiodophenyl)propanamido)acetic Acid, CAS: 2086260-61-7, stock: 7.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆I₄N₂O₅.

Prilocaine-d7 Hydrochloride, CAS: /, stock: 5.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄D₇ClN₂O.

QX 314 Bromide, CAS: 24003-58-5, stock: 4.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₇BrN₂O.

QX 314 Bromide-d5, CAS: /, stock: 9.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂D₅BrN₂O.

QX 572, CAS: 1042-42-8, stock: 4.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₂ClN₃O₂.

(S)-2-Amino-3-(4-(3-(4-(4-((S)-2-amino-2-carboxyethyl)-2,6-diiodophenoxy)-2,6-diiodophenoxy)-4-hydroxy-5-iodophenoxy)-3,5-diiodophenyl)propanoic Acid, CAS: 2088032-62-4, stock: 3.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₁I₇N₂O₈.

(S)-2-Amino-3-(4-(4-((4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodobenzoyl)oxy)-3-iodophenoxy)-3,5-diiodophenyl)propanoic Acid, Ester-bridged, CAS: 2086266-94-4, stock: 8.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₁₆I₇NO₇.

QX 572-d6, CAS: /, stock: 4.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆D₆ClN₃O₂.

[2-[(2,6-Dimethylphenyl)amino]-2-oxoethyl]carbamic Acid 1,1-Dimethylethyl Ester, CAS: 153407-40-0, stock: 9.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂N₂O₃.

(S)-2-Amino-3-(4-(4-(4-hydroxy-3,5-diiodophenoxy)-3-iodophenoxy)-3,5-diiodophenyl)propanoic Acid, CAS: /, stock: 7.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₄I₅NO₅.

(S)-2-Amino-3-(4-(4-(4-hydroxy-3-iodophenoxy)-3-iodophenoxy)-3,5-diiodophenyl)propanoic Acid, CAS: 2086263-05-8, stock: 7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₅I₄NO₅.

[2-[(2,6-Dimethylphenyl)amino]-2-oxoethyl]carbamic Acid-d6 1,1-Dimethylethyl Ester, CAS: /, stock: 10g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆D₆N₂O₃.

(S)-2-Amino-3-(4-(4-(5-(4-((S)-2-amino-2-carboxyethyl)-2,6-diiodophenoxy)-2-hydroxy-3-iodophenoxy)-3-iodophenoxy)-3,5-diiodophenyl)propanoic Acid, CAS: 1638929-80-2, stock: 7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₂I₆N₂O₈.

(S)-2-Amino-3-(4-(4-(5-(4-((S)-2-amino-2-carboxyethyl)-2,6-diiodophenoxy)-2-hydroxyphenoxy)-3-iodophenoxy)-3,5-diiodophenyl)propanoic Acid, CAS: 2088032-58-8, stock: 5.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₃I₅N₂O₈.

2-(2-Hydroxy-2-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)acetamido)-3-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)propanoic Acid, Amide-Bridged, CAS: /, stock: 5.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₁₇I₈NO₈.

2-(3-(4-Hydroxy-3,5-diiodophenoxy)-2,4-diiodobenzamido)-3-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)propanoic Acid, Amide-Bridged, CAS: /, stock: 5.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₁₆I₇NO₇.

3,3’,5-Triiodo Thyroacetic Acid, CAS: 51-24-1, stock: 4.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₉I₃O₄.

3,3’,5-Triiodo-L-thyronine, CAS: 03/02/6893, stock: 6.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂I₃NO₄.

3,3’,5’-Triiodo-L-thyronine, CAS: 5817-39-0, stock: 3.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂I₃NO₄.

3,5,3’,5’-Tetraiodo Thyroacetamide, CAS: 176258-88-1, stock: 1.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₉I₄NO₃.

3,5,3’,5’-Tetraiodo Thyroacetic Acid, CAS: 67-30-1, stock: 7.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₈I₄O₄.

(-)-Dimenthyl Fumarate, CAS: 34675-24-6, stock: 8.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₀O₄.

3,5,3’,5’-Tetraiodo Thyromandelic Acid, CAS: 93647-48-4, stock: 4.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₈I₄O₅.

2-Amino-6-iodopurine, CAS: 19690-23-4, stock: 3.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄IN₅.

Lobucavir, CAS: 127759-89-1, stock: 9.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N₅O₃.

Lobucavir-d4, CAS: 1346597-42-9, stock: 7.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁D₄N₅O₃.

[(1S)-(1α,2β,3β)]-3-(2-Amino-6-iodo-7H-purin-7-yl)-1,2-cyclobutanedimethanol Dibenzoate Ester;, CAS: 1246812-29-2, stock: 3.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₄IN₅O₄.

4-(4-Ethyl-2,6-diiodophenoxy)-2,6-diiodo-phenol, CAS: 176258-89-2, stock: 1.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀I₄O₂.

4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodo-benzenemethanol, CAS: 2055-94-9, stock: 6.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈I₄O₃.

α-Amino-4-hydroxy-3,5-diiodo-benzeneacetic Acid, CAS: 854646-83-6, stock: 6.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇I₂NO₃.

α-Hydroxy-4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodo-N-methyl-benzeneacetamide, CAS: 2088032-68-0, stock: 2.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁I₄NO₄.

β-Hydroxy Thyroxine, CAS: 107849-54-7, stock: 7.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁I₄NO₅.

Levothyroxine N-Methylamide, CAS: /, stock: 1.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄I₄N₂O₃.

N-Acetyl L-Thyroxine, CAS: 26041-51-0, stock: 7.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₃I₄NO₅.

N-Formyl Thyroxine, CAS: 671235-41-9, stock: 9.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁I₄NO₅.

O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-b-hydroxy-L-tyrosine, CAS: 107849-54-7, stock: 7.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁I₄NO₅.

O-Methylthyroxine, CAS: 4367-89-9, stock: 2.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃I₄NO₄.

Thyroxine, CAS: 51-48-9, stock: 4.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁I₄NO₄.

Thyroxine 4’-O-β-D-Glucuronide, CAS: 21462-56-6, stock: 8.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₉I₄NO₁₀.

Thyroxine Acyl-β-D-Glucuronide, CAS: 909880-81-5, stock: 7.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₉I₄NO₁₀.

Thyroxine Acyl-β-D-Glucuronide-13C6, CAS: /, stock: 4.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅¹³C₆H₁₉I₄NO₁₀.

(R)-6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone, CAS: 101328-85-2, stock: 8.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₃O.

Thyroxine Sodium Salt, CAS: 55-03-8, stock: 1.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀I₄NNaO₄.

Thyroxine-13C6, CAS: 1217780-14-7, stock: 3.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉¹³C₆H₁₁I₄NO₄.

(R)-N-Acetyl-6-(4-aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone, CAS: 220246-81-1, stock: 1.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅N₃O₂.

2-(2-(4-(4-Methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)hydrazono)malonamide, CAS: /, stock: 4.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆N₆O₃.

Thyroxine-13C6 4’-O-β-D-Glucuronide Disodium Salt, CAS: /, stock: 1.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅¹³C₆H₁₇I₄NNa₂O₁₀.

3(4-Aminophenyl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one, CAS: 36725-28-7, stock: 8.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₃O.

4-Amino-6-ethoxy-5-[[4-[(4R)-1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl]phenyl]azo]-α-[[4-[(4R)-1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl]phenyl]hydrazono]-2-pyrimidineacetonitrile, CAS: 618458-79-0, stock: 9.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₀N₁₂O₃.

Dextrosimendan, CAS: 144238-75-5, stock: 3.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂N₆O.

Levosimendan, CAS: 141505-33-1, stock: 4.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂N₆O.

Levosimendan Triazene Impurity, CAS: /, stock: 3.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₃N₇O₂.

Simendan, CAS: 131741-08-7, stock: 1.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂N₆O.

(17α)-13-Ethyl-3-methoxy-18,19-dinorpregna-2,5(10)-dien-20-yn-17-ol (Levonorgestrel Impurity T), CAS: 14507-51-8, stock: 4.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₀O₂.

(17β)-13-Ethyl-3-methoxygona-1,3,5(10),8-tetraen-17-ol, CAS: 7443-72-3, stock: 3.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆O₂.

(3E)-17-Deacetylnorgestimate, CAS: 74183-55-4, stock: 1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₉NO₂.

(3Z)-17-Desacetyl Norgestimate, CAS: 74183-54-3, stock: 5.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₉NO₂.

10β-Hydroxy D-(-)-Norgestrel, CAS: 21508-50-9, stock: 5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈O₃.

13-Ethyl-17-hydroxy-18,19-dinor-17α-pregn-5(10)-en-20-yn-3-one(Levo Norgestrel Impurity), CAS: 19914-67-1, stock: 3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈O₂.

13-Ethyl-17α-trimethylsilylethynyl-3-triflate-18,19-dinor-pregna-3,5-dien-17-ol, CAS: /, stock: 4.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₅F₃O₄SSi.

13-Ethyl-18,19-dinor-17α-pregn-4-en-20-yn-17-ol (~90%)(Levo Norgestrel Impurity), CAS: 32419-58-2, stock: 3.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₀O.

13-Ethyl-3,17α-trimethylsilylethynyl-18,19-dinor-pregna-3,5-dien-17-ol, CAS: /, stock: 9.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₄OSi₂.

13-Ethyl-3-ethynyl-18,19-dinor-17α-pregna-3,5-dien-20-yn-17-ol(Levo Norgestrel Impurity), CAS: 1337972-89-0, stock: 5.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈O.

13-Ethyl-3-methoxy-18,19-dinorpregna-2,5(10)-dien-20-yn-17-ol, CAS: 799-43-9, stock: 8.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₀O₂.

13-Ethyl-3-methoxygona-2,5(10)-dien-17β-ol, CAS: 1038-28-4, stock: 2.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀O₂.

13-Ethylgon-5(10)en-3,17-dione, CAS: 4222-96-2, stock: 5.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₆O₂.

16β-Hydroxy-17-epi-norethisterone, CAS: /, stock: 7.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆O₃.

17-Desacetyl Norgestimate-d6 (Major), CAS: 1263184-13-9, stock: 5.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃D₆NO₂.

17-epi-Norethindrone, CAS: 38673-36-8, stock: 6.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆O₂.

5(6)-Dehydro-4(5)-dihydro D-(-)-Norgestrel (~90%), CAS: 100021-05-4, stock: 2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈O₂.

5α-Dihydrolevonorgestrel, CAS: 78088-19-4, stock: 6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₀O₂.

6(7)-Dehydro Norgestrel, CAS: 51087-61-7, stock: 3.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆O₂.

6-Oxo D-(-)-Norgestrel, CAS: 1175109-63-3, stock: 7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆O₃.

6-Oxo D-(-)-Norgestrel-d6, CAS: /, stock: 2.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀D₆O₃.

6α-Hydroxy Levonorgestrel, CAS: 87585-03-3, stock: 2.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈O₃.

6β-Acetyl Levonorgestrel Acetate, CAS: /, stock: 2.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₂O₄.

6β-Hydroxy Levonorgestrel 17-Acetate, CAS: /, stock: 8.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₀O₄.

6β-Hydroxylevonorgestrel, CAS: 55555-97-0, stock: 2.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈O₃.

8(14)-Dehydro Norgestrel, CAS: 110785-09-6, stock: 1.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆O₂.

D-(-)-Norgestrel Sulfate Sodium Salt, CAS: /, stock: 7.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈O₅S.

D-(-)-Norgestrel-d8, CAS: /, stock: 7.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀D₈O₂.

D-Ethyl Gonendione, CAS: 21800-83-9, stock: 8.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₆O₂.

Δ5(10),6,8(9)-D-(-)-Norgestrel, CAS: 155683-59-3, stock: 8.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆O.

Levonorgestrel Glycidol, CAS: 117635-12-8, stock: 8.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₄O₆.

Methoxygonadiene, CAS: 2322-77-2, stock: 2.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈O₂.

rac 6β-Hydroxy Norgestrel, CAS: 20402-61-3, stock: 2.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈O₃.

(R)-Rexamino, CAS: 165035-66-5, stock: 8.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂O.

(S)-Rexamino, CAS: 165035-65-4, stock: 9.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂O.

2-Hydroxy Levamisole, CAS: 1292908-42-9, stock: 2.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂N₂OS.

4-Amino Levamisole Dihydrochloride, CAS: /, stock: 6.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₃S  •2HCl.

4-Carboxy Levamisole, CAS: /, stock: 9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂N₂O₂S.

4-Hydroxy Levamisole, CAS: 69359-04-2, stock: 8.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂N₂OS.

4-Nitro Levamisole, CAS: 76497-81-9, stock: 4.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁N₃O₂S.

4-Phenyl-2-imidazolidinone, CAS: 27129-49-3, stock: 9.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂O.

DL-2-Oxo-3-(2-mercaptoethyl)-5-phenylimidazolidine, CAS: 32190-33-3, stock: 2.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₂OS.

Levamisole Hydrochloride, CAS: 16595-80-5, stock: 5.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃ClN₂S.

Levamisole Phosphate, CAS: 32093-35-9, stock: 3.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂N₂S • H  ₃O₄P.

Levamisole-d5 Hydrochloride, CAS: 1246819-64-6, stock: 2.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈D₅ClN₂S.

N-(4-Chlorophenyl)-5,6-dihydro-4H-1,3-thiazin-2-amine, CAS: 103039-04-9, stock: 5.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁ClN₂S.

Rexamino, CAS: 52883-35-9, stock: 2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂O.

(4-Acetyl-L-Serine)Leuprorelin Trifluoroacetic Acid Salt, CAS: /, stock: 7.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₁H₈₆N₁₆O₁₃  • x(C ₂HF₃O₂).

Leuprolide Acetate EP Impurity D, CAS: 1926163-25-8, stock: 6.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₁H₈₆N₁₆O₁₃.

Leuprolide Acetate EP Impurity E, CAS: 1926163-23-6, stock: 1.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₉H₈₄N₁₆O₁₂.

Leuprolide Acetate EP Impurity F, CAS: 1872435-00-1, stock: 8.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₉H₈₄N₁₆O₁₂.

Leuprolide Acetate EP Impurity I, CAS: /, stock: 6.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₉H₈₄N₁₆O₂₀.

Leuprolide-d10 Trifluoroacetic Acid Salt, CAS: /, stock: 9.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₁H₇₅D₁₀F₃N₁₆O₁₄.

4,4’,4’’-Methylidynetrisbenzonitrile (Letrozole Impurity), CAS: 113402-31-6, stock: 6.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₃N₃.

4-(1H-1,2,4-Triazol-1-ylmethyl)benzonitrile, CAS: 112809-25-3, stock: 6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈N₄.

4-(4-Cyanobenzyl)-1,2,4-triazole, CAS: 112809-27-5, stock: 8.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈N₄.

4-Descyano-4-bromo-letrozole, CAS: 143030-54-0, stock: 6.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁BrN₄.

Bis(4-cyanophenyl)methanol, CAS: 134521-16-7, stock: 9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀N₂O.

Bis(4-cyanophenyl)methanol-d4, CAS: 1361326-42-2, stock: 1.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₆D₄N₂O.

Iso Letrozole, CAS: 112809-52-6, stock: 7.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₁N₅.

Letrozole, CAS: 112809-51-5, stock: 2.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₁N₅.

Letrozole N-Oxide, CAS: /, stock: 6.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₁N₅O.

Letrozole-d4 (major), CAS: 1133712-96-5, stock: 8.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₇D₄N₅.

Tris(4-cyanophenyl)methanol, CAS: 117678-98-5, stock: 6.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₃N₃O.

1-[(3,3-Diphenylpropyl)methylamino]-2-methyl-2-propanol, CAS: 100442-33-9, stock: 1.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₇NO.

1-[(3,3-Diphenylpropyl)methylamino]-2-methyl-2-propanol-d3, CAS: 1189689-16-4, stock: 8.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄D₃NO.

Dehydro Lercanidipine, CAS: 887769-34-8, stock: 8.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₉N₃O₆.

Dehydro Lercanidipine-d3, CAS: /, stock: 2.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₆D₃N₃O₆.

N-Methyl 3,3-Diphenylpropionamide-d3, CAS: 1189967-22-3, stock: 9.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄D₃NO.

Nitrendipine Dipropyl Ester, CAS: 77888-05-2, stock: 5.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆N₂O₆.

Nitrendipine Dipropyl-d7 Ester, CAS: /, stock: 8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₉D₇N₂O₆.

Nitrendipine Propyl Ester, CAS: 225785-54-6, stock: 7.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂N₂O₆.

Nitrendipine Propyl-d7 Ester, CAS: /, stock: 1.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₅D₇N₂O₆.

((2,5-Dimethylphenyl)sulfonyl)leucine, CAS: 1009793-82-1, stock: 9.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₁NO₄S.

((2,6-Dichlorophenyl)sulfonyl)leucine, CAS: 1009003-67-1, stock: 2.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₄SCl₂.

((4-(2-Methoxyphenoxy)phenyl)sulfonyl)leucine, CAS: 1008647-74-2, stock: 4.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃NO₆S.

(-)-Actinonin, CAS: 13434-13-4, stock: 5.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₅N₃O₅.

(1R,3S,5S,8aS)-Tetrahydro-5-phenyl-1,3-dipropyl-3H,8H-oxazolo[4,3-c][1,4]oxazin-8-one, CAS: 208932-18-7, stock: 7.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₅NO₃.

(2R,3R)-3-Hydroxynorleucine, CAS: 59286-26-9, stock: 3.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₃.

(2R,3S)-3-Hydroxynorleucine, CAS: 59286-25-8, stock: 8.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₃.

(2R,3S)-β-Hydroxyleucine, CAS: 87421-23-6, stock: 6.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₃.

(2S,2’S,5R)-5-Hydroxy Lysinonorleucine Hydrochloride, CAS: 869111-51-3, stock: 8.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₈Cl₃N₃O₅.

(2S,2’S,5S)-5-Hydroxy Lysinonorleucine, CAS: 869184-38-3, stock: 5.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₅N₃O₅.

(2S,2’S,5S)-5-Hydroxy Lysinonorleucine-d4, CAS: /, stock: 7.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₁D₄N₃O₅.

(2S,3R)-2-Amino-3-(benzyloxy)-4-methylpentanoic Acid Methyl Ester, CAS: /, stock: 1.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₁NO₃.

(2S,3R)-3-Hydroxy-2-((1S)-2-hydroxy-1-phenylethylamino)hexanoic Acid Methyl Ester, CAS: 208932-22-3, stock: 6.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₃NO₄.

(2S,3R)-3-Hydroxynorleucine, CAS: 10148-69-3, stock: 8.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₃.

(2S,3R)-β-Hydroxyleucine Hydrochloride, CAS: 1598376-94-3, stock: 4.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄ClNO₃.

(2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid (Orlistat Impurity), CAS: 130793-28-1, stock: 6.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₅NO₆.

(2S,3S)-(2S,3R)-2-Amino-3-hydroxy-4-methylpentanoic Acid Hydrochloride Salt, CAS: 1276018-25-7, stock: 4.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄ClNO₃.

(2S,3S)-3-Hydroxynorleucine, CAS: 10148-68-2, stock: 5.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₃.

(2S,3S,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid(Orlistat Impurity) (>80%), CAS: 130676-66-3, stock: 8.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₅NO₆.

(2S,3S,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid-d3(Mixture of Diastereomers), CAS: 1356932-14-3, stock: 4.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₂D₃NO₆.

(3S,3’S,5S,5’S,6R,6’R)3,3’-[[(Phenylmethyl)imino]bis[(3R)-3-hydroxy-4,1-butanediyl]]bis[2-oxo-5,6-diphenyl-4-morpholinecarboxylic Acid Bis(tert-butyl) Ester, CAS: 869111-56-8, stock: 5.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₇H₆₇N₃O₁₀.

(3S,3’S,5S,5’S,6R,6’R)3,3’-[[(Phenylmethyl)imino]bis[(3S)-3-hydroxy-4,1-butanediyl]]bis[2-oxo-5,6-diphenyl-4-morpholine, CAS: /, stock: 8.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₅₁N₃O₆.

(3S,3’S,5S,5’S,6R,6’R)3,3’-[[(Phenylmethyl)imino]bis[(3S)-3-hydroxy-4,1-butanediyl]]bis[2-oxo-5,6-diphenyl-4-morpholinecarboxylic Acid Bis(tert-butyl) Ester, CAS: 869111-60-4, stock: 6.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₇H₆₇N₃O₁₀.

(3S,5S,6R)-2-Oxo-3-[2-((S)-oxiranyl)ethyl]-5,6-diphenyl-4-morpholine, CAS: /, stock: 9.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁NO₃.

(3S,5S,6R)-2-Oxo-3-[2-(2R)-2-oxiranylethyl]-5,6-diphenyl-4-morpholinecarboxylic Acid tert-Butyl Ester, CAS: 753010-14-9, stock: 3.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₉NO₅.

(3S,5S,6R)-2-Oxo-3-[2-(2S)-2-oxiranylethyl]-5,6-diphenyl-4-morpholinecarboxylic Acid tert-Butyl Ester, CAS: 753010-15-0, stock: 5.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₉NO₅.

(3S,5S,6R)-3-[(3R)-4-Bromo-3-hydroxybutyl]-2-oxo-5,6-diphenyl-4-morpholinecarboxylic Acid tert-Butyl Ester, CAS: 869111-53-5, stock: 9.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₀BrNO₅.

(3S,5S,6R)-3-[(3S)-4-Bromo-3-hydroxybutyl]-2-oxo-5,6-diphenyl-4-morpholinecarboxylic Acid tert-Butyl Ester, CAS: 869111-54-6, stock: 5.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₀BrNO₅.

(4S)-4-Hydroxy-L-isoleucine, CAS: 55399-93-4, stock: 2.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₃.

(5R)-2-((R)-1-(Benzyloxy)-2-methylpropyl)-5-isopropyl-3,6-dimethoxy-2,5-dihydropyrazine, CAS: /, stock: 8.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀N₂O₃.

(5R,5’R)-Dihydroxy Lysinonorleucine, CAS: 869111-52-4, stock: 2.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₅N₃O₆.

(5R,5’S)-Dihydroxy Lysinonorleucine, CAS: /, stock: 4.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₅N₃O₆.

(5S,5’R)-Dihydroxy Lysinonorleucine, CAS: 869111-63-7, stock: 2.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₅N₃O₆.

(5S,5’S)-Dihydroxy Lysinonorleucine, CAS: 32619-23-1, stock: 2.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₅N₃O₆.

(5S,5’S)-Dihydroxy Lysinonorleucine-d4, CAS: /, stock: 3.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₁D₄N₃O₆.

(αR,2S,5R)-2,5-Dihydro-3,6-dimethoxy-α,5-bis(1-methylethyl)-2-pyrazinemethanol, CAS: 1620989-93-6, stock: 7.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₄N₂O₃.

(L-Leucinethiol)2 Dihydrochloride (disulfide bond), CAS: 112157-33-2, stock: 1.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₈N₂S₂ • 2 HCl.

(R)-3-((tert-Butoxycarbonyl)amino)-5-methylhexanoic Acid, CAS: 146398-18-7, stock: 9.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₃NO₄.

(R)-N-Fmoc-alpha-methylleucine, CAS: 1231709-23-1, stock: 4.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅NO₄.

1,4-Dihydro-7-methoxy-4-oxo-6-quinolinecarboxamide, CAS: 417724-81-3, stock: 8.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀N₂O₃.

(R,R,R,R)-Orlistat, CAS: 104872-27-7, stock: 5.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₃NO₅.

4-(4-Amino-3-chlorophenoxy)-7-methoxy-6-quinolinecarboxamide, CAS: 417722-93-1, stock: 2.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄ClN₃O₃.

(R,R,S,S)-Orlistat, CAS: 1225451-00-2, stock: 4.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₃NO₅.

(R,S,R,R)-Orlistat, CAS: 1620409-08-6, stock: 9.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₃NO₅.

4-Chloro-7-methoxy-6-quinolinecarboxamide, CAS: 417721-36-9, stock: 5.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉ClN₂O₂.

Demethyl Lenvatinib Quinolone, CAS: 1788901-76-7, stock: 1.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₇ClN₄O₅.

(R,S,S,S)-Orlistat Tetradecyl Ester, CAS: 1356019-45-8, stock: 4.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₅₇NO₅.

Desamino Hydroxy Descyclopropyl Lenvatinib, CAS: /, stock: 6.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄ClN₃O₅.

(S)-(S)-1-((2S,3S)-3-(4-methylpentyl)-4-oxooxetan-2-yl)tridecan-2-yl 2-formamido-4-Methylpentanoate, CAS: /, stock: 3.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₃NO₅.

Desamino Hydroxy Lenvatinib, CAS: 417717-21-6, stock: 5.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₈ClN₃O₅.

Descyclopropyl Lenvatinib, CAS: 417719-51-8, stock: 9.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅ClN₄O₄.

(S)-(S)-1-((2S,3S)-3-(6-methylheptyl)-4-oxooxetan-2-yl)tridecan-2-yl 2-formamido-4-Methylpentanoate, CAS: /, stock: 3.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₅₇NO₅.

(S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethylamine N-Acetyl-L-leucine Salt, CAS: 608141-43-1, stock: 5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₄N₂O₇S.

Desquinolinyl Lenvatinib, CAS: 796848-79-8, stock: 7.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁ClN₂O₂.

Lenvatinib, CAS: 417716-92-8, stock: 7.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₉ClN₄O₄.

(S)-2-Amino-5-oxo-hexanoic Acid Hydrobromide, CAS: 1217856-43-3, stock: 8.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂BrNO₃.

Lenvatinib N-Oxide, CAS: 1788901-86-9, stock: 2.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₉ClN₄O₅.

Lenvatinib-d5, CAS: /, stock: 3.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₄D₅ClN₄O₄.

(S)-tert-Butyl 2-((tert-butoxycarbonyl)amino)-6-hydroxyhexanoate, CAS: 213176-15-9, stock: 9.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₉NO₅.

(S,R,R,R)-Orlistat, CAS: 111466-61-6, stock: 7.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₃NO₅.

O-Demethyl Lenvatinib, CAS: 417717-04-5, stock: 6.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₇ClN₄O₄.

Phenyl N-​(2-​Chloro-​4-​hydroxyphenyl)​carbamate, CAS: 796848-80-1, stock: 8.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀ClNO₃.

(S,R,S,S)-Orlistat, CAS: 111466-63-8, stock: 8.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₃NO₅.

(S,S,R,R)-Orlistat, CAS: 111466-62-7, stock: 7.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₃NO₅.

(S,S,R,S)-Orlistat, CAS: 130193-42-9, stock: 6.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₃NO₅.

1-Amino-1-cyclopentanecarboxylic Acid, CAS: 52-52-8, stock: 3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NO₂.

1-Amino-1-cyclopentanecarboxylic Acid Methyl Ester, CAS: 78388-61-1, stock: 7.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃NO₂.

1-Propanethiol, CAS: 107-03-9, stock: 5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₈S.

2-​Ethyl-​2,​5-​dihydro-​4-​hydroxy-​3-​methyl-​5-​oxo-2-​furancarboxylic Acid Methyl Ester, CAS: 112026-00-3, stock: 6.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂O₅.

2-Chloro-N-methyl-5-(trifluoromethyl)-4-pyrimidinamine, CAS: 515824-43-8, stock: 3.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅ClF₃N₃.

3-Methyl-4-nitropyrazole, CAS: 5334-39-4, stock: 8.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅N₃O₂.

3-Oxopentanoic Acid, CAS: 10191-25-0, stock: 8.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈O₃.

3-[(tert-Butoxycarbonyl)amino]-3-(3-fluorophenyl)propanoic Acid, CAS: 284493-59-0, stock: 9.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈NO₄F.

3-[(tert-Butoxycarbonyl)amino]-3-(4-fluorophenyl)propanoic Acid, CAS: 284493-72-7, stock: 4.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈NO₄F.

4,5-Dehydro-leucine, CAS: 87392-13-0, stock: 9.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NO₂.

4,5-Dimethyl-3-hydroxy-2(5H)-furanone, CAS: 28664-35-9, stock: 5.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈O₃.

4,5-Dimethyl-3-hydroxy-2(5H)-furanone-13C2, CAS: 156420-66-5, stock: 1.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₂H₈O₃.

4,5-Dimethyl-3-hydroxy-2(5H)-furanone-13C3, CAS: /, stock: 5.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³C₃H₈O₃.

4-Methyl-2-[(4-methylphenyl)sulfonylamino]pentanoic Acid, CAS: 67368-40-5, stock: 4.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉NO₄S.

4-Methyl-L-leucine-d3, CAS: /, stock: 9.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂D₃NO₂.

4-Nitrobenzylsulfonyl Chloride, CAS: 4025-75-6, stock: 1.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆ClNO₄S.

5-Dimethylaminonaphthalene-1-sulfonyl-L-leucine, CAS: 1100-22-7, stock: 9.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄N₂O₄S.

5-Methyl-L-norleucine, CAS: 31872-98-7, stock: 6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅NO₂.

5-Methyl-L-norleucine Orlistat Analogue, CAS: 1356847-30-7, stock: 7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₅NO₅.

5-Methylhexyl Orlistat Decyl Ester, CAS: 1356354-21-6, stock: 4.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₅₁NO₅.

5H-Bis[1,3]dioxolo[4,5-b:4’,5’-d]pyran Isoleucine, CAS: /, stock: 3.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₀N₂O₇.

6,6,6-Trifluoronorleucine, CAS: 120200-04-6, stock: 8.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀NO₂F₃.

6-Bromo-5-hydroxy-N-[(phenylmethoxy)carbonyl]-L-norleucine 1,1-Dimethylethyl Ester, CAS: 495401-21-3, stock: 1.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆BrNO₅.

6-Bromo-5-oxo-N-[(phenylmethoxy)carbonyl]-L-norleucine 1,1-Dimethylethyl Ester, CAS: 224629-58-7, stock: 3.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄BrNO₅.

6-Diazo-5-oxo-L-norleucine, CAS: 157-03-9, stock: 1.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉N₃O₃.

6-Hydroxy-N-[(phenylmethoxy)carbonyl]-L-norleucine, CAS: 102922-72-5, stock: 8.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₅.

6-Oxo-N-[(phenylmethoxy)carbonyl]-L-norleucine Phenylmethyl Ester, CAS: 87829-74-1, stock: 5.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃NO₅.

6-[(3R,4R)-3-(Acetyloxy)-N,4-dimethyl-6-oxo-L-norleucine] Cyclosporin A, CAS: 121584-52-9, stock: 9.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₂H₁₀₉N₁₁O₁₄.

Allenic Norleucine, CAS: 18751-91-2, stock: 6.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉NO₂.

Aloc-l-nle(6-oh)-oh dcha, CAS: 1263045-06-2, stock: 4.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇NO₅.

Angiotensin (1-7), CAS: 51833-78-4, stock: 1.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₆₂N₁₂O₁₁.

Benzoyl-DL-leucine, CAS: 17966-67-5, stock: 9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₃.

Benzyl (2S)-2-carbobenzyloxyamino-6-hydroxyhexanoate, CAS: 84246-49-1, stock: 3.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅NO₅.

Benzyl (2S,3S,5S)-2-Hexyl-3-benzyloxy-5-[[(S)-2-(formylamino)-4-(methyl-d3)-pentanoyl]oxy]hexadecanoate, CAS: 1356931-00-4, stock: 6.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₆₄D₃NO₆.

Benzyl DL-N-[1-oxo-1-(pyrrolidin-1-yl)propan-2-yl]carbamate, CAS: 56487-30-0, stock: 5.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀N₂O₃.

Beta-Alanyl-DL-Leucine, CAS: 102029-56-1, stock: 6.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈N₂O₃.

Bis(4-hydroxyphenyl)acetic Acid, CAS: 40232-93-7, stock: 2.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂O₄.

Boc-allo-Ile-OH, CAS: 35264-07-4, stock: 4.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁NO₄.

BOC-Aza-DL-Leucine, CAS: 851653-36-6, stock: 6.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₀N₂O₄.

Boc-Cycloleucine, CAS: 35264-09-6, stock: 9.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₉NO₄.

Boc-D-Norleucine, CAS: 55674-63-0, stock: 2.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁NO₄.

Boc-l-6-hydroxynorleucine, CAS: 77611-37-1, stock: 5.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁NO₅.

Boc-l-beta-homoisoleucine, CAS: 218608-82-3, stock: 7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₃NO₄.

Boc-L-isoleucine Methyl Ester, CAS: 17901-01-8, stock: 2.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₃NO₄.

Boc-L-leucine N’-Methoxy-N’-methylamide, CAS: 87694-50-6, stock: 7.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₆N₂O₄.

Boc-N-methyl-D-isoleucine, CAS: 267223-87-0, stock: 8.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₃NO₄.

BOC-N-Methyl-D-leucine, CAS: 89536-84-5, stock: 1.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₃NO₄.

Boc-N-methyl-D-norleucine, CAS: 161450-84-6, stock: 3.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₃NO₄.

BOC-N-Methyl-L-isoleucine, CAS: 52498-32-5, stock: 7.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₃NO₄.

Boc-N-methyl-L-leucine, CAS: 53363-89-6, stock: 5.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₃NO₄.

Boc-N-methyl-L-norleucine (oil), CAS: 117903-25-0, stock: 9.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₃NO₄.

Bovine ISLR (Immunoglobulin superfamily containing leucine-rich repeat protein) ELISA Kit (96T), CAS: /, stock: 1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Bovine LRRN1 (Leucine-rich repeat neuronal protein 1) ELISA Kit (96T), CAS: /, stock: 4.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Bovine LRRTM1 (Leucine-rich repeat transmembrane neuronal protein 1) ELISA Kit (96T), CAS: /, stock: 9.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Bovine SPZ1 (Spermatogenic leucine zipper protein 1) ELISA Kit (96T), CAS: /, stock: 4.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

BQ 788, CAS: 156161-89-6, stock: 2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₅₀N₅NaO₇.

BQ 788-d2, CAS: /, stock: 2.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₄₈D₂N₅NaO₇.

BX-795, CAS: 702675-74-9, stock: 6.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆IN₇O₂S.

BX-795 Hydrochloride, CAS: 1472611-45-2, stock: 4.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆IN₇O₂S • HC l.

Bzl-Ile-OH, CAS: 1859-49-0, stock: 3.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉NO₂.

(S)-3-Amino(piperidine-3-d1)-2,6-dione hydrochloride, CAS: 1398112-31-6, stock: 6.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈DClN₂O₂.

Chicken IARS2 (Isoleucine--tRNA ligase, mitochondrial) ELISA Kit (96T), CAS: /, stock: 4.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

(S)-5-Amino-2-(4-nitro-1-oxoisoindolin-2-yl)-5-oxopentanoic Acid, CAS: 874760-71-1, stock: 9.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃N₃O₆.

Chlorosulfuron, CAS: 64902-72-3, stock: 9.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂ClN₅O₄S.

2-(4-Amino-1-oxoisoindolin-2-yl)pentanediamide, CAS: /, stock: 2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆N₄O₃.

2-(4-Nitro-1-oxoisoindolin-2-yl)pentanedioic Acid, CAS: 295357-72-1, stock: 4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂N₂O₇.

Cyclo(L-prolyl-L-leucyl), CAS: 2873-36-1, stock: 7.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₈N₂O₂.

Cyclo(Leu-Leu), CAS: 952-45-4, stock: 2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂N₂O₂.

3-(4-Amino-1,3-dihydro-5-hydroxy-1-oxo-2H-isoindol-2-yl)-2,6-piperidinedione, CAS: 1421593-78-3, stock: 1.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃N₃O₄.

Cyclosporin AM 4N, CAS: 89270-23-5, stock: 5.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₁H₁₀₉N₁₁O₁₂.

Cyclosporin AM 4N Acetate, CAS: /, stock: 3.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₃H₁₁₁N₁₁O₁₃.

4-(4-Amino-1-oxoisoindolin-2-yl)-4-carbamoyl Butyric Acid, CAS: 2197414-57-4, stock: 9.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄N₃O₄.

Cyclosporin AM 4N-D3, CAS: /, stock: 4.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₁H₁₀₆D₃N₁₁O₁₂.

Cyclosporin AM 9, CAS: 89270-25-7, stock: 3.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₂H₁₁₁N₁₁O₁₃.

4-Nitro Lenalidomide, CAS: 827026-45-9, stock: 3.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁N₃O₅.

Cyclosporin AM 9-d6, CAS: /, stock: 1.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₂H₁₀₅D₆N₁₁O₁₃.

CZC 54252, CAS: 1191911-27-9, stock: 6.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅ClN₆O₄S.

Lenalidomide, CAS: 191732-72-6, stock: 2.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃N₃O₃.

Lenalidomide Lactosamine Adduct, CAS: /, stock: 8.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₃N₃O₁₃.

D-Ala-leu, CAS: 67113-60-4, stock: 3.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈N₂O₃.

Lenalidomide N(imido)-Glucoside, CAS: /, stock: 1.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃N₃O₈.

Lenalidomide t-Butyl Propylcarbamate, CAS: /, stock: 6.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈N₄O₅.

D-allo-Isoleucine, CAS: 1509-35-9, stock: 9.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₂.

D-allo-Isoleucine Ethyl Ester Hydrochloride, CAS: 315700-65-3, stock: 9.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₇NO₂ • HCl.

Lenalidomide-d5, CAS: /, stock: 2.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈D₅N₃O₃.

D-Isoleucine, CAS: 319-78-8, stock: 8.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₂.

D-Isoleucine Methyl Ester Hydrochloride, CAS: 167223-42-9, stock: 5.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅NO₂  • HCl.

N-(2-Aminoethyl) Lenalidomide BP-1-108 Amide, CAS: /, stock: 2.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₅₄N₆O₈S.

D-Leucine, CAS: 328-38-1, stock: 5.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₂.

D-Leucine Methyl Ester Hydrochloride, CAS: 5845-53-4, stock: 5.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆ClNO₂.

N-(3-Aminohexanoyl) Lenalimolide SF-1-088 Amide, CAS: /, stock: 6.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₃H₆₂N₆O₁₁S.

N-(3-Aminopropanoyl) Lenalidomide BP-1-108 Amide, CAS: /, stock: 5.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₅₄N₆O₉S.

D-Leucine tert-Butyl Ester Hydrochloride, CAS: 13081-32-8, stock: 6.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₂ClNO₂.

D-Norleucine, CAS: 327-56-0, stock: 2.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₂.

N-(3-Aminopropanoyl) Lenalidomide Hydrochloride, CAS: /, stock: 4.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈N₄O₄•HCl.

N-(3-Aminopropanoyl) Lenalimolide SF-1-088 Amide, CAS: /, stock: 4.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀H₅₆N₆O₁₁S.

D-Norleucine methyl ester hydrochloride, CAS: 60687-33-4, stock: 9.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅NO₂ • HCl.

N-(3-Aminopropyl) Lenalidomide SF-1-088 Amide, CAS: /, stock: 4.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀H₅₈N₆O₁₀S.

N-(3-Aminopropyl) Lenalimolide BP-1-108 Amide, CAS: /, stock: 2.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₅₆N₆O₈S.

D-tert-Leucine, CAS: 26782-71-8, stock: 7.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₂.

N-(6-Aminohexanoyl) Lenalidomide BP-1-108 Amide, CAS: /, stock: 5.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₁H₆₀N₆O₉S.

N-(6-Aminohexanoyl) Lenalidomide Hydrochloride, CAS: /, stock: 5.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄N₄O₄•HCl.

Dansyl-L-isoleucine, CAS: 1100-21-6, stock: 7.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄N₂O₄S.

Dansyl-L-leucine Cyclohexylammonium Salt, CAS: 42954-58-5, stock: 8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄N₂O₄S  •  C₆H₁₃N.

N-Formyl Lenalidomide, CAS: /, stock: 9.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃N₃O₄.

N-Hydroxy Lenalidomide, CAS: /, stock: 1.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃N₃O₄.

N-Methyl Lenalidomide, CAS: /, stock: 7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅N₃O₃.

N-[2-(2,6-Dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-4-yl]-acetamide, CAS: 1421593-80-7, stock: 7.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅N₃O₄.

N-[2-Aminoethyl) Lenalidomide Trifluoroacetic Acid Salt, CAS: /, stock: 8.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈N₄O₃ • x(C ₂HF₃O₂).

N-[3-(Aminoethyl) Lenalidomide SF-1-088 Amide, CAS: /, stock: 4.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₉H₅₆N₆O₁₀S.

N-[3-(Aminopropyl) Lenalidomide SF-1-088 Amide, CAS: /, stock: 2.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀H₅₈N₆O₁₀S.

N-[3-Aminopropyl] Lenalidomide Trifluoroacetic Acid Salt, CAS: /, stock: 2.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀N₄O₃ • x(C ₂HF₃O₂).

Diprotin A, CAS: 90614-48-5, stock: 9.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₁N₃O₄.

DL-6-Hydroxy Norleucine, CAS: 305-77-1, stock: 2.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₃.

rac Lenalidomide-13C5, CAS: 1219332-91-8, stock: 5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³C₅H₁₃N₃O₃.

DL-Alanyl-DL-leucine, CAS: 1999-42-4, stock: 6.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈N₂O₃.

DL-allo-Isoleucine, CAS: 08/04/3107, stock: 5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₂.

DL-alpha-Methylleucine, CAS: 144-24-1, stock: 4.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅NO₂.

DL-Isoleucine, CAS: 443-79-8, stock: 9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₂.

DL-leucine, CAS: 328-39-2, stock: 9.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₂.

(2Z)-2-Cyano-N-(4-cyanophenyl)-3-hydroxy-2-Butenamide, CAS: 202057-74-7, stock: 2.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉N₃O₂.

DL-Norleucine, CAS: 616-06-8, stock: 6.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₂.

DL-Norleucine methyl ester hydrochloride, CAS: 77300-48-2, stock: 5.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆ClNO₂.

2-Cyano-N-[3-methyl-4-(trifluoromethyl)phenyl]-acetamide, CAS: 179637-55-9, stock: 2.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉F₃N₂O.

Dl-norleucineamide, CAS: 4748-00-9, stock: 6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄N₂O.

Dl-tert-leucine, CAS: 33105-81-6, stock: 8.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₂.

2-Cyano-N-[4-(trifluoromethyl)phenyl]acetamide, CAS: 24522-30-3, stock: 9.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇F₃N₂O.

Ennlatin A, CAS: 2503-13-1, stock: 4.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₆₃N₃O₉.

3-Methylisoxazole-4-carboxylic Acid, CAS: 17153-20-7, stock: 8.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅NO₃.

3-Methylisoxazole-4-carboxylic Acid Ethyl Ester, CAS: 20328-15-8, stock: 7.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉NO₃.

Fmoc-4,5-dehydro-L-leucine, CAS: 87720-55-6, stock: 5.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁NO₄.

Fmoc-allo-ile-oh, CAS: 251316-98-0, stock: 7.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃NO₄.

4-(Trifluoromethyl)aniline, CAS: 455-14-1, stock: 9.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆F₃N.

Fmoc-Cycloleucine, CAS: 117322-30-2, stock: 5.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁NO₄.

Fmoc-D-homoleucine, CAS: 204320-60-5, stock: 6.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅NO₄.

5-Desmethyl-3-methyl Leflunomide, CAS: 208401-20-1, stock: 8.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉F₃N₂O₂.

5-Hydroxy Leflunomide (Metabolite M2), CAS: 1058722-46-5, stock: 1.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉F₃N₂O₃.

Fmoc-d-nle-oh, CAS: 112883-41-7, stock: 7.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃NO₄.

Fmoc-l-beta-homoisoleucine, CAS: 193954-27-7, stock: 3.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅NO₄.

5-Hydroxy Leflunomide-d4 (Metabolite M2), CAS: 1794789-76-6, stock: 9.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₅D₄F₃N₂O₃.

5-Methylisoxazole-3-carboxylic Acid, CAS: 3405-77-4, stock: 3.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅NO₃.

Fmoc-l-beta-homoleucine, CAS: 193887-44-4, stock: 8.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅NO₄.

5-Methylisoxazole-3-carboxylic-d4 Acid, CAS: 1267623-84-6, stock: 4.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅HD₄NO₃.

Fmoc-L-Leu-OH, CAS: 35661-60-0, stock: 8.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃NO₄.

Fmoc-L-Leu-OH-d10, CAS: 1190594-22-9, stock: 1.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₃D₁₀NO₄.

5-Methylisoxazole-4-carboxylic Acid, CAS: 42831-50-5, stock: 1.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅NO₃.

Fmoc-l-norleucine n-hydroxysuccinimide ester, CAS: 201026-08-6, stock: 3.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₆N₂O₆.

Fmoc-Leu-OH-5,5,5-d3, CAS: 538372-74-6, stock: 7.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀D₃NO₄.

Fmoc-N-Me-D-Leu-OH, CAS: 103478-63-3, stock: 8.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅NO₄.

Fmoc-N-Me-Leu-OH, CAS: 103478-62-2, stock: 6.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅NO₄.

Leflunomide, CAS: 75706-12-6, stock: 3.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉F₃N₂O₂.

Leflunomide 3-Isomer, CAS: 61643-23-0, stock: 1.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉F₃N₂O₂.

Fmoc-N-Me-Nle-OH, CAS: 112883-42-8, stock: 8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅NO₄.

Fmoc-Nle-OH, CAS: 77284-32-3, stock: 4.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃NO₄.

Leflunomide EP Impurity F, CAS: 1403564-06-6, stock: 9.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉F₃N₂O₂.

Leflunomide EP Impurity G, CAS: 724429-16-7, stock: 3.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂N₂O₂.

Foxy 5, CAS: 881188-51-8, stock: 8.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₂N₆O₁₂S₂.

Leflunomide-d4, CAS: 1189987-23-2, stock: 1.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₅D₄F₃N₂O₂.

Methyl 5-Methyl-3-isoxazolecarboxylate, CAS: 19788-35-3, stock: 3.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇NO₃.

Fructose-isoleucine (mixture of diastereomers), CAS: 87304-79-8, stock: 7.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₃NO₇.

Fructose-leucine (mixture of diastereomers), CAS: 34393-18-5, stock: 6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₃NO₇.

Gallidermin, CAS: 117978-77-5, stock: 7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉₈H₁₄₁N₂₅O₂₃S₄.

Gamma-methyl-L-leucine, CAS: 57224-50-7, stock: 9.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅NO₂.

GGTI-2133, CAS: 191102-79-1, stock: 6.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₈N₄O₃.

GGTI-2133-d7, CAS: /, stock: 5.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₁D₇N₄O₃.

GGTI-2147, CAS: 191102-87-1, stock: 9.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₀N₄O₃.

Gly-Leu, CAS: 869-19-2, stock: 5.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆N₂O₃.

Glycyl-D-leucine, CAS: 688-13-1, stock: 8.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆N₂O₃.

Glycyl-Dl-norleucine, CAS: 1504-41-2, stock: 1.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆N₂O₃.

Glycylglycyl-l-isoleucine, CAS: 69242-40-6, stock: 5.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉N₃O₄.

Glyoxylic Acid Hydrate-13C2, CAS: /, stock: 1.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ³C₂H₄O₄.

GNE 7915, CAS: 1351761-44-8, stock: 8.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁F₄N₅O₃.

GNE-0877, CAS: 1374828-69-9, stock: 2.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆F₃N₇.

GNE-0877-d3, CAS: /, stock: 9.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃D₃F₃N₇.

GNE-3511, CAS: 1496581-76-0, stock: 2.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆F₂N₆O.

H-DL-Leu-OMe Hydrochloride, CAS: 6322-53-8, stock: 8.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆ClNO₂.

H-Ile-ile-oh, CAS: 42537-99-5, stock: 5.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₄N₂O₃.

Hippuryl-L-histidyl-L-leucine, CAS: 31373-65-6, stock: 9.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇N₅O₅.

Human IARS (Isoleucine--tRNA ligase, cytoplasmic) ELISA Kit (96T), CAS: /, stock: 6.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human ISLR (Immunoglobulin superfamily containing leucine-rich repeat protein) ELISA Kit (96T), CAS: /, stock: 2.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human LAP(Leucine Peptidase) ELISA Kit (96T), CAS: /, stock: 3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human LGR4(Leucine-rich repeat-containing G-protein coupled receptor 4) ELISA Kit (96T), CAS: /, stock: 5.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human LRFN1 (Leucine-rich repeat and fibronectin type III domain-containing protein 1) ELISA Kit (96T), CAS: /, stock: 2.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human LRG1(Leucine-rich alpha-2-glycoprotein) ELISA Kit (96T), CAS: /, stock: 7.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human LRGUK (Leucine-rich repeat and guanylate kinase domain-containing protein) ELISA Kit (96T), CAS: /, stock: 7.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human LRRK1 (Leucine-rich repeat serine/threonine-protein kinase 1) ELISA Kit (96T), CAS: /, stock: 7.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human LRRK2(Leucine-rich repeat serine/threonine-protein kinase 2) ELISA Kit (96T), CAS: /, stock: 2.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human LRRN1 (Leucine-rich repeat neuronal protein 1) ELISA Kit (96T), CAS: /, stock: 9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human LRTM1 (Leucine-rich repeat and transmembrane domain-containing protein 1) ELISA Kit (96T), CAS: /, stock: 6.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human LZTR1 (Leucine-zipper-like transcriptional regulator 1) ELISA Kit (96T), CAS: /, stock: 1.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human MELK (Maternal embryonic leucine zipper kinase) ELISA Kit (96T), CAS: /, stock: 3.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human MELK(Maternal embryonic leucine zipper kinase) ELISA Kit (96T), CAS: /, stock: 3.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human PRELP(Proline Arginine Rich End Leucine Rich Repeat Protein) ELISA Kit (96T), CAS: /, stock: 2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

ICI 154129, CAS: 83420-94-4, stock: 6.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₄₆N₄O₆S.

(S)-Laudanine, CAS: 3122-95-0, stock: 9.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅NO₄.

ICI 174,864, CAS: 89352-67-0, stock: 4.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₅₃N₅O₇.

Isopentyl Orlistat Tetradecyl Ester, CAS: /, stock: 5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₅NO₅.

α-Aminocyclohexanecarboxylic Acid, CAS: 2756-85-6, stock: 9.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃NO₂.

α-​Fructoselysine Dihydrochloride, CAS: 96192-34-6, stock: 2.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₄N₂O₇ • 2(HCl).

α-Fructose L-Arginine, CAS: 25020-14-8, stock: 9.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₄N₄O₇.

JMV 390-1, CAS: 148473-36-3, stock: 6.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₅N₃O₆.

JMV 449, CAS: 139026-66-7, stock: 7.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₆₆N₈O₇.

L-6-Hydroxy Norleucine, CAS: 6033-32-5, stock: 1.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₃.

L-Allo-isoleucine, CAS: 1509-34-8, stock: 8.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₂.

L-Allo-isoleucine-d10, CAS: 202529-06-4, stock: 3.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃D₁₀NO₂.

L-AP6, CAS: 78944-89-5, stock: 1.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄NO₅P.

L-​Isoleucine Benzyl Ester 4-Toluenesulfonate Salt, CAS: 16652-75-8, stock: 3.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₇NO₅S.

L-​Isoleucine-​15N, CAS: 59935-30-7, stock: 6.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃¹⁵NO₂.

L-​Leucine-​1-​13C, CAS: 74292-94-7, stock: 5.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₃NO₂.

L-​Leucine-​β-​naphthylamide, CAS: 732-85-4, stock: 1.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀N₂O.

L-beta-Homoisoleucine Hydrochloride, CAS: 219310-10-8, stock: 9.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆ClNO₂.

L-Isoleucine, CAS: 73-32-5, stock: 6.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₂.

L-Isoleucine Methyl Ester Hydrochloride, CAS: 18598-74-8, stock: 6.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆ClNO₂.

L-Isoleucine N-Carboxyanhydride, CAS: 45895-90-7, stock: 9.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₁NO₃.

L-Isoleucine tert-Butyl Ester Hydrochloride, CAS: 69320-89-4, stock: 6.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₂ClNO₂.

L-Isoleucine-d10, CAS: /, stock: 8.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃D₁₀NO₂.

L-Leucinamide hydrochloride, CAS: 10466-61-2, stock: 4.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄N₂O •HCl.

L-Leucine, CAS: 61-90-5, stock: 5.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₂.

L-Leucine (d10, 98%), CAS: 106972-44-5, stock: 8.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃D₁₀NO₂.

L-Leucine 4-methoxy-β-naphthylamide Hydrochloride, CAS: 4467-68-9, stock: 8.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₃ClN₂O₂.

L-Leucine Benzyl Ester p-Toluenesulfonate, CAS: 1738-77-8, stock: 1.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₇NO₅S.

L-Leucine chloromethyl ketone hydrochloride, CAS: 54518-92-2, stock: 1.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅Cl₂NO.

L-Leucine Ethyl Ester Hydrochloride, CAS: 2743-40-0, stock: 9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₇NO₂ • HCl.

L-Leucine-d3, CAS: 87828-86-2, stock: 4.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀D₃NO₂.

L-Leucyl-D-leucine, CAS: 17665-02-0, stock: 3.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₄N₂O₃ •  ₂H₂O.

(15S)-Latanoprost, CAS: 145773-22-4, stock: 7.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₀O₅.

(15S)-Latanoprost Acid, CAS: 41639-84-3, stock: 1.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₄O₅.

(3aR,4R,5R,6aS)-5-Hydroxy-4-(2-(2-phenethyl-1,3-dioxolan-2-yl)ethyl)hexahydro-2H-cyclopenta[b]furan-2-one, CAS: /, stock: 3.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆O₅.

Lipstatin, CAS: 96829-59-3, stock: 9.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₉NO₅.

(3aR,4R,5R,6aS)-Hexahydro-4-[(3R)-3-hydroxy-5-phenylpentyl]-2H-cyclopenta[b]furan-2,5-diol, CAS: 352276-28-9, stock: 4.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆O₄.

Lysino Norleucine, CAS: 25612-46-8, stock: 7.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₅N₃O₄.

Lysino Norleucine Disodium Salt, CAS: /, stock: 9.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₃N₃Na₂O₄.

(3aR,4R,5R,6aS)-Hexahydro-4-[(3R)-5-phenyl-3-[(tetrahydro-2H-pyran-2-yl)oxy]pentyl]-5-[(tetrahydro-2H-pyran-2-yl)oxy]-2H-cyclopenta[b]furan-2-ol, CAS: 856453-29-7, stock: 4.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₂O₆.

(3aR,4R,5R,6aS)-Hexahydro-4-[2-[2-(2-phenylethyl)-1,3-dioxolan-2-yl]ethyl]-2H-cyclopenta[b]furan-2,5-diol, CAS: /, stock: 9.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈O₅.

Methyl (2R,3S)-2-Benzylamino-2-(t-butyldimethylsilyloxymethyl)-3-hydroxy-4-methylpentanoate, CAS: 145451-92-9, stock: 2.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₇NO₄Si.

Methyl (2R,3S)-2-Benzylamino-3-hydroxy-2-hydroxymethyl-4-methylpentanoate, CAS: 145451-91-8, stock: 1.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₃NO₄.

(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[2-[2-(2-phenylethyl)-1,3-dioxolan-2-yl]ethyl]cyclopentyl]-5-heptenoic Acid 1-Methylethyl Ester, CAS: 511229-73-5, stock: 8.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₂O₆.

(E)-7-((1R,2R,3R,5S)-3,5-Bis((tert-butyldimethylsilyl)oxy)-2-((S)-3-((tert-butyldimethylsilyl)oxy)-5-phenylpentyl)cyclopentyl)hept-5-enoic Acid Isopropyl Ester, CAS: /, stock: 4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₈₂O₅Si₃.

MLi-2, CAS: 1627091-47-7, stock: 8.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅N₅O₂.

Mouse Batf (Basic leucine zipper transcriptional factor ATF-like) ELISA Kit (96T), CAS: /, stock: 7.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

(Z)-Isopropyl-8-((4R,5R,6S)-6-hydroxy-2-phenethyloctahydrocyclopenta[b]pyran-5-yl)hept-5-enoate (Latanoprost Impurity), CAS: /, stock: 9.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₄O₄.

11-O-Formyl Latanoprost, CAS: /, stock: 6.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₀O₆.

Mouse Iars (Isoleucine--tRNA ligase, cytoplasmic) ELISA Kit (96T), CAS: /, stock: 5.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Iars2 (Isoleucine--tRNA ligase, mitochondrial) ELISA Kit (96T), CAS: /, stock: 6.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

15-Keto Latanoprost, CAS: 135646-98-9, stock: 4.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₈O₅.

15-Keto Latanoprost Acid, CAS: 369585-22-8, stock: 3.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₂O₅.

Mouse Islr (Immunoglobulin superfamily containing leucine-rich repeat protein) ELISA Kit (96T), CAS: /, stock: 4.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse LGR-5(leucine-rich repeat-containing g-protein coupled receptor 5) ELISA Kit (96T), CAS: /, stock: 8.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

15-O-Formyl Latanoprost, CAS: /, stock: 5.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₀O₆.

2-Nor Latanoprost, CAS: /, stock: 9.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₈O₅.

Mouse Lrfn1 (Leucine-rich repeat and fibronectin type III domain-containing protein 1) ELISA Kit (96T), CAS: /, stock: 9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Lrguk (Leucine-rich repeat and guanylate kinase domain-containing protein) ELISA Kit (96T), CAS: /, stock: 2.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

4-Phenylbutanal, CAS: 18328-11-5, stock: 7.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O.

Mouse Lrpprc (Leucine-rich PPR motif-containing protein, mitochondrial) ELISA Kit (96T), CAS: /, stock: 5.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Lrrk1 (Leucine-rich repeat serine/threonine-protein kinase 1) ELISA Kit (96T), CAS: /, stock: 6.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

9-Acetyl Latanoprost, CAS: /, stock: 4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₂O₅.

9-O-Formyl Latanoprost, CAS: /, stock: 4.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₀O₆.

Mouse Lrrn1 (Leucine-rich repeat neuronal protein 1) ELISA Kit (96T), CAS: /, stock: 9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Lrrtm1 (Leucine-rich repeat transmembrane neuronal protein 1) ELISA Kit (96T), CAS: /, stock: 4.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Desisopropyl N-Dihydroxypropyl Dehydrolatanoprostamide, CAS: 1193782-16-9, stock: 6.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₇NO₆.

Latanoprost, CAS: 130209-82-4, stock: 4.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₀O₅.

Mouse Lrtm1 (Leucine-rich repeat and transmembrane domain-containing protein 1) ELISA Kit (96T), CAS: /, stock: 4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse LRWD1 (Leucine-rich repeat and WD repeat-containing protein 1) ELISA Kit (96T), CAS: /, stock: 7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Latanoprost Acid, CAS: 41639-83-2, stock: 5.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₄O₅.

Latanoprost Acid-d4, CAS: 1224443-47-3, stock: 1.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₀D₄O₅.

Mouse Lztr1 (Leucine-zipper-like transcriptional regulator 1) ELISA Kit (96T), CAS: /, stock: 4.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Melk (Maternal embryonic leucine zipper kinase) ELISA Kit (96T), CAS: /, stock: 9.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Latanoprost-d4, CAS: /, stock: 9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₆D₄O₅.

Mouse Spz1 (Spermatogenic leucine zipper protein 1) ELISA Kit (96T), CAS: /, stock: 2.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Tril (TLR4 interactor with leucine rich repeats) ELISA Kit (96T), CAS: /, stock: 1.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Latanoprostene Bunod, CAS: 860005-21-6, stock: 8.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₁NO₈.

Polyquaternium 1, CAS: 75345-27-6, stock: 1.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  (C₆H₁₂ClN)n C₁₆H₃₆Cl₂N₂O₆.

N,N’-Dicarbobenzyloxy-Lysinonorleucine Dibenzylester, CAS: /, stock: 1.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₄₉N₃O₈.

Polyquaternium 1 (36000-40000 Da), CAS: 75345-27-6, stock: 1.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇₁₄H₃₄₃₂Cl₂₈₅N₂₈₅O₆.

trans-(15S)-Latanoprost, CAS: 1235141-39-5, stock: 1.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₀O₅.

N-(1,1-Dioxidotetrahydro-3-thienyl)leucine, CAS: 792893-05-1, stock: 8.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉NO₄S.

N-(1,3-Dioxobutyl)-L-isoleucine Methyl Ester, CAS: 62972-98-9, stock: 7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₉NO₄.

trans-(15S)-Latanoprost Acid, CAS: /, stock: 9.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₄O₅.

trans-Latanoprost, CAS: 913258-34-1, stock: 8.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₀O₅.

N-(1-Oxotetradecyl)-L-seryl-L-isoleucyl-L-tyrosyl-L-arginyl-L-arginylglycyl-L-alanyl-L-arginyl-L-arginyl-L-tryptophyl-L-arginyl-L-lysyl-L-Leucine, CAS: 863987-12-8, stock: 7.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉₀H₁₅₄N₃₀O₁₇.

N-(2,4-Dinitrophenyl)-L-leucine, CAS: 1655-57-8, stock: 3.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅N₃O₆.

trans-Latanoprost Acid, CAS: 903549-49-5, stock: 3.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₄O₅.

N-(Benzyloxycarbonyl)-D-leucine, CAS: 28862-79-5, stock: 7.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₄.

[1R-[1α(Z),2β,3α,5α]]-7-[3,5-Dihydroxy-2-[2-[2-(2-phenylethyl)-1,3-dioxolan-2-yl]ethyl]cyclopentyl]-5-heptenoic Acid, CAS: 59619-40-8, stock: 5.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₆O₆.

N-2-Naphthalenyl-L-leucine, CAS: 99631-79-5, stock: 7.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉NO₂.

N-2-Nitrophenylsulfenyl-L-isoleucine Dicyclohexylammonium Salt, CAS: 10382-52-2, stock: 1.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂O₄S  •  C₁₂H₂₃N.

2-Bromo-3,4-dihydro-6-methoxy-1-[4-(phenylmethoxy)phenyl]naphthalene, CAS: 869006-52-0, stock: 1.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁BrO₂.

N-Acetyl-4,5-dehydro-DL-leucine, CAS: 87325-65-3, stock: 5.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₃NO₃.

N-Acetyl-D-leucine, CAS: 19764-30-8, stock: 6.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₃.

3,4-Dihydro-6-methoxy-2-phenyl-1-[4-(phenylmethoxy)phenyl]naphthalene, CAS: 308812-06-8, stock: 8.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₆O₂.

cis-4-(1,2,3,4-Tetrahydro-6-methoxy-2-phenyl-1-naphthalenyl)phenol, CAS: 14089-22-6, stock: 3.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₂O₂.

N-Acetyl-DL-norleucine, CAS: 7682-16-8, stock: 7.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₃.

N-Acetyl-L-(-)-leucine, CAS: 1188-21-2, stock: 7.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₃.

Lasofoxifene, CAS: 180916-16-9, stock: 2.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₁NO₂.

Lasofoxifene 2-Oxide, CAS: 366017-88-1, stock: 4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₉NO₃.

N-Acetyl-L-leucine-N-methylamide-d16, CAS: 1276197-56-8, stock: 2.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂D₁₆N₂O₂.

N-Acetylisoleucine, CAS: 3077-46-1, stock: 6.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₃.

Lasofoxifene β-D-Glucuronide, CAS: 1048953-95-2, stock: 1.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₉NO₈.

Lasofoxifene Sulfate, CAS: 1048953-96-3, stock: 2.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₁NO₅S.

N-​(1-Deoxy-​D-​fructos-​1-​yl)​-L-​cysteine, CAS: 846568-65-8, stock: 4.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₇S.

N-​Boc-​6-​azido-​L-​norleucine (Dicyclohexylammoniu​m) Salt, CAS: 1217451-48-3, stock: 7.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀N₄O₄ • C ₁₂H₂₃N.

Lasofoxifene-d4 β-D-Glucuronide, CAS: /, stock: 6.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₅D₄NO₈.

Lasofoxifene-d4 Sulfate, CAS: 1246817-62-8, stock: 9.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₇D₄NO₅S.

N-Benzoyl-L-leucine-beta-naphthylamide, CAS: 94441-89-1, stock: 9.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₄N₂O₂.

N-Benzyl L-Isoleucinamide, CAS: 129253-02-7, stock: 1.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀N₂O.

Lasofoxifene-d5 2-Oxide, CAS: /, stock: 8.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₄D₅NO₃.

rac 7-Methoxy Lasofoxifene, CAS: 4796-75-2, stock: 2.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₃NO₂.

N-Benzyl-N-methyl-isoleucine, CAS: 4125-97-7, stock: 5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₁NO₂.

N-Boc-4,5-dehydro-L-leucine Dicyclohexylamine Salt, CAS: 87720-54-5, stock: 4.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₉NO₄ • ( C₁₂H₂₃N).

rac Lasofoxifene-d4, CAS: 1126626-61-6, stock: 10g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₇D₄NO₂.

rac-Lasofoxifene, CAS: 180915-78-0, stock: 3.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₁NO₂.

N-Boc-D-isoleucine, CAS: 55721-65-8, stock: 8.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁NO₄.

N-Boc-D-leucine, CAS: 16937-99-8, stock: 8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁NO₄.

N-Boc-L-isoleucine, CAS: 13139-16-7, stock: 8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁NO₄.

N-Carbobenzoxy-d-leucine dicyclohexylammonium salt, CAS: 7662-58-0, stock: 5.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₂N₂O₄.

N-Carbobenzoxy-dl-leucine, CAS: 3588-60-1, stock: 6.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₄.

N-Carbobenzoxy-dl-norleucine, CAS: 15027-13-1, stock: 9.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₄.

N-Carboxyleucine Anhydride, CAS: 3190-70-3, stock: 8.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₁NO₃.

N-Cbz-D-isoleucine, CAS: 28862-89-7, stock: 4.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₄.

N-Cbz-L-isoleucine, CAS: 3160-59-6, stock: 6.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₄.

N-Cbz-L-isoleucine Dicyclohexylamine Salt, CAS: 26699-00-3, stock: 9.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₂N₂O₄.

N-Chloroacetyl-DL-isoleucine, CAS: 1115-24-8, stock: 6.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄ClNO₃.

N-Chloroacetyl-L-leucine, CAS: 688-12-0, stock: 6.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄NO₃Cl.

N-Deformyl-N-benzyloxycarbonyl Orlistat, CAS: 108051-94-1, stock: 9.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₅₉NO₆.

N-Desformyl N-Acetyl (S,S,R,S)-Orlistat  (Orlistat Impurity), CAS: 1356841-82-1, stock: 6.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₅NO₅.

N-Fmoc-5,5,5,5’,5’,5’-Hexafluoro-L-leucine, CAS: 918667-71-7, stock: 6.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₇F₆NO₄.

N-Fmoc-D-isoleucine, CAS: 143688-83-9, stock: 1.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃NO₄.

N-Fmoc-D-leucine, CAS: 114360-54-2, stock: 5.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃NO₄.

N-Fmoc-L-isoleucine, CAS: 71989-23-6, stock: 9.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃NO₄.

N-Fmoc-L-isoleucine-d10, CAS: /, stock: 2.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₃D₁₀NO₄.

N-Formyl-L-leucine, CAS: 6113-61-7, stock: 7.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃NO₃.

N-Formyl-L-leucine (3S,4R,6S)-3-Hexyltetrahydro-2-oxo-6-undecyl-2H-pyran-4-yl Ester, CAS: 130793-27-0, stock: 7.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₃NO₅.

N-Formyl-L-leucine (3S,4S,6S)-3-Hexyltetrahydro-2-oxo-6-undecyl-2H-pyran-4-yl Ester, CAS: 130676-65-2, stock: 8.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₃NO₅.

N-Formyl-L-leucine (3S,4S,6S)-3-Hexyltetrahydro-2-oxo-6-undecyl-2H-pyran-4-yl Ester, CAS: /, stock: 7.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₃NO₅.

N-Formyl-L-leucine (3S,4S,6S)-3-Hexyltetrahydro-2-oxo-6-undecyl-2H-pyran-4-yl-d3 Ester, CAS: /, stock: 5.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₀D₃NO₅.

N-Formyl-L-leucine [S-(E)]-1-(2-Nonenyl)dodecyl Ester, CAS: 130676-63-0, stock: 6.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₅₃NO₃.

N-Formyl-L-leucine(1S)-1-[(2S,3S)-2-hydroxy-3-[(R)-1-phenylethylcarbomoyl)]nonyl]dodecyl Ester(Orlistat Impurity), CAS: /, stock: 6.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₆₄N₂O₅.

N-Formyl-L-leucine(1S)-1-[(2S,3S)-2-hydroxy-3-[(R)-1-phenylethylcarbomoyl)]nonyl]dodecyl-d3 Ester(Orlistat Impurity), CAS: /, stock: 7.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₆₁D₃N₂O₅.

N-Formyl-L-leucine-d3, CAS: 1356930-28-3, stock: 2.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀D₃NO₃.

N-Glycyl-l-isoleucine, CAS: 19461-38-2, stock: 4.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆N₂O₃.

N-Jasmonyl-L-Isoleucine (Mixture of Diastereomers), CAS: /, stock: 1.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₉NO₄.

N-Jasmonyl-L-Isoleucine tert-Butyl Ester (Mixture of Diastereomers), CAS: /, stock: 4.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₇NO₄.

N-Jasmonyl-L-Isoleucine-d3 (Mixture of Diastereomers), CAS: /, stock: 6.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆D₃NO₄.

N-Me-L-norleucine hydrochloride, CAS: 1899809-63-2, stock: 1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅NO₂ • HCl.

N-Methyl-DL-leucine, CAS: 2566-33-8, stock: 2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅NO₂.

N-tert-Butylcarbamoyl-L-tert-leucine-d9, CAS: /, stock: 9.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃D₉N₂O₃.

N-tert-Butylcarbamoyl-L-tert-leucine-d9 Benzyl Ester, CAS: 1795786-80-9, stock: 5.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉D₉N₂O₃.

N-[(+)-Isojasmonoyl]-(S)-isoleucine-15N, CAS: /, stock: 6.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₉¹⁵NO₄.

N-[(-)-Jasmonoyl]-(L)-isoleucine, CAS: 120330-92-9, stock: 3.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₉NO₄.

(+)-Lappaconitine >90%, CAS: 32854-75-4, stock: 5.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₄N₂O₈.

N-[(-)-Jasmonoyl]-(L)-leucine, CAS: 1272649-73-6, stock: 5.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₉NO₄.

(+)-N-Deacetyllappaconitine, CAS: 11033-64-0, stock: 5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₂N₂O₇.

Lappaconitine Hydrobromide, CAS: 97792-45-5, stock: 6.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₅BrN₂O₈.

Ranaconitine, CAS: 1360-76-5, stock: 5.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₄N₂O₉.

N-[(4-Methylphenyl)sulfonyl]-L-leucine 4-Methyl-2-oxo-2H-1-benzopyran-7-yl Ester, CAS: 152061-78-4, stock: 2.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₅NO₆S.

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-methyl-L-alloisoleucine, CAS: 1821797-58-3, stock: 4.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅NO₄.

N2-[(Phenylmethoxy)carbonyl]-L-lysine-phenylmethyl Ester Benzensulfonic Acid, CAS: /, stock: 7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆N₂O₄ • C ₆H₆O₃S.

N6-[(1,1-Dimethylethoxy)carbonyl]-N2-[(phenylmethoxy)carbonyl]-L-lysine-phenylmethyl Ester, CAS: 128972-27-0, stock: 3.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₄N₂O₆.

NTRC 824, CAS: 1623002-61-8, stock: 5.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₆F₃N₃O₆S.

O-t-Butyl N-Carboxybenzyl Lysinonorlecine N’’-Boc Cyclo-O’,N’-diphenylethane N’’-Boc, CAS: 869111-59-1, stock: 8.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₅₇N₃O₉.

O-tBu-N-Fmoc-4-hydroxy Isoleucine, CAS: /, stock: 5.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₁NO₅.

Octyl Orlistat, CAS: 1243011-56-4, stock: 7.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₅₇NO₅.

Orlistat, CAS: 96829-58-2, stock: 6.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₃NO₅.

Orlistat Dimer Impurity, CAS: 881900-54-5, stock: 8.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₇H₁₀₆N₂O₉.

Orlistat Tetradecyl Ester, CAS: 686744-60-5, stock: 1.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₅₇NO₅.

Orlistat-d3, CAS: 1356930-46-5, stock: 1.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₀D₃NO₅.

OTSSP167, CAS: 1431697-89-0, stock: 8.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₈Cl₂N₄O₂.

p-Toluidine Hydrochloride, CAS: 540-23-8, stock: 5.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉N  •  HCl.

PD-149163, CAS: 169528-11-4, stock: 9.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₇₁N₉O₆.

Phthaloyl-L-Isoleucine, CAS: 29588-88-3, stock: 1.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅NO₄.

Pulcherriminic Acid, CAS: 957-86-8, stock: 1.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀N₂O₄.

Pyridoxylidene-L-isoleucine Potassium Salt, CAS: 57212-58-5, stock: 8.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉KN₂O₄.

Rat Lrfn1 (Leucine-rich repeat and fibronectin type III domain-containing protein 1) ELISA Kit (96T), CAS: /, stock: 7.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Lrpprc (Leucine-rich PPR motif-containing protein, mitochondrial) ELISA Kit (96T), CAS: /, stock: 3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Lrrn1 (Leucine-rich repeat neuronal protein 1) ELISA Kit (96T), CAS: /, stock: 2.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Spz1 (Spermatogenic leucine zipper protein 1) ELISA Kit (96T), CAS: /, stock: 2.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Tril (TLR4 interactor with leucine rich repeats) ELISA Kit (96T), CAS: /, stock: 4.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Tril(TLR4 interactor with leucine rich repeats) ELISA Kit (96T), CAS: /, stock: 4.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Surfactin, CAS: 24730-31-2, stock: 8.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₃H₉₃N₇O₁₃.

TC NTR1 17, CAS: 1146757-96-1, stock: 5.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₇ClN₄O₅.

tert-Butoxycarbonyl-L-leucine, CAS: 13139-15-6, stock: 9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁NO₄.

threo-3-Hydroxy-L-norleucine Methyl Ester, CAS: 139564-70-8, stock: 9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅NO₃.

Verrucofortine, CAS: 113706-21-1, stock: 8.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₁N₃O₃.

White Line Inducing Principle [WLIP], CAS: 135096-89-8, stock: 7.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₄H₉₅N₉O₁₆.

Z-Ala-Pro-Leu-Oh, CAS: 108074-19-7, stock: 1.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₁N₃O₆.

Z-D-Allo-ile-oh dcha, CAS: 55723-45-0, stock: 9.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₄.

Z-Lys(Boc)-Leu-OMe, CAS: 37178-11-3, stock: 5.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₁N₃O₇.

[Leu5]-Enkephalin Acetate, CAS: 81678-16-2, stock: 9.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₇N₅O₇ •xC₂H₄O₂.

(3R)-3,6-Dihydro-2H-1,4-thiazine-3,5-dicarboxylic Acid 3-Ethyl Ester, CAS: 944115-20-2, stock: 6.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁NO₄S.

(3R)-3,6-Dihydro-2H-1,4-thiazine-3,5-dicarboxylic Acid 3-Ethyl Ester-d5, CAS: /, stock: 3.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆D₅NO₄S.

Lanthionine, CAS: 922-55-4, stock: 4.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂N₂O₄S.

N,N’-Diacetyl-L-lanthionine Disodium Salt, CAS: /, stock: 2.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂Na₂O₆S.

2-(Methyl-d3-sulfonyl)-ethan-1,1,2,2-d4-amine, CAS: 1009409-32-8, stock: 4.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₂D₇NO₂S.

2-(Methylsulfinyl)ethylamine Hydrochloride, CAS: 60501-55-5, stock: 6.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₁₀ClNOS.

2-Amino-5-iodobenzonitrile, CAS: 132131-24-9, stock: 8.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅N₂I.

3-(Morpholinosulfonyl)phenylboronic Acid, CAS: 871329-60-1, stock: 7.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄BNO₅S.

3-Chloro-4-(3-fluorobenzyloxy)aniline, CAS: 202197-26-0, stock: 3.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁ClFNO.

3-Desfluoro 2-Fluoro Lapatinib, CAS: /, stock: 3.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₆ClFN₄O₄S.

4-Chloro-6-iodoquinazoline, CAS: 98556-31-1, stock: 4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄ClIN₂.

5-[4-[[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-2-furancarboxaldehyde, CAS: 231278-84-5, stock: 5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₁₇ClFN₃O₃.

6-Iodoquinazolin-4-one, CAS: 16064-08-7, stock: 8.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅IN₂O.

Butyl Chloroformate, CAS: 592-34-7, stock: 5.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉ClO₂.

Des(sulfonylethyl)amino Hydroxy Lapatinib, CAS: 320337-48-2, stock: 5.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₁₉ClFN₃O₃.

Deschloro Lapatinib, CAS: 633370-23-7, stock: 3.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₇FN₄O₄S.

Desfluoro Lapatinib, CAS: /, stock: 7.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₇ClN₄O₄S.

Lapatinib, CAS: 231277-92-2, stock: 3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₆ClFN₄O₄S.

Lapatinib Ditosylate, CAS: 388082-77-7, stock: 1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₄₂ClFN₄O₁₀S₃.

Lapatinib Ditosylate Monohydrate, CAS: 388082-78-8, stock: 1.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₆ClFN₄O₄S  •  2(C₇H₈O₃S)  •  H₂O.

Lapatinib-13C2,15N, CAS: 1246819-07-7, stock: 8.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇¹³C₂H₂₆ClFN₃¹⁵NO₄S.

Lapatinib-13C2,15N Ditosylate, CAS: 1246819-08-8, stock: 8.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁¹³C₂H₄₂ClFN₃¹⁵NO₁₀S₃.

Lapatinib-d7 Dihydrochloride, CAS: /, stock: 1.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₁D₇Cl₃FN₄O₄S.

Lapatinib-d7 Ditosylate, CAS: 1009307-24-7, stock: 3.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₃₅D₇ClFN₄O₁₀S₃.

Lapatinib-d7 Sulfoxide Dihydrochloride, CAS: /, stock: 2.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₁₉D₇ClFN₄O₃S   • 2(HCl).

N-(Benzyloxycarbonyl)ethanolamine-13C2,15N, CAS: 1216647-82-3, stock: 3.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³C₂H₁₃¹⁵NO₃.

N-De[2-(methylsulfonyl)ethyl] Lapatinib, CAS: 697299-82-4, stock: 4.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₀ClFN₄O₂.

N-[3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl]-6-iodoquinazolin-4-amine Hydrochloride, CAS: 851684-46-3, stock: 8.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₅Cl₂FIN₃O.

N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[2-((1-Oxyl-2,2,5,5-tetramethylpyrroline-3-yl)carbamido)ethyl]amino]methyl]-2-furanyl]-4-quinazolinamine, CAS: /, stock: 2.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₃₇ClFN₆O₄.

N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[hydroxy[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-quinazolinamine, CAS: 1360431-86-2, stock: 6.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₆ClFN₄O₅S.

N-{5-[4-[[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-furan-2-ylmethyl} Lapatinib, CAS: /, stock: 5.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₅H₄₃Cl₂F₂N₇O₆S.

O-De(3-fluorobenzyl) Lapatinib Ditosylate Salt, CAS: /, stock: 9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₇ClN₄O₁₀S₃.

[2-(Methylsulfonyl)ethyl]carbamic Acid Benzyl Ester, CAS: 146698-94-4, stock: 3.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₄S.

[2-(Methylsulfonyl)ethyl]carbamic Acid-13C2,15N Benzyl Ester, CAS: 1215476-69-9, stock: 3.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉¹³C₂H₁₅¹⁵NO₄S.

(3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl Acetate, CAS: 112525-75-4, stock: 2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂F₃NO₃.

2,3-Lutidine, CAS: 583-61-9, stock: 6.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉N.

2-Chloromethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine, Hydrochloride, CAS: 127337-60-4, stock: 9.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀Cl₂F₃NO.

3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinemethanol, CAS: 103577-66-8, stock: 2.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀F₃NO₂.

4-Detrifluoroethoxy-4-methylsulfonyl Lansoprazole Sulfone, CAS: 1648891-88-6, stock: 6.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅N₃O₄S₂.

4-Hydroxy Lansoprazole Sulfide, CAS: 131926-95-9, stock: 8.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄F₃N₃O₂S.

4-Methyl-3-(2,2,2-trifluoroethoxy)-5H-pyrido[1’,2’:4,5][1,2,4]thiadiazino[2,3-a]benzimidazol-13-ium Chloride, CAS: 111712-17-5, stock: 6.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃ClF₃N₃OS.

5-Hydroxy Lansoprazole Potassium Salt, CAS: 1329613-29-7, stock: 8.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃F₃KN₃O₃S.

5-Hydroxy Lansoprazole Sulfide, CAS: 131926-96-0, stock: 3.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄F₃N₃O₂S.

7-(3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)-7H-benzo[4,5]imidazo[2,1-b]benzo[4,5]imidazo[2,1-d][1,3,5]thiadiazine, CAS: 1781244-56-1, stock: 8.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₆F₃N₅OS.

Des(trifluoroethyl) Lansoprazole Sulfide, CAS: 131926-97-1, stock: 1.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃N₃OS.

Desthia-oxa-lansoprazole, CAS: /, stock: 4.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄F₃N₃O₂.

N-[3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl] Benzimidazolone, CAS: /, stock: 10g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄F₃N₃O₂.

Complanatoside A, CAS: 146501-37-3, stock: 6.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₀O₁₈.

Desacetyllanatoside C, CAS: 17598-65-1, stock: 3.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₇₄O₁₉.

Digitoxin 3’’’-Acetate, CAS: 1111-39-3, stock: 10g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₆₆O₁₄.

α-Acetyl Digoxin, CAS: 5511-98-8, stock: 4.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₆₆O₁₅.

Lanatoside C, CAS: 17575-22-3, stock: 1.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₉H₇₆O₂₀.

((((R)-1-(6-((((5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)amino)methyl)amino)-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphonic Acid, CAS: 1962115-01-0, stock: 5.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄FN₈O₇PS.

((2R,5S)-5-(4-Amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolan-2-yl)methyl hydrogen ((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphonate, CAS: 1962114-95-9, stock: 7.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂FN₈O₆PS.

(1R,2S,5R)-Menthol-5R-hydroxy-[1,3]-oxathiolane-2R-carboxylate, CAS: 147126-62-3, stock: 8.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₄O₄S.

(1S,2R,4R)-1-Isopropyl-2,4-dimethylcyclohexyl-emtricitabine Uracil Carboxylate, CAS: 1422361-25-8, stock: 8.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₅FN₂O₅S.

(2R)-5-Methoxy-1,3-oxathiolane-2-methanol, CAS: 528567-32-0, stock: 8.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₃S.

(2R)-5-Methoxy-1,3-oxathiolane-2-methanol 2-Benzoate, CAS: 528567-33-1, stock: 6.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O₄S.

(2R,5R)-(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl 5-((3-Fluoro-6-hydroxypyridin-2-yl)amino)-1,3-oxathiolane-2-carboxylate, CAS: /, stock: 7.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₇FN₂O₄S.

(2R,5R)-(1R,2S,5R)-5-Methyl-2-(1-methylethyl)cyclohexyl  5-(4-Amino-2-oxo-1(2H)-pyrimidinyl)-1,3-Oxathiolane-2-carboxylate, CAS: 147126-80-5, stock: 4.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₇N₃O₄S.

(2R,5R)-L-Menthol-5-(acetyloxy)-1,3-oxathiolane-2-carboxylate, CAS: 147027-09-6, stock: 7.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₆O₅S.

(2R,5S)-5-(3,4-Dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-1,3-oxathiolane-2-carboxylic Acid  (1R,2S,5R)-5-Methyl-2-(1-methylethyl)cyclohexyl Ester, CAS: 389128-28-3, stock: 2.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆N₂O₅S.

(2R,5S)-5-(4-Amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl)-1,3-oxathiolane-2-carboxylic Acid (1R,2S,5R)-5-Methyl-2-(1-methylethyl)cyclohexyl Ester, CAS: 764659-72-5, stock: 7.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆FN₃O₄S.

(2R,5S)-L-Menthol-5-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1,3-oxathiolane-2-carboxylate, CAS: 147027-10-9, stock: 4.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₇N₃O₄S.

(2R,5S)-L-Menthol-5-(4-amino-2-oxo-1(2H)-pyrimidinyl-13C)-1,3-oxathiolane-2-carboxylate, CAS: /, stock: 2.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇¹³CH₂₇N₃O₄S.

(2R,5S)-L-Menthol-5-(4-amino-2-oxo-1(2H)-pyrimidinyl-15N2,13C)-1,3-oxathiolane-2-carboxylate, CAS: 1322623-13-1, stock: 9.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇¹³CH₂₇N¹⁵N₂O₄S.

(2R,5S)-L-Menthol-5-(acetyloxy)-1,3-oxathiolane-2-carboxylate, CAS: 147126-65-6, stock: 7.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₆O₅S.

(2R-cis)-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]-2,4(1H,3H)-pyrimidinedione, CAS: 145986-07-8, stock: 6.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₂O₄S.

(2R-cis)-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]-2,4(1H,3H)-pyrimidinedione-13C, 15N2, CAS: /, stock: 9.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇¹³CH₁₀¹⁵N₂O₄S.

(2S,5S)-(1R,2S,5R)-5-Methyl-2-(1-methylethyl)cyclohexyl  5-(4-Amino-2-oxo-1(2H)-pyrimidinyl)-1,3-Oxathiolane-2-carboxylate, CAS: /, stock: 4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₇N₃O₄S.

(2S,5S)-D-Menthol-5-(acetyloxy)-1,3-oxathiolane-2-carboxylate, CAS: 147126-68-9, stock: 6.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₆O₅S.

(2S-cis)-5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2,4(1H,3H)-pyrimidinedione, CAS: 145281-92-1, stock: 9.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉FN₂O₄S.

(S)-(5-Methoxy-1,3-oxathiolan-2-yl)methanol, CAS: /, stock: 5.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₃S.

2’-Epi-Lamivudine, CAS: 136846-20-3, stock: 7.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁N₃O₃S.

4’-Epi Lamivudine, CAS: 139757-68-9, stock: 1.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁N₃O₃S.

4’-Epi Lamivudine-15N2,13C, CAS: 1246815-07-5, stock: 8.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇¹³CH₁₁N¹⁵N₂O₃S.

5-Acetyloxy-1,3-oxathiolane-2-carboxylic Acid, CAS: 440105-45-3, stock: 6.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈O₅S.

5-Fluoro ent-Lamivudine Acid D-Menthol Ester, CAS: 764659-79-2, stock: 4.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆FN₃O₄S.

cis-1-[2-[(Acetyloxy)methyl]-1,3-oxathiolan-5-yl]-5-fluoro-2,4(1H,3H)-pyrimidinedione, CAS: 144963-94-0, stock: 5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁FN₂O₅S.

cis-L-Menthol-5-(acetyloxy)-1,3-oxathiolane-2-carboxylate, CAS: /, stock: 2.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₆O₅S.

D-Menthol-5S-hydroxy-[1,3]-oxathiolane-2S-carboxylate, CAS: /, stock: 2.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₄O₄S.

D-Menthyl 2,2-Dihydroxyacetate, CAS: 1402543-99-0, stock: 9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₄.

Emtricitabine, CAS: 143491-57-0, stock: 1.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀FN₃O₃S.

Emtricitabine (1.0 mg/mL in Methanol), CAS: 143491-57-0, stock: 4.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀FN₃O₃S.

Emtricitabine Diphosphate Triethylammonium Salt (~90%), CAS: /, stock: 2.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂FN₃O₉P₂S  • x(C ₈H₁₅N).

Emtricitabine N,N’-Methylene Dimer, CAS: /, stock: 2.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀F₂N₆O₆S₂.

Emtricitabine N,N’-Methylene t-Butyldimethylsilyl Dimer, CAS: /, stock: 4.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₈F₂N₆O₆S₂Si₂.

Emtricitabine-13C,15N2, CAS: 1217820-69-3, stock: 2.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇¹³CH₁₀FN¹⁵N₂O₃S.

Emtricitabine-d2,15N, CAS: /, stock: 3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈D₂FN₂¹⁵NO₃S.

ent-Emtricitabine, CAS: 137530-41-7, stock: 3.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀FN₃O₃S.

ent-Lamivudine, CAS: 134680-32-3, stock: 7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁N₃O₃S.

ent-Lamivudine Acid (1S,2R,5S)-5-Methyl-2-isopropylcyclohexyl Ester, CAS: 147126-74-7, stock: 6.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₇N₃O₄S.

ent-Lamivudine Triphosphate Triethylammonium Salt, CAS: /, stock: 3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄N₃O₁₂P₃S  . [C₆H₁₅N]ₓ.

Isomer-II of EMTRI-111, CAS: /, stock: 1.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆FN₃O₄S.

L-Menthol-5-(acetyloxy)-1,3-oxathiolane-2-carboxylate, CAS: 200396-20-9, stock: 6.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₆O₅S.

L-Menthyl 2,2-Dihydroxyacetate, CAS: 111969-64-3, stock: 8.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₄.

Lamivudine, CAS: 134678-17-4, stock: 4.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁N₃O₃S.

Lamivudine (R)-Sulfoxide, CAS: 160552-54-5, stock: 6.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁N₃O₄S.

Lamivudine Acid, CAS: 173829-09-9, stock: 1.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉N₃O₄S.

Lamivudine Acid-13C,15N2, CAS: 1391052-30-4, stock: 1.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇¹³CH₉N¹⁵N₂O₄S.

Lamivudine Dimer, CAS: /, stock: 4.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂N₆O₆S₂.

Lamivudine Diphosphate Ammonium Salt, CAS: 1187058-41-8, stock: 5.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₉N₅O₉P₂S.

Lamivudine Monophosphate Triethylammonium Salt, CAS: /, stock: 9.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₃O₆PS:[C₆H₁₅N]ₓ.

Lamivudine S-Oxide, CAS: 1235712-40-9, stock: 3.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁N₃O₄S.

Lamivudine Salicylate, CAS: 173522-96-8, stock: 2.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇N₃O₆S.

Lamivudine Triphosphate Triethylamine Salt (90%), CAS: /, stock: 8.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄N₃O₁₂P₃S  . [C₆H₁₅N]ₓ.

Lamivudine-13C,15N2 S-Oxide (Mixture of Diastereomers), CAS: /, stock: 3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇¹³CH₁₁N¹⁵N₂O₄S.

Lamivudine-13C1,d2, CAS: /, stock: 7.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇¹³CH₉D₂N₃O₃S.

Lamivudine-15N2,13C, CAS: 1217746-03-6, stock: 1.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇¹³CH₁₁N¹⁵N₂O₃S.

N-Acetyl O-Benzyl 5’-Epi Lamivudine, CAS: 131086-33-4, stock: 9.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇N₃O₅S.

N-Acetyl O-Benzyl Lamivudine, CAS: 1091585-30-6, stock: 10g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇N₃O₅S.

Phosphonic Acid Mono[[(2R,5S)-5-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1,3-oxathiolan-2-yl]methyl] Ester, CAS: 1128100-81-1, stock: 6.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₃O₅PS.

Phosphonic Acid Mono[[(2S,5R)-5-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1,3-oxathiolan-2-yl]methyl] Ester Triethylamine Salt, CAS: /, stock: 7.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₃O₅PS  . (C₆H₁₅N)ₓ.

rac Lamivudine Acid, CAS: 173602-25-0, stock: 3.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉N₃O₄S.

rac Lamivudine Acid-13C,15N2, CAS: 1391052-30-4, stock: 5.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇¹³CH₉N¹⁵N₂O₄S.

rac-cis-Lamivudine Acid (1R,2S,5R)-5-Methyl-2-isopropylcyclohexyl Ester, CAS: 1322623-20-0, stock: 9.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₇N₃O₄S.

trans-L-Menthol-5-(acetyloxy)-1,3-oxathiolane-2-carboxylate, CAS: /, stock: 4.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₆O₅S.

Uracil, CAS: 66-22-8, stock: 8.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄N₂O₂.

2,3-Dichlorobenzoyl Nitrile, CAS: 77668-42-9, stock: 7.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₃Cl₂NO.

2,3-Dichlorobenzoyl Nitrile-13C2,D3, CAS: /, stock: 6.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³C₂D₃Cl₂NO.

3,4-Dichlorobenzoyl Cyanide, CAS: 35022-44-7, stock: 4.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₃Cl₂NO.

3,5-Didesamino-3,5-dioxo Lamotrigine, CAS: 661463-79-2, stock: 3.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅Cl₂N₃O₂.

3-Dechloro-4-chloro Lamotrigine, CAS: 38943-76-9, stock: 9.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇Cl₂N₅.

5,5’-(Methylenebis(azanediyl))bis(6-(2,3-dichlorophenyl)-1,2,4-triazin-3-ol), CAS: /, stock: 5.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₂Cl₄N₈O₂.

5-Desamino 5-Oxo-2,5-dihydro Lamotrigine, CAS: 252186-78-0, stock: 8.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆Cl₂N₄O.

Lamotrigine 3,3-Dimer, CAS: 1797983-48-2, stock: 1.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₄Cl₄N₁₀.

Lamotrigine 5,5-Dimer, CAS: /, stock: 8.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₄Cl₄N₁₀.

Lamotrigine Isethionate, CAS: 113170-86-8, stock: 3.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃Cl₂N₅O₄S.

Lamotrigine N-Acetate, CAS: 77668-57-6, stock: 2.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉Cl₂N₅O.

Lamotrigine N-Acetyl N’-Benzyl, CAS: /, stock: 4.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅Cl₂N₅O.

Lamotrigine N2-Oxide, CAS: 136565-76-9, stock: 7.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇Cl₂N₅O.

Lamotrigine N’-Benzyl, CAS: /, stock: 2.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃Cl₂N₅.

Sipatrigine, CAS: 130800-90-7, stock: 1.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆Cl₃N₅.

(2Z)-4-[[4-(1-Piperidinylmethyl)-2-pyridinyl]oxy]-2-buten-1-amine Hydrocholride, CAS: /, stock: 3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₃N₃O.

(Z)-2-((Furan-2-ylmethyl)sulfinyl)-n-(4-((3-(piperidin-1-ylmethyl)pyridin-2-yl)oxy)but-2-en-1-yl)acetamide, CAS: 118288-08-7, stock: 6.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₉N₃O₄S.

rac trans-Lafutidine, CAS: 206449-94-7, stock: 3.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₉N₃O₄S.

1,2:5,6-Dianhydro-3,4-diacetylgalactitol, CAS: 57230-48-5, stock: 3.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄O₆.

2,3,4,6-Tetrakis-O-(phenylmethyl)-D-galactitol, CAS: 158570-84-4, stock: 7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₈O₆.

3-Deoxy-3-fluoro-D-galactitol, CAS: 864720-85-4, stock: 7.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃FO₅.

3-O-(β-galactopyranosyl)D-glucitol, CAS: /, stock: 3.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₄O₁₁.

D-(-)-N-Methylgalactamine, CAS: 7115-46-0, stock: 5.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₇NO₅.

Dulcitol Diepoxide, CAS: 23261-20-3, stock: 6.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀O₄.

Dulcitol-13C6 Diepoxide, CAS: /, stock: 3.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₁₀O₄.

Lactitol, CAS: 585-86-4, stock: 8.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₄O₁₁.

Lactitol-13C6, CAS: /, stock: 6.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³C₆H₂₄O₁₁.

N-[(3S,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-piperidinyl]-acetamide, CAS: 117894-14-1, stock: 9.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆N₂O₄.

N-[(3S,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-piperidinyl]-acetamide 6-Sulfate, CAS: /, stock: 9.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆N₂O₇S.

(Dimethylamino)ethyl Methanethiosulfonate Hydrochloride, CAS: 355803-75-7, stock: 7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₄ClNO₂S₂.

1,2,3,4,6-Penta-O-benzoyl-D-galactopyranoside, CAS: 3006-48-2, stock: 1.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₃₂O₁₁.

1,2,3,4,6-pentaacetate-α-D-Galactopyranose, CAS: 4163-59-1, stock: 2.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

1,2,3,4-Tetra-O-benzoyl-D-glucuronic Acid, CAS: /, stock: 3.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₂₆O₁₁.

1,2,3,4-Tetra-O-benzoyl-D-glucuronic-13C6 Acid, CAS: /, stock: 9.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈¹³C₆H₂₆O₁₁.

1,2,4,6-Tetra-O-acetyl-3-O-(2,3,4,6-tetra-O-acetyl-α-D-galactopyranosyl)-D-galactose, CAS: 123809-61-0, stock: 5.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₈O₁₉.

1,2:3,4-Di-O-isopropylidene-α-D-galactopyranose, CAS: 06/06/4064, stock: 6.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀O₆.

1,4-Bis(prop-2-ynoxy)benzene, CAS: 34596-36-6, stock: 8.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀O₂.

1,6-Anhydro-3,4-O-isopropylidene-2-tosyl-β-D-galactopyranose, CAS: 81028-98-0, stock: 3.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀O₇S.

1,6-Anhydro-beta-D-galactose-13C6, CAS: /, stock: 2.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₁₀O₅.

1,6-Anhydro-β-D-galactose, CAS: 644-76-8, stock: 5.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀O₅.

1-Deoxy-1-[(4S)-4-(2-methylpropyl)-2-oxo-1-pyrrolidinyl]-D-tagatopyranose     (α/β Mixture), CAS: /, stock: 2.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₅NO₆.

1-Thio-β-D-galactose Sodium Salt, CAS: 42891-22-5, stock: 8.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NaO₅S.

1-Triacontyl Methanethiosulfonate, CAS: 887407-63-8, stock: 5.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₆₄O₂S₂.

2,3,4,-Tri-O-benzyl-L-fucopyranose, CAS: 60431-34-7, stock: 3.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₀O₅.

2,3,4,6-Tetra-O-acetyl-N-(β-D-galactopyranosyl)-N’-[(2-methanethiosulfonyl)ethyl]urea, CAS: /, stock: 4.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₈N₂O₁₂S₂.

2,3,4,6-Tetra-O-benzoyl-D-galactopyranoside, CAS: 627466-84-6, stock: 7.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₂₈O₁₀.

2,3,4,6-Tetra-O-benzoyl-α-D-galactopyranoside Trichloroacetimidate, CAS: 138479-78-4, stock: 3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₂₈Cl₃NO₁₀.

2,3,4,6-Tetra-O-benzyl-D-galactopyranose, CAS: 53081-25-7, stock: 3.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₆O₆.

2,3,4,6-Tetra-O-trimethylsilyl-N-(β-D-galactopyranosyl)-N’-[(2-methanethiosulfonyl)ethyl]urea, CAS: /, stock: 6.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₅₂N₂O₈S₂Si₄.

2,3,4-Tri-O-benzoyl-L-fucopyranose, CAS: 485821-70-3, stock: 8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₄O₈.

2,4-Bis(acetylamino)-2,4,6-trideoxy-D-galactose, CAS: 68567-47-5, stock: 8.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈N₂O₅.

2-(Methylamino)ethyl Methanethiosulfonate Hydrobromide, CAS: 760998-74-1, stock: 1.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₂BrNO₂S₂.

2-(N,N-Dimethyl-N-propargylammonium)ethylmethanethiosulfonate Bromide 90%, CAS: /, stock: 7.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆BrNO₂S₂.

2-Acetamido-2-deoxy-3-O-(β-D-2-acetamido-2-deoxyglucopyranosyl)-D-galactopyranose, CAS: 95673-98-6, stock: 8.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₈N₂O₁₁.

2-Acetamido-2-deoxy-4-O-(β-D-2-acetamido-2-deoxyglucopyranosyl)-α-D-galactopyranose, CAS: /, stock: 1.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₈N₂O₁₁.

2-Acetamido-2-deoxy-6-O-(β-D-2-acetamido-2-deoxyglucopyranosyl)-α-D-galactopyranose, CAS: 452316-31-3, stock: 2.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₈N₂O₁₁.

2-Aminoethyl Methanethiosulfonate Hydrobromide, CAS: 16599-33-0, stock: 7.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₁₀BrNO₂S₂.

2-Aminoethyl Methanethiosulfonate Hydrochloride, CAS: 37597-96-9, stock: 9.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₁₀ClNO₂S₂.

2-Azido-2-deoxy-D-galactose, CAS: 68733-26-6, stock: 4.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁N₃O₅.

2-Bromoethyl Methanethiosulfonate, CAS: 26139-15-1, stock: 3.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₇BrO₂S₂.

2-Carboxyethyl Methanethiosulfonate, CAS: 92953-12-3, stock: 3.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈O₄S₂.

2-Chloroethyl Methanethiosulfonate, CAS: 13700-02-2, stock: 9.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₇ClO₂S₂.

2-Deoxy-2-fluoro-D-galactose, CAS: 51146-53-3, stock: 4.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁FO₅.

2-Deoxy-D-galactose, CAS: 1949-89-9, stock: 2.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₅.

2-Hydroxyethyl Methanethiosulfonate, CAS: 13700-08-8, stock: 1.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₈O₃S₂.

2-Hydroxyethyl-1,1,2,2-d4 Methanethiosulfonate, CAS: 1020719-50-9, stock: 9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃D₄H₄O₃S₂.

2-O-(α-D-Galactopyranosyl)-D-galactose, CAS: 93601-68-4, stock: 2.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₁₁.

2-O-(α-D-Glucopyranosyl)-D-galactose, CAS: 7368-73-2, stock: 6.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₁₁.

2-O-α-L-Fucopyranosyl-D-galactose, CAS: 24656-24-4, stock: 6.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₁₀.

2’-Fucosyllactose, CAS: 41263-94-9, stock: 4.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₂O₁₅.

3,4,6-Tri-O-acetyl-2-azido-2-deoxy-D-galactose, CAS: 83025-10-9, stock: 4.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇N₃O₈.

3-Aminopropyl Methanethiosulfonate Hydrobromide, CAS: 92953-13-4, stock: 5.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₂BrNO₂S₂.

3-Butynyl Methanethiosulfonate, CAS: 1170318-61-2, stock: 9.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈O₂S₂.

3-Deoxy-3-fluoro-1,2:5,6-bis-O-(1-methylethylidene)-α-D-galactofuranose, CAS: 22435-76-3, stock: 8.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉FO₅.

3-Deoxy-3-fluoro-D-galactose, CAS: 52904-86-6, stock: 4.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁FO₅.

3-Fucosyllactose, CAS: 41312-47-4, stock: 3.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₂O₁₅.

3-O-(α-D-Galactopyranosyl)-D-galactose, CAS: 13168-24-6, stock: 7.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₁₁.

3-O-(α-L-Fucopyranosyl)-D-galactose, CAS: 120375-11-3, stock: 7.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₁₀.

3-O-β-D-Galactopyranosyl-D-galactose, CAS: 5188-48-7, stock: 1.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₁₁.

3-O-β-Galactosyl Isomaltol, CAS: 82756-28-3, stock: 9.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₈.

3-Sialyl-D-galactose (α/β mixture), CAS: 38711-45-4, stock: 2.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₉NO₁₄.

4,6-O-Benzylidene-N-acetyl-D-galactosamine, CAS: 420118-03-2, stock: 2.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉NO₆.

4-Deoxy-4-fluoro-D-galactose, CAS: 40010-20-6, stock: 1.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁FO₅.

4-Hydroxybenzyl Methanethiosulfonate, CAS: 491868-12-3, stock: 8.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀O₃S₂.

4-Methylumbelliferyl β-D-Galactopyranoside-6-sulfate Sodium Salt, CAS: 206443-06-3, stock: 3.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇NaO₁₁S.

4-O-(α-D-Galactopyranosyl)-D-galactose, CAS: 13117-26-5, stock: 5.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₁₁.

4-O-(α-L-Fucopyranosyl)-D-galactose, CAS: 24667-50-3, stock: 5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₁₀.

4-O-β-Galactopyranosyl-D-mannopyranoside, CAS: 20869-27-6, stock: 5.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₁₁.

4-Pentynyl Methanethiosulfonate, CAS: 1076199-31-9, stock: 3.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀O₂S₂.

5-Thio-L-galactose(α /β-Mixture), CAS: /, stock: 9.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₅S.

6-Azido-6-deoxy-D-galactose, CAS: 66927-03-5, stock: 5.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁N₃O₅.

6-Hydroxyhexyl Methanethiosulfonate, CAS: 212261-98-8, stock: 3.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆O₃S₂.

6-O-α-Sialyl-2-acetamido-2-deoxy-D-galactopyranoside, CAS: 72506-87-7, stock: 7.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₂N₂O₁₄.

6-O-[2-(Acetylamino)-2-deoxy-β-D-glucopyranosyl]-D-galactose, CAS: 20212-77-5, stock: 5.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₅NO₁₁.

6-Sialyl-D-galactose Potassium Salt (α/β mixture), CAS: 82731-28-0, stock: 5.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₈KNO₁₄.

8-[4-(Aminoethyl Methanethiosulfonyl)phenyl] Bodipy, CAS: /, stock: 2.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆BF₂N₃O₂S₂.

Allyl Methanethiosulfonate, CAS: 14202-77-8, stock: 2.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈O₂S₂.

Benzyl Methanethiosulfonate, CAS: 7559-62-8, stock: 10g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀O₂S₂.

beta-D-Galactose Pentaacetate, CAS: 4163-60-4, stock: 9.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂O₁₁.

Bodipy Isothiocyanate, CAS: 1349031-04-4, stock: 9.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈BF₂N₃S.

Bromo 2,3,4,6-Tetra-O-acetyl-α-D-galactopyranoside(Stabilized with 2% (wt/wt) CaCO3), CAS: 3068-32-4, stock: 9.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉BrO₉.

Butyl Methanethiosulfonate, CAS: 52017-46-6, stock: 7.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂O₂S₂.

Carboxymethyl Lactose Sodium Salt, CAS: /, stock: 4.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₉Na₇O₂₅.

Carboxymethyl Methanethiosulfonate, CAS: 13700-15-7, stock: 9.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₆O₄S₂.

(R)-2-Amino-N-benzyl-3-methoxypropionamide, CAS: 196601-69-1, stock: 1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O₂.

Chondroitin Disaccharide di-4S Disodium Salt, CAS: 136144-56-4, stock: 5.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NNa₂O₁₄S.

(R)-tert-Butyl 1-(Benzylamino)-3-methoxy-1-oxopropan-2-ylcarbamate, CAS: 880468-89-3, stock: 3.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄N₂O₄.

(S)-((1-Amino-3-methoxy-1-oxopropan-2-yl)amino)actinium, CAS: /, stock: 4.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉AcN₂O₂.

1,3-Dibenzylurea, CAS: 1466-67-7, stock: 8.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆N₂O.

2-(Acetylamino)-N-(phenylmethyl)propanamide, CAS: 93782-09-3, stock: 3.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂O₂.

D-Dulcitol-1,1’-d2, CAS: /, stock: 2.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂D₂O₆.

D-Dulcitol-1-13C, CAS: /, stock: 1.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₄O₆.

Boc-D-serine, CAS: 6368-20-3, stock: 3.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₅.

D-Dulcitol-2-13C, CAS: /, stock: 1.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₄O₆.

Boc-D-serine Benzylamide, CAS: 1253790-58-7, stock: 2.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂N₂O₄.

D-Dulcitol-2-d, CAS: /, stock: 9.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃DO₆.

Desacetyl Desmethyl Lacosamide, CAS: 175481-39-7, stock: 3.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O₂.

Desmethyl Lacosamide, CAS: 175481-38-6, stock: 2.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂O₃.

D-Dulcitol-3-13C, CAS: /, stock: 5.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₄O₆.

D-Dulcitol-6-13C, CAS: /, stock: 2.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₄O₆.

Epi-Lacosamide, CAS: 175481-37-5, stock: 5.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O₃.

Epi-Lacosamide-d3, CAS: 1795786-76-3, stock: 8.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅D₃N₂O₃.

D-Fucose, CAS: 3615-37-0, stock: 9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₅.

D-Galactosamine, Hydrochloride, CAS: 1772-03-8, stock: 1.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄ClNO₅.

D-Galactosamine-1-13C Hydrochloride, CAS: 478518-54-6, stock: 9.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₄ClNO₅.

D-Galactosamine-15N Hydrochloride, CAS: 478518-55-7, stock: 8.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄Cl¹⁵NO₅.

Lacosamide impurity H: N-Acetyl-O-methyl-D-seryl-O-methyl-N-(phenylmethyl)-D-serinamide, CAS: /, stock: 5.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₅N₃O₅.

Lacosamide impurity I: (R)-N-benzyl-2-(3-benzylureido)-3-methoxypropanamide, CAS: /, stock: 8.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃N₃O₃.

D-Galactose Pentaacetate, CAS: 25878-60-8, stock: 5.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂O₁₁.

Lacosamide-d6, CAS: /, stock: 8.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂D₆N₂O₃.

(2E)​-4-​(4-​hydroxyphenyl)​-2-​butanone Oxime, CAS: /, stock: 5.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₂.

Methyl 2-chloro-3-methoxypropionate, CAS: 36997-03-2, stock: 8.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉ClO₃.

N-Benzyl 2-(benzylamino)-3-methoxypropionamide, CAS: 1379592-20-7, stock: 7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₂N₂O₂.

(αR)-α-Methyl-N-(phenylmethyl)benzenepropanamine, CAS: 75659-06-2, stock: 3.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁N.

(αR)-α-Methyl-N-(phenylmethyl)benzenepropanamine-d3, CAS: /, stock: 7.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈D₃N.

N-Benzyloxycarbonyl-D-serine, CAS: 6081-61-4, stock: 6.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₅.

3-Bromo Labetalol, CAS: /, stock: 9.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃BrN₂O₃.

N-Descarboxymethyl-N-carboxyethyl Lacosamide (Impurity), CAS: 1318777-56-8, stock: 5.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀N₂O₃.

N-Descarboxymethyl-N-carboxyethyl Lacosamide-D3 (Impurity), CAS: /, stock: 3.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇D₃N₂O₃.

3-Bromo Labetalol Hydrochloride Salt, CAS: /, stock: 7.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃BrN₂O₃ •HCl.

N-Methyl Lacosamide, CAS: /, stock: 2.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀N₂O₃.

N-Methyl Lacosamide, CAS: /, stock: 2.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀N₂O₃.

5,6,7,8-Tetrahydronaphtho[2,3-d]-1,3-dioxol-6-amine, CAS: 101625-35-8, stock: 2.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₂.

N-Methyl Lacosamide-d3, CAS: /, stock: 2.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇D₃N₂O₃.

O-Acetyl Lacosamide, CAS: 1318777-54-6, stock: 4.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈N₂O₄.

O-Desmethyl N-Methyl Lacosamide, CAS: /, stock: 1.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O₃.

D-Galactose-6-O-sulphate Sodium Salt, CAS: 125455-62-1, stock: 1.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁O₉SNa.

D-Lactose, CAS: 5965-66-2, stock: 9.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₁₁.

N-[(1S)-1-(Hydroxymethyl)-3-phenylpropyl]carbamic Acid-d2 Phenyl Methyl Ester, CAS: /, stock: 8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉D₂NO₃.

rac 4-(3-Aminobutyl)phenol, CAS: 52846-75-0, stock: 5.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅NO.

rac 4-(3-Aminobutyl)phenol-d6, CAS: 1189890-45-6, stock: 8.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉D₆NO.

D-Penicillamine O-Lactose Adduct Hydrochloride (>70%), CAS: /, stock: 2.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₁NO₁₂S   •  HCl.

Dansylamidoethyl Methanethiosulfonate, CAS: 355115-41-2, stock: 3.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀N₂O₄S₃.

(S)​-​1-​(Pyridin-​2-​yl)​ethanol, CAS: 59042-90-9, stock: 4.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉NO.

Decyl Methanethiosulfonate, CAS: 190852-38-1, stock: 4.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₄O₂S₂.

Dodecyl Methanethiosulfonate, CAS: 355803-77-9, stock: 7.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₈O₂S₂.

1-[2-Nitro-3-(phenylmethoxy)phenyl]ethanone, CAS: 224044-60-4, stock: 3.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃NO₄.

2-(Acetylamino)-2-[2-[2-nitro-3-(phenylmethoxy)phenyl]-2-oxoethyl]propanedioic Acid 1,3-Diethyl Ester, CAS: 224044-62-6, stock: 9.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆N₂O₉.

Dulcitol, CAS: 608-66-2, stock: 4.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄O₆.

Dulcitol-13C6, CAS: /, stock: 4.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₁₄O₆.

2-(Bromomethyl)-1-chloro-3-nitrobenzene, CAS: 56433-01-3, stock: 9.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅BrClNO₂.

2-Acetamido-2-(2-(2-amino-3-hydroxyphenyl)-2-oxoethyl)malonic Acid Diethyl Ester, CAS: /, stock: 1.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂N₂O₇.

epi-Lactose, CAS: 50468-56-9, stock: 7.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₁₁.

epi-Lactose-1-13C, CAS: /, stock: 7.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁¹³CH₂₁O₁₁.

2-Amino-3-hydroxybenzoate Potassium Salt, CAS: /, stock: 1.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆KNO₃.

Ethylmethanethiosulfonate-2-carboxy[(5’-amino-1’-carboxypentyl)iminodiacetic Acid] Amide Tri-tert-butyl ester, CAS: /, stock: 3.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₈N₂O₉S₂.

Ethylmethanethiosulfonate-2-carboxy[(5’-amino-1’-carboxypentyl)iminodiacetic Acid] Amide, Trifluoroacetic Acid Salt, CAS: /, stock: 7.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₅F₃N₂O₁₁S₂.

2-Bromo-1-[2-nitro-3-(phenylmethoxy)phenyl]ethanone, CAS: 224044-61-5, stock: 6.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂BrNO₄.

3,4-Dimethoxy-N-[4-(3-nitrophenyl)-5-(1-piperidinylmethyl)-2-thiazolyl]-benzenesulfonamide, CAS: 1008119-83-2, stock: 8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆N₄O₆S₂.

3-Hydroxy-DL-kynurenine, CAS: 484-78-6, stock: 6.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O₄.

Hexadecyl Methanethiosulfonate, CAS: 7559-47-9, stock: 6.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₆O₂S₂.

Hexatriacontyl Methanethiosulfonate, CAS: 887406-39-5, stock: 9.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₇₆O₂S₂.

anti- Kynurenine 3 monooxygenase antibody, CAS: /, stock: 4.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human Galactose-Deficient IgA1(Galactose-Deficient IgA1) ELISA Kit (96T), CAS: /, stock: 1.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

anti- Kynurenine 3 monooxygenase antibody, CAS: /, stock: 6.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Bovine AADAT (Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial) ELISA Kit (96T), CAS: /, stock: 2.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

α,β-Duloxetine Lactose Adduct, CAS: /, stock: 1.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₉NO₁₁S.

Human AADAT (Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial) ELISA Kit (96T), CAS: /, stock: 4.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

α-D-Galactose 1-Phosphate Dipotassium Salt, CAS: 19046-60-7, stock: 3.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁K₂O₉P.

α-D-Galactose-1,2-13C2 1-Phosphate Dipotassium Salt, CAS: /, stock: 9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₂H₁₁K₂O₉P.

Human AADAT(Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial) ELISA Kit (96T), CAS: /, stock: 1.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human CCBL1(Kynurenine--oxoglutarate transaminase 1) ELISA Kit (96T), CAS: /, stock: 8.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

α-D-Galactose-1-13C 1-Phosphate Dipotassium Salt, CAS: /, stock: 4.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₁K₂O₉P.

α-D-Galactose-13C6 1-Phosphate Dipotassium Salt, CAS: /, stock: 4.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₁₁K₂O₉P.

3-Benzoyl-4-(2-(2-nitrophenyl)-2-oxoethyl)-2-phenyloxazolidin-5-one, CAS: /, stock: 7.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₈N₂O₆.

Human KMO {ECO:0000255|HAMAP-Rule:MF_03018, (Kynurenine 3-monooxygenase) ELISA Kit (96T), CAS: /, stock: 5.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human KMO(Kynurenine 3-monooxygenase) ELISA Kit (96T), CAS: /, stock: 1.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

α-D-Galactose-2-13C 1-Phosphate Dipotassium Salt, CAS: /, stock: 4.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₁K₂O₉P.

Human KYN(Kynurenine) ELISA Kit (96T), CAS: /, stock: 4.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

KYN(Kynurenine) ELISA Kit (96T), CAS: /, stock: 8.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

β-D-Galactopyranosylamine, CAS: 6318-23-6, stock: 5.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₅.

β-L-Fucopyranosylamine, CAS: 103419-79-0, stock: 3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₄.

κ-​Carrageenan, CAS: 11114-20-8, stock: 3.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  (C₁₂H₁₇O₁₂S)n.

7-Chlorokynurenic acid, CAS: 18000-24-3, stock: 4.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆ClNO₃.

Monkey KYN(Kynurenine) ELISA Kit (96T), CAS: /, stock: 6.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Aadat (Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial) ELISA Kit (96T), CAS: /, stock: 3.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

L-Fucose, CAS: 2438-80-4, stock: 7.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₅.

L-Fucose-1-13C, CAS: 83379-38-8, stock: 2.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₂O₅.

7-Chlorokynurenic Acid Sodium Salt, CAS: 1263094-00-3, stock: 1.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₅ClNNaO₃.

Kukoamine B, CAS: 164991-67-7, stock: 2.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₂N₄O₆.

Mouse Kmo (Kynurenine 3-monooxygenase) ELISA Kit (96T), CAS: /, stock: 4.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse KYN(Kynurenine) ELISA Kit (96T), CAS: /, stock: 4.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

L-Fucose-13C6, CAS: 478518-52-4, stock: 4.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₁₂O₅.

L-Fucose-2-13C, CAS: 83379-37-7, stock: 3.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₂O₅.

Human Kynurenic acid(Kynurenic acid) ELISA Kit (96T), CAS: /, stock: 2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

N-Acetyl-1-(2’-Amino-2,4’-dichlorophenyl)ethan-1-one, CAS: 68095-20-5, stock: 4.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉Cl₂NO₂.

L-Fucose-3-13C, CAS: 478518-50-2, stock: 9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₂O₅.

L-Fucose-6-13C, CAS: 478518-51-3, stock: 2.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₂O₅.

Kynurenic Acid, CAS: 492-27-3, stock: 9.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇NO₃.

Kynurenic Acid Hydrate, CAS: 345909-35-5, stock: 1.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇NO₃ • x(H ₂O).

Kynurenic Acid Sodium Salt, CAS: 03/02/2439, stock: 6.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆NNaO₃.

Kynurenic Acid-d5, CAS: 350820-13-2, stock: 7.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂D₅NO₃.

L-Tryptophan-d5 (Major), CAS: /, stock: 4.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₇D₅N₂O₂.

Lactose 6’-Sulfate, CAS: 1015758-24-3, stock: 2.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₁₄S.

rac α-Methyl Kynurenine, CAS: 1798018-43-5, stock: 1.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₂O₃.

Rat Aadat (Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial) ELISA Kit (96T), CAS: /, stock: 4.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Aadat(Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial) ELISA Kit (96T), CAS: /, stock: 3.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Lactose Monohydrate, CAS: 10039-26-6, stock: 3.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₄O₁₂.

Xanthurenic Acid, CAS: 59-00-7, stock: 7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇NO₄.

Rat Kmo (Kynurenine 3-monooxygenase) ELISA Kit (96T), CAS: /, stock: 1.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Kmo( Kynurenine 3-monooxygenase) ELISA Kit (96T), CAS: /, stock: 8.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Lactose Octaacetate, CAS: 6291-42-5, stock: 1.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₈O₁₉.

Xanthurenic Acid-d4, CAS: 1329611-28-0, stock: 2.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₃D₄NO₄.

Ro 61-8048, CAS: 199666-03-0, stock: 8.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅N₃O₆S₂.

UPF 648, CAS: 213400-34-1, stock: 8.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈Cl₂O₃.

Lactosyl Maprotiline, CAS: /, stock: 4.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₃NO₁₀.

Lactosyl Maprotiline-d5, CAS: /, stock: 2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₈D₅NO₁₀.

Levothyroxine Lactose Adduct, CAS: /, stock: 6.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₁I₄NO₁₄.

Memantine-Galactose Adduct, CAS: /, stock: 5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₁NO₅.

Methyl β-D-Galactopyranoside, CAS: 1824-94-8, stock: 2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄O₆.

Mouse Galt (Galactose-1-phosphate uridylyltransferase) ELISA Kit (96T), CAS: /, stock: 9.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

MTSEA-DBCO, CAS: /, stock: 3.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄N₂O₃S₂.

N-Acetyl-D-galactosamine, CAS: 1811-31-0, stock: 3.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₆.

N-Acetyl-D-galactosamine-13C, CAS: 478518-53-5, stock: 2.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇¹³CH₁₅NO₆.

N-Acetyl-L-fucosamine, CAS: /, stock: 1.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₅.

N-β-D-Galactopyranosyl-N’-[(2-methanethiosulfonyl)ethyl]urea, CAS: 550325-50-3, stock: 8.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₀N₂O₈S₂.

Neoagarooctaose, CAS: 25023-94-3, stock: 2.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₇₄O₃₇.

Neopentyl Methanthiosulfonate, CAS: 190852-37-0, stock: 9.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄O₂S₂.

Octyl Methanethiosulfonate, CAS: 7559-45-7, stock: 3.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₀O₂S₂.

PD 224378, CAS: 466678-44-4, stock: 5.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₅NO₁₁.

PD 312236, PD 312237 Mixture, CAS: /, stock: 5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₅NO₁₁.

Pentyl Methanethiosulfonate, CAS: 4212-64-0, stock: 4.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄O₂S₂.

Phenylaminomethyl D-Lactose + 1-​Deoxy-​4-​O-​β-​D-​galactopyranosyl-​1-​[(4-phenyl)​amino]​-β-​D-​fructofuranose (2:1), CAS: /, stock: 1.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₇NO₁₀ +  C₁₈H₂₇NO₁₀.

Phenylmethanethiosulfonate, CAS: 1197-26-8, stock: 1.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈O₂S₂.

Pregabalin Lactam Conjugate with Galactose, CAS: /, stock: 3.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₅NO₁₁.

Propafenone Lactose Adduct, CAS: /, stock: 6.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₄₇NO₁₃.

Propargyl Methanethiosulfonate, CAS: 7651-65-2, stock: 6.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆O₂S₂.

Ranolazine-β-D-lactoside, CAS: /, stock: 7.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₅₃N₃O₁₄.

Rat Galt (Galactose-1-phosphate uridylyltransferase) ELISA Kit (96T), CAS: /, stock: 3.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

S-(3-Chloro-3-oxopropyl) Methanesulfonothioate, CAS: /, stock: 4.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇ClO₃S₂.

Saxagliptin Lactose Adduct, CAS: /, stock: 5.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₃N₃O₁₂.

Sodium (2-Sulfonatoethyl)methanethiosulfonate, CAS: 184644-83-5, stock: 7.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₇NaO₅S₃.

Sodium (3-Sulfonatopropyl) Methanethiosulfonate, CAS: 385398-83-4, stock: 9.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉NaO₅S₃.

Sodium (4-Sulfonatobutyl)methanethiosulfonate, CAS: 385398-78-7, stock: 4.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁NaO₅S₃.

Sodium (5-Sulfonatopentyl) Methanethiosulfonate, CAS: 385398-80-1, stock: 3.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NaO₅S₃.

tert-Butylethyl Methanethiosulfonate, CAS: 492442-75-8, stock: 8.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆O₂S₂.

2-​(Chloromethyl)​-​5-​hydroxy-4H-​pyran-​4-​one, CAS: 7559-81-1, stock: 6.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅ClO₃.

UDP-D-galactose disodium salt, CAS: 137868-52-1, stock: 6.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂N₂Na₂O₁₇P₂.

Uridine Diphosphate-α-D-[UL-13C6]galactose Disodium Salt, CAS: /, stock: 1.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉¹³C₆H₂₂N₂Na₂O₁₇P₂.

3-Hydroxy-2,6-bis(hydroxymethyl)-4-pyrone, CAS: 2029-49-4, stock: 8.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈O₅.

Uridine-5’-diphosphate-4-deoxy-4-fluoro-α-D-galactose, CAS: 190852-32-5, stock: 8.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₃FN₂O₁₆P₂.

Vortioxetine Lactose Adduct, CAS: /, stock: 7.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₂N₂O₁₀S.

Allo Maltol, CAS: 644-46-2, stock: 7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆O₃.

Kojic Acid, CAS: 501-30-4, stock: 5.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆O₄.

N-(2,4-Dichlorophenyl)-1,4-dihydro-5-methoxy-4-oxo-2-Pyridinecarboxamide, CAS: 1246060-75-2, stock: 7.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀Cl₂N₂O₃.

[2-(Aminocarbonyl)ethyl] Methanethiosulfonate, CAS: 351422-28-1, stock: 7.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉NO₃S₂.

[2-(Trimethylammonium)ethyl] Methanethiosulfonate Chloride, CAS: /, stock: 7.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₆ClNO₂S₂.

[2-(Trimethylammonium)ethyl]methanethiosulfonate Bromide, CAS: 91774-25-3, stock: 9.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₆BrNO₂S₂.

[4-(Trimethylammonium)benzyl] Methanethiosulfonate Bromide, CAS: /, stock: 9.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₈BrNO₂S₂.

[4-(Trimethylammonium)butyl] Methanethiosulfonate Bromide (Technical Grade, >80%), CAS: /, stock: 5.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₂₀BrNO₂S₂.

[5-(Trimethylammonium)pentyl] Methanethiosulfonate Bromide, CAS: /, stock: 8.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₂BrNO₂S₂.

[6-(Trimethylammonium)hexyl] Methanethiosulfonate Bromide, CAS: 1041424-77-4, stock: 9.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₄BrNO₂S₂.

[7-(Trimethylammonium)hepyl] Methanethiosulfonate Bromide, CAS: 1159174-26-1, stock: 8.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₆BrN₂O₂S₂.

2-Deoxy-1,3:4,5-di-O-isopropylidene-2-oxamoylamino-D-mannitol, CAS: 128741-75-3, stock: 5.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₄N₂O₇.

Kifunensine, CAS: 109944-15-2, stock: 2.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₂O₆.

Kifunensine Diacetonide, CAS: 134234-43-8, stock: 5.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀N₂O₆.

Kifunensine-13C2 ,15N, CAS: /, stock: 4.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³C₂H₁₂N¹⁵NO₆.

10-Deoxo-9,10-dehydro Ketotifen, CAS: 4673-38-5, stock: 9.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉NS.

4-(1-Methyl-4-piperidinyl)-4H-benzo[4,5]cyclohepta[1,2-b]thiophene-4-ol, CAS: 4506-57-4, stock: 9.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁NOS.

4-Hydroxy Ketotifen, CAS: 126939-27-3, stock: 1.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁NO₂S.

4-Hydroxy-9,10-dehydro-10-methoxy Ketotifen, CAS: 59743-88-3, stock: 7.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃NO₂S.

4-Oxo Ketotifen, CAS: 1346603-71-1, stock: 8.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉NOS.

4H-Benzo[4,5]cyclohepta[1,2-b]thiophen-4-one, CAS: 4506-53-0, stock: 1.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈OS.

9,10-Dihydro-4H-benzo[4,5]cyclohepta[1,2-b]thiophen-4-one (90%), CAS: 1622-55-5, stock: 4.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀OS.

9,10-Dioxo Ketotifen, CAS: 43076-16-0, stock: 4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇NO₂S.

9-Oxo Ketotifen, CAS: 34580-09-1, stock: 6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉NOS.

Ketotifen, CAS: 34580-13-7, stock: 3.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉NOS.

Ketotifen Fumarate, CAS: 34580-14-8, stock: 8.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₃NO₅S.

Ketotifen N-Oxide, CAS: 88456-70-6, stock: 1.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉NO₂S.

Ketotifen N-Oxide Hydrochloride, CAS: 59743-91-8, stock: 7.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉NO₂S  • HCl.

Ketotifen-d3 Fumarate, CAS: 1795138-23-6, stock: 7.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₀D₃NO₅S.

(R)-Ketorolac, CAS: 66635-93-6, stock: 4.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃NO₃.

(R)-Ketorolac Glucuronide, CAS: 233666-91-6, stock: 2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁NO₉.

(R)-Ketorolac Glucuronide Benzyl Ester, CAS: /, stock: 2.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₇NO₉.

(S)-Ketorolac, CAS: 66635-92-5, stock: 1.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃NO₃.

(S)-Ketorolac Glucuronide, CAS: 233666-90-5, stock: 7.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁NO₉.

(S)-Ketorolac Glucuronide Benzyl Ester, CAS: /, stock: 6.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₇NO₉.

1-Keto Ketorolac, CAS: 113502-52-6, stock: 7.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁NO₂.

1-Keto Ketorolac-d5, CAS: /, stock: 1.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₆D₅NO₂.

1-Methoxy Ketorolac Methyl Ester, CAS: /, stock: 5.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇NO₄.

2-Bromo-4-chloro-N-methyl-N-phenyl-butanamide, CAS: 328936-18-1, stock: 6.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃BrClNO.

3-Benzoyl-1-tosylpyrrole, CAS: 139261-90-8, stock: 5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅NO₃S.

4-Benzoyl-1H-pyrrole-2-acetic Acid Ethyl Ester, CAS: 141054-42-4, stock: 7.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅NO₃.

4-Chloro-N-Methyl-N-phenyl-2-(2-pyrrolyl)butanamide, CAS: 328936-20-5, stock: 4.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇ClN₂O.

4-Hydroxy Ketorolac, CAS: 111930-01-9, stock: 7.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃NO₄.

4-Hydroxy Ketorolac-d4, CAS: 1346605-32-0, stock: 5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₉D₄NO₄.

5-Benzoyl-1H-pyrrole-2-acetic Acid Ethyl Ester, CAS: 141054-41-3, stock: 8.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅NO₃.

Descarboxy 1-Hydroxy Ketorolac, CAS: 154476-25-2, stock: 5.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃NO₂.

Ethyl 2-(1H-Pyrrol-2-yl)acetate, CAS: 4778-25-0, stock: 7.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁NO₂.

Ethyl 2-(4-Benzoyl-1-(2-chloroethyl)-1H-pyrrol-2-yl)acetate, CAS: /, stock: 4.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈ClNO₃.

Ethyl 2-(4-Benzoyl-1-(2-iodoethyl)-1H-pyrrol-2-yl)acetate, CAS: /, stock: 3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈INO₃.

Ketorolac Methyl Ester, CAS: 80965-09-9, stock: 3.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅NO₃.

Ketorolac-d5, CAS: 1215767-66-0, stock: 5.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₈D₅NO₃.

N-Methyl-N-phenyl-2,3-dihydro-1H-pyrrolizine-1-carboxamide, CAS: 328936-22-7, stock: 2.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆N₂O.

Phenyl(1H-pyrrol-3-yl)methanone, CAS: 7126-41-2, stock: 1.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉NO.

rac 1-Hydroxy Ketorolac Methyl Ester, CAS: 1391051-90-3, stock: 8.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅NO₄.

rac 1-Hydroxy Ketorolac Methyl Ester-d3, CAS: 1794752-29-6, stock: 9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂D₃NO₄.

rac 1-Methoxy Ketorolac, CAS: 1391053-45-4, stock: 5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅NO₄.

rac Ketorolac, CAS: 74103-06-3, stock: 2.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃NO₃.

rac Ketorolac 6-Benzoyl Isomer, CAS: 1026936-07-1, stock: 2.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃NO₃.

rac Ketorolac 7-Benzoyl Isomer, CAS: 1391052-68-8, stock: 7.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃NO₃.

rac Ketorolac 7-Benzoyl Isomer-d5, CAS: 1795013-70-5, stock: 2.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₈D₅NO₃.

rac Ketorolac Acyl-β-D-glucuronide(Mixture of Diastereomers), CAS: /, stock: 8.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁NO₉.

rac Ketorolac Ethyl Ester 6-Benzoyl Isomer, CAS: /, stock: 4.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇NO₃.

rac Ketorolac Tromethamine Salt, CAS: 74103-07-4, stock: 7.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄N₂O₆.

rac Ketorolac-d4, CAS: 1216451-53-4, stock: 9.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₉D₄NO₃.

rac Ketoroloc Tris Amide Impurity, CAS: 167105-80-8, stock: 4.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂N₂O₅.

rac Ketoroloc Tris Amide Impurity-d4, CAS: 1794829-23-4, stock: 1.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈D₄N₂O₅.

(2-(3-Bromophenyl)propoxy)triisopropylsilane, CAS: /, stock: 4.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₁BrOSi.